WO2004058214A1 - Article d'hygiene personnelle du type tissu - Google Patents
Article d'hygiene personnelle du type tissu Download PDFInfo
- Publication number
- WO2004058214A1 WO2004058214A1 PCT/US2003/040232 US0340232W WO2004058214A1 WO 2004058214 A1 WO2004058214 A1 WO 2004058214A1 US 0340232 W US0340232 W US 0340232W WO 2004058214 A1 WO2004058214 A1 WO 2004058214A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- web
- fibers
- article
- skin
- personal care
- Prior art date
Links
- 239000000203 mixture Substances 0.000 claims abstract description 236
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 60
- 210000004209 hair Anatomy 0.000 claims abstract description 49
- 238000009736 wetting Methods 0.000 claims abstract description 4
- 239000000835 fiber Substances 0.000 claims description 430
- 239000004094 surface-active agent Substances 0.000 claims description 128
- 239000002243 precursor Substances 0.000 claims description 103
- -1 polyolefms Polymers 0.000 claims description 75
- 239000003795 chemical substances by application Substances 0.000 claims description 72
- 238000011282 treatment Methods 0.000 claims description 69
- 238000000034 method Methods 0.000 claims description 56
- 239000012530 fluid Substances 0.000 claims description 54
- 230000003750 conditioning effect Effects 0.000 claims description 52
- 229920000642 polymer Polymers 0.000 claims description 40
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 22
- 229920000728 polyester Polymers 0.000 claims description 19
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 15
- 239000000194 fatty acid Substances 0.000 claims description 15
- 229930195729 fatty acid Natural products 0.000 claims description 15
- 235000019271 petrolatum Nutrition 0.000 claims description 15
- 239000000516 sunscreening agent Substances 0.000 claims description 15
- 239000004264 Petrolatum Substances 0.000 claims description 14
- 229940066842 petrolatum Drugs 0.000 claims description 14
- 239000000344 soap Substances 0.000 claims description 14
- 150000004665 fatty acids Chemical class 0.000 claims description 13
- 230000000475 sunscreen effect Effects 0.000 claims description 13
- 239000002537 cosmetic Substances 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 12
- 235000011187 glycerol Nutrition 0.000 claims description 11
- 229930195733 hydrocarbon Natural products 0.000 claims description 11
- 150000002430 hydrocarbons Chemical class 0.000 claims description 11
- 239000001993 wax Substances 0.000 claims description 10
- 239000002738 chelating agent Substances 0.000 claims description 8
- 230000001747 exhibiting effect Effects 0.000 claims description 8
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 8
- 229920002678 cellulose Polymers 0.000 claims description 7
- 229920001296 polysiloxane Polymers 0.000 claims description 7
- 229940088594 vitamin Drugs 0.000 claims description 7
- 229930003231 vitamin Natural products 0.000 claims description 7
- 235000013343 vitamin Nutrition 0.000 claims description 7
- 239000011782 vitamin Substances 0.000 claims description 7
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- 229920000297 Rayon Polymers 0.000 claims description 6
- 206010040844 Skin exfoliation Diseases 0.000 claims description 6
- 230000001153 anti-wrinkle effect Effects 0.000 claims description 6
- 239000007854 depigmenting agent Substances 0.000 claims description 6
- 239000002964 rayon Substances 0.000 claims description 6
- 208000035484 Cellulite Diseases 0.000 claims description 5
- 239000004166 Lanolin Substances 0.000 claims description 5
- 206010049752 Peau d'orange Diseases 0.000 claims description 5
- 239000002202 Polyethylene glycol Substances 0.000 claims description 5
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 5
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 5
- 239000003963 antioxidant agent Substances 0.000 claims description 5
- 235000006708 antioxidants Nutrition 0.000 claims description 5
- 239000001913 cellulose Substances 0.000 claims description 5
- 230000035876 healing Effects 0.000 claims description 5
- 235000019388 lanolin Nutrition 0.000 claims description 5
- 229940039717 lanolin Drugs 0.000 claims description 5
- 229920001223 polyethylene glycol Polymers 0.000 claims description 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 5
- 229920002994 synthetic fiber Polymers 0.000 claims description 5
- 239000010457 zeolite Substances 0.000 claims description 5
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 claims description 4
- 206010003694 Atrophy Diseases 0.000 claims description 4
- 229910019142 PO4 Inorganic materials 0.000 claims description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 150000001412 amines Chemical class 0.000 claims description 4
- 230000003255 anti-acne Effects 0.000 claims description 4
- 230000000843 anti-fungal effect Effects 0.000 claims description 4
- 230000000845 anti-microbial effect Effects 0.000 claims description 4
- 230000035618 desquamation Effects 0.000 claims description 4
- 229940031766 diethanolamine cetyl phosphate Drugs 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 229940075529 glyceryl stearate Drugs 0.000 claims description 4
- GKKMCECQQIKAHA-UHFFFAOYSA-N hexadecyl dihydrogen phosphate;2-(2-hydroxyethylamino)ethanol Chemical compound OCCNCCO.CCCCCCCCCCCCCCCCOP(O)(O)=O GKKMCECQQIKAHA-UHFFFAOYSA-N 0.000 claims description 4
- 239000012510 hollow fiber Substances 0.000 claims description 4
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical class OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 claims description 4
- 230000003020 moisturizing effect Effects 0.000 claims description 4
- 229940100460 peg-100 stearate Drugs 0.000 claims description 4
- 235000021317 phosphate Nutrition 0.000 claims description 4
- 229920002545 silicone oil Polymers 0.000 claims description 4
- 229940035044 sorbitan monolaurate Drugs 0.000 claims description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 4
- 239000008158 vegetable oil Substances 0.000 claims description 4
- 235000010469 Glycine max Nutrition 0.000 claims description 3
- 150000001298 alcohols Chemical class 0.000 claims description 3
- 239000002280 amphoteric surfactant Substances 0.000 claims description 3
- 235000012000 cholesterol Nutrition 0.000 claims description 3
- 150000001840 cholesterol esters Chemical class 0.000 claims description 3
- 150000001841 cholesterols Chemical class 0.000 claims description 3
- 150000003013 phosphoric acid derivatives Chemical class 0.000 claims description 3
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 3
- 229940068968 polysorbate 80 Drugs 0.000 claims description 3
- 229920000053 polysorbate 80 Polymers 0.000 claims description 3
- 150000003467 sulfuric acid derivatives Chemical class 0.000 claims description 3
- 235000007586 terpenes Nutrition 0.000 claims description 3
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 claims description 2
- 244000068988 Glycine max Species 0.000 claims description 2
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 claims description 2
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 2
- 239000004147 Sorbitan trioleate Substances 0.000 claims description 2
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 claims description 2
- 229930182558 Sterol Natural products 0.000 claims description 2
- 230000003078 antioxidant effect Effects 0.000 claims description 2
- 229940073669 ceteareth 20 Drugs 0.000 claims description 2
- 150000002191 fatty alcohols Chemical class 0.000 claims description 2
- 229930182478 glucoside Natural products 0.000 claims description 2
- 150000002306 glutamic acid derivatives Chemical class 0.000 claims description 2
- 150000002334 glycols Chemical class 0.000 claims description 2
- ZUVCYFMOHFTGDM-UHFFFAOYSA-N hexadecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(O)=O ZUVCYFMOHFTGDM-UHFFFAOYSA-N 0.000 claims description 2
- 229940100463 hexyl laurate Drugs 0.000 claims description 2
- 239000008172 hydrogenated vegetable oil Substances 0.000 claims description 2
- 239000003589 local anesthetic agent Substances 0.000 claims description 2
- 239000002736 nonionic surfactant Substances 0.000 claims description 2
- 229940100518 polyglyceryl-4 isostearate Drugs 0.000 claims description 2
- 229920005862 polyol Polymers 0.000 claims description 2
- 150000003077 polyols Chemical class 0.000 claims description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 claims description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 claims description 2
- 229940113124 polysorbate 60 Drugs 0.000 claims description 2
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 claims description 2
- LMWHCJFWODXSMN-UHFFFAOYSA-M sodium;1-dodecoxydodecane;octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCOCCCCCCCCCCCC LMWHCJFWODXSMN-UHFFFAOYSA-M 0.000 claims description 2
- 235000019337 sorbitan trioleate Nutrition 0.000 claims description 2
- 229960000391 sorbitan trioleate Drugs 0.000 claims description 2
- 229940100459 steareth-20 Drugs 0.000 claims description 2
- 150000003432 sterols Chemical class 0.000 claims description 2
- 235000003702 sterols Nutrition 0.000 claims description 2
- 150000003445 sucroses Chemical class 0.000 claims description 2
- 239000012209 synthetic fiber Substances 0.000 claims description 2
- 239000003945 anionic surfactant Substances 0.000 claims 1
- 125000004387 flavanoid group Chemical group 0.000 claims 1
- 102000011782 Keratins Human genes 0.000 abstract description 23
- 108010076876 Keratins Proteins 0.000 abstract description 23
- 239000010410 layer Substances 0.000 description 53
- 239000004744 fabric Substances 0.000 description 47
- 239000004615 ingredient Substances 0.000 description 36
- 239000000463 material Substances 0.000 description 31
- 239000004743 Polypropylene Substances 0.000 description 30
- 229920001155 polypropylene Polymers 0.000 description 30
- 239000000126 substance Substances 0.000 description 30
- 230000008569 process Effects 0.000 description 28
- 239000004698 Polyethylene Substances 0.000 description 21
- 239000003921 oil Substances 0.000 description 21
- 235000019198 oils Nutrition 0.000 description 21
- 229920000573 polyethylene Polymers 0.000 description 21
- 238000012360 testing method Methods 0.000 description 21
- 230000008901 benefit Effects 0.000 description 18
- 239000002250 absorbent Substances 0.000 description 16
- 230000002745 absorbent Effects 0.000 description 16
- 239000002585 base Substances 0.000 description 16
- 239000000047 product Substances 0.000 description 16
- 125000002091 cationic group Chemical group 0.000 description 15
- 239000000839 emulsion Substances 0.000 description 15
- 239000003205 fragrance Substances 0.000 description 14
- 230000008021 deposition Effects 0.000 description 13
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- 230000009977 dual effect Effects 0.000 description 12
- 239000006260 foam Substances 0.000 description 11
- 239000004745 nonwoven fabric Substances 0.000 description 11
- 238000012545 processing Methods 0.000 description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 230000014759 maintenance of location Effects 0.000 description 10
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 9
- 125000000129 anionic group Chemical group 0.000 description 9
- 229920006317 cationic polymer Polymers 0.000 description 9
- 239000002453 shampoo Substances 0.000 description 9
- 239000003995 emulsifying agent Substances 0.000 description 8
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 7
- 238000004140 cleaning Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 230000001815 facial effect Effects 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- 238000007789 sealing Methods 0.000 description 7
- 239000011800 void material Substances 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- 239000000853 adhesive Substances 0.000 description 6
- 230000001070 adhesive effect Effects 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 239000002480 mineral oil Substances 0.000 description 6
- 235000010446 mineral oil Nutrition 0.000 description 6
- 229960003512 nicotinic acid Drugs 0.000 description 6
- 239000002304 perfume Substances 0.000 description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 108010077895 Sarcosine Proteins 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- 239000011230 binding agent Substances 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 229930003935 flavonoid Natural products 0.000 description 5
- 235000017173 flavonoids Nutrition 0.000 description 5
- 210000000497 foam cell Anatomy 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 238000005507 spraying Methods 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000008406 cosmetic ingredient Substances 0.000 description 4
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 4
- 239000008240 homogeneous mixture Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 229940057950 sodium laureth sulfate Drugs 0.000 description 4
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 description 4
- 238000009732 tufting Methods 0.000 description 4
- 239000002888 zwitterionic surfactant Substances 0.000 description 4
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 3
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 3
- AOHBGMDQHXJADT-UHFFFAOYSA-N 2-(2-dodecanoyloxypropanoyloxy)propanoic acid Chemical compound CCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C(O)=O AOHBGMDQHXJADT-UHFFFAOYSA-N 0.000 description 3
- 239000004215 Carbon black (E152) Substances 0.000 description 3
- 244000303965 Cyamopsis psoralioides Species 0.000 description 3
- 206010013786 Dry skin Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 229930003537 Vitamin B3 Natural products 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 235000011399 aloe vera Nutrition 0.000 description 3
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 3
- BTBJBAZGXNKLQC-UHFFFAOYSA-N ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 description 3
- 229940063953 ammonium lauryl sulfate Drugs 0.000 description 3
- 229940121375 antifungal agent Drugs 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 239000003212 astringent agent Substances 0.000 description 3
- 238000003287 bathing Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 230000037336 dry skin Effects 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 239000008204 material by function Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- BOUCRWJEKAGKKG-UHFFFAOYSA-N n-[3-(diethylaminomethyl)-4-hydroxyphenyl]acetamide Chemical compound CCN(CC)CC1=CC(NC(C)=O)=CC=C1O BOUCRWJEKAGKKG-UHFFFAOYSA-N 0.000 description 3
- 239000002121 nanofiber Substances 0.000 description 3
- 229960003966 nicotinamide Drugs 0.000 description 3
- 235000005152 nicotinamide Nutrition 0.000 description 3
- 239000011570 nicotinamide Substances 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- 239000011664 nicotinic acid Substances 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 239000011164 primary particle Substances 0.000 description 3
- 239000002516 radical scavenger Substances 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 229960004889 salicylic acid Drugs 0.000 description 3
- 108700004121 sarkosyl Proteins 0.000 description 3
- 238000005201 scrubbing Methods 0.000 description 3
- 239000002356 single layer Substances 0.000 description 3
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 3
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 description 3
- NTYZDAJPNNBYED-UHFFFAOYSA-M sodium;2-(2-dodecanoyloxypropanoyloxy)propanoate Chemical compound [Na+].CCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O NTYZDAJPNNBYED-UHFFFAOYSA-M 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- 239000012815 thermoplastic material Substances 0.000 description 3
- 239000004408 titanium dioxide Substances 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- 235000019160 vitamin B3 Nutrition 0.000 description 3
- 239000011708 vitamin B3 Substances 0.000 description 3
- 238000009941 weaving Methods 0.000 description 3
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- GFAZGHREJPXDMH-UHFFFAOYSA-N 1,3-dipalmitoylglycerol Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCC GFAZGHREJPXDMH-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 2
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 2
- SHGLJXBLXNNCTE-UHFFFAOYSA-N 2-(4-hydroxyphenyl)chromen-4-one Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=CC=CC=C2O1 SHGLJXBLXNNCTE-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- MVQVNTPHUGQQHK-UHFFFAOYSA-N 3-pyridinemethanol Chemical compound OCC1=CC=CN=C1 MVQVNTPHUGQQHK-UHFFFAOYSA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 244000144927 Aloe barbadensis Species 0.000 description 2
- 235000002961 Aloe barbadensis Nutrition 0.000 description 2
- FSNVAJOPUDVQAR-AVGNSLFASA-N Arg-Lys-Arg Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O FSNVAJOPUDVQAR-AVGNSLFASA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 206010021639 Incontinence Diseases 0.000 description 2
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 229920004142 LEXAN™ Polymers 0.000 description 2
- 239000004418 Lexan Substances 0.000 description 2
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 2
- 229920001410 Microfiber Polymers 0.000 description 2
- 229920002292 Nylon 6 Polymers 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- GCSPRLPXTPMSTL-IBDNADADSA-N [(2s,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[C@@]1([C@]2(CO)[C@H]([C@H](O)[C@@H](CO)O2)O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GCSPRLPXTPMSTL-IBDNADADSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- WUOACPNHFRMFPN-UHFFFAOYSA-N alpha-terpineol Chemical compound CC1=CCC(C(C)(C)O)CC1 WUOACPNHFRMFPN-UHFFFAOYSA-N 0.000 description 2
- 229940098323 ammonium cocoyl isethionate Drugs 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- WUADCCWRTIWANL-UHFFFAOYSA-N biochanin A Chemical compound C1=CC(OC)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O WUADCCWRTIWANL-UHFFFAOYSA-N 0.000 description 2
- 229940036350 bisabolol Drugs 0.000 description 2
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000004204 candelilla wax Substances 0.000 description 2
- 235000013868 candelilla wax Nutrition 0.000 description 2
- 229940073532 candelilla wax Drugs 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 2
- 229940071160 cocoate Drugs 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical class O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 2
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000004299 exfoliation Methods 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 229940048866 lauramine oxide Drugs 0.000 description 2
- 235000019136 lipoic acid Nutrition 0.000 description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 2
- 229920001684 low density polyethylene Polymers 0.000 description 2
- 239000004702 low-density polyethylene Substances 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000000873 masking effect Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 239000003658 microfiber Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 235000021313 oleic acid Nutrition 0.000 description 2
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- KAICRBBQCRKMPO-UHFFFAOYSA-N phosphoric acid;pyridine-3,4-diamine Chemical compound OP(O)(O)=O.NC1=CC=NC=C1N KAICRBBQCRKMPO-UHFFFAOYSA-N 0.000 description 2
- 235000002949 phytic acid Nutrition 0.000 description 2
- 229940068041 phytic acid Drugs 0.000 description 2
- 239000000467 phytic acid Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 239000005297 pyrex Substances 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 2
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 2
- 229960003656 ricinoleic acid Drugs 0.000 description 2
- 238000011012 sanitization Methods 0.000 description 2
- 238000007790 scraping Methods 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 229940080236 sodium cetyl sulfate Drugs 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 229940048106 sodium lauroyl isethionate Drugs 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 229940060304 sodium myristoyl sarcosinate Drugs 0.000 description 2
- 229940102541 sodium trideceth sulfate Drugs 0.000 description 2
- ZUFONQSOSYEWCN-UHFFFAOYSA-M sodium;2-(methylamino)acetate Chemical compound [Na+].CNCC([O-])=O ZUFONQSOSYEWCN-UHFFFAOYSA-M 0.000 description 2
- KLYDBHUQNXKACI-UHFFFAOYSA-M sodium;2-[2-(2-tridecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O KLYDBHUQNXKACI-UHFFFAOYSA-M 0.000 description 2
- KHCOJQDJOCNUGV-UHFFFAOYSA-M sodium;2-[methyl(tetradecanoyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCCCC(=O)N(C)CC([O-])=O KHCOJQDJOCNUGV-UHFFFAOYSA-M 0.000 description 2
- BRMSVEGRHOZCAM-UHFFFAOYSA-M sodium;2-dodecanoyloxyethanesulfonate Chemical compound [Na+].CCCCCCCCCCCC(=O)OCCS([O-])(=O)=O BRMSVEGRHOZCAM-UHFFFAOYSA-M 0.000 description 2
- GGHPAKFFUZUEKL-UHFFFAOYSA-M sodium;hexadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCOS([O-])(=O)=O GGHPAKFFUZUEKL-UHFFFAOYSA-M 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- 239000004753 textile Substances 0.000 description 2
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 229960002663 thioctic acid Drugs 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- CRDAMVZIKSXKFV-YFVJMOTDSA-N (2-trans,6-trans)-farnesol Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CO CRDAMVZIKSXKFV-YFVJMOTDSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- 239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Substances 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- TUBPSFQENHCYBW-HVDRVSQOSA-N (2s)-2-aminopentanedioic acid;2-[bis(2-hydroxyethyl)amino]ethanol Chemical compound OC(=O)[C@@H](N)CCC(O)=O.OCCN(CCO)CCO TUBPSFQENHCYBW-HVDRVSQOSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WSWCOQWTEOXDQX-MQQKCMAXSA-M (E,E)-sorbate Chemical compound C\C=C\C=C\C([O-])=O WSWCOQWTEOXDQX-MQQKCMAXSA-M 0.000 description 1
- RBOZTFPIXJBLPK-HWAYABPNSA-N (NE)-N-[(2E)-1,2-bis(furan-2-yl)-2-hydroxyiminoethylidene]hydroxylamine Chemical compound O\N=C(/C(=N\O)/C1=CC=CO1)\C1=CC=CO1 RBOZTFPIXJBLPK-HWAYABPNSA-N 0.000 description 1
- DMBUODUULYCPAK-UHFFFAOYSA-N 1,3-bis(docosanoyloxy)propan-2-yl docosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCC DMBUODUULYCPAK-UHFFFAOYSA-N 0.000 description 1
- WRGQSWVCFNIUNZ-GDCKJWNLSA-N 1-oleoyl-sn-glycerol 3-phosphate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)COP(O)(O)=O WRGQSWVCFNIUNZ-GDCKJWNLSA-N 0.000 description 1
- OAAZUWWNSYWWHG-UHFFFAOYSA-N 1-phenoxypropan-1-ol Chemical compound CCC(O)OC1=CC=CC=C1 OAAZUWWNSYWWHG-UHFFFAOYSA-N 0.000 description 1
- IBLKWZIFZMJLFL-UHFFFAOYSA-N 1-phenoxypropan-2-ol Chemical compound CC(O)COC1=CC=CC=C1 IBLKWZIFZMJLFL-UHFFFAOYSA-N 0.000 description 1
- WCOXQTXVACYMLM-UHFFFAOYSA-N 2,3-bis(12-hydroxyoctadecanoyloxy)propyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC(O)CCCCCC)COC(=O)CCCCCCCCCCC(O)CCCCCC WCOXQTXVACYMLM-UHFFFAOYSA-N 0.000 description 1
- MQFYRUGXOJAUQK-UHFFFAOYSA-N 2-[2-[2-(2-octadecanoyloxyethoxy)ethoxy]ethoxy]ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOCCOCCOCCOC(=O)CCCCCCCCCCCCCCCCC MQFYRUGXOJAUQK-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- OYINQIKIQCNQOX-UHFFFAOYSA-M 2-hydroxybutyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCC(O)C[N+](C)(C)C OYINQIKIQCNQOX-UHFFFAOYSA-M 0.000 description 1
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- HCXVJBMSMIARIN-ZETWWWAOSA-N 24alpha-Ethyl-koprostanol Natural products CC[C@H](C=C[C@H](C)[C@H]1CC[C@@H]2[C@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C)C(C)C HCXVJBMSMIARIN-ZETWWWAOSA-N 0.000 description 1
- BGVCGTNXEKDVCB-UHFFFAOYSA-N 4-hydroxy-3-methylnaphthalene-1,2-dione Chemical compound C1=CC=C2C(=O)C(=O)C(C)=C(O)C2=C1 BGVCGTNXEKDVCB-UHFFFAOYSA-N 0.000 description 1
- VFMMPHCGEFXGIP-UHFFFAOYSA-N 7,8-Benzoflavone Chemical compound O1C2=C3C=CC=CC3=CC=C2C(=O)C=C1C1=CC=CC=C1 VFMMPHCGEFXGIP-UHFFFAOYSA-N 0.000 description 1
- NUGPQONICGTVNA-UHFFFAOYSA-N 7-hydroxy-2-(2-hydroxyphenyl)-1-benzopyran-4-one Chemical compound C=1C(O)=CC=C(C(C=2)=O)C=1OC=2C1=CC=CC=C1O NUGPQONICGTVNA-UHFFFAOYSA-N 0.000 description 1
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 229920002972 Acrylic fiber Polymers 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-NRHJOKMGSA-N Brassicasterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@](C)([C@H]([C@@H](/C=C/[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 OILXMJHPFNGGTO-NRHJOKMGSA-N 0.000 description 1
- BYUQATUKPXLFLZ-UIOOFZCWSA-N CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CN=CN1 Chemical compound CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CN=CN1 BYUQATUKPXLFLZ-UIOOFZCWSA-N 0.000 description 1
- 241000282836 Camelus dromedarius Species 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 1
- 108010087806 Carnosine Proteins 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 241001340526 Chrysoclista linneella Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 240000000491 Corchorus aestuans Species 0.000 description 1
- 235000011777 Corchorus aestuans Nutrition 0.000 description 1
- 235000010862 Corchorus capsularis Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 description 1
- 229920000727 Decyl polyglucose Polymers 0.000 description 1
- 229920001174 Diethylhydroxylamine Polymers 0.000 description 1
- 239000001692 EU approved anti-caking agent Substances 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- FDQYIRHBVVUTJF-ZETCQYMHSA-N His-Gly-Gly Chemical compound [O-]C(=O)CNC(=O)CNC(=O)[C@@H]([NH3+])CC1=CN=CN1 FDQYIRHBVVUTJF-ZETCQYMHSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- MQYXUWHLBZFQQO-CWFQSGEHSA-N Lupenol Natural products C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@H](C(=C)C)[C@H]5[C@H]4CC[C@@H]3[C@]21C MQYXUWHLBZFQQO-CWFQSGEHSA-N 0.000 description 1
- 229920002821 Modacrylic Polymers 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 1
- USSFUVKEHXDAPM-UHFFFAOYSA-N Nicotinamide N-oxide Chemical compound NC(=O)C1=CC=C[N+]([O-])=C1 USSFUVKEHXDAPM-UHFFFAOYSA-N 0.000 description 1
- 229920000305 Nylon 6,10 Polymers 0.000 description 1
- 229920002302 Nylon 6,6 Polymers 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical class CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241000282372 Panthera onca Species 0.000 description 1
- LULCPJWUGUVEFU-UHFFFAOYSA-N Phthiocol Natural products C1=CC=C2C(=O)C(C)=C(O)C(=O)C2=C1 LULCPJWUGUVEFU-UHFFFAOYSA-N 0.000 description 1
- 229920000289 Polyquaternium Polymers 0.000 description 1
- 241000203482 Polyscias Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920002651 Polysorbate 85 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- OILXMJHPFNGGTO-ZRUUVFCLSA-N UNPD197407 Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)C=C[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZRUUVFCLSA-N 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 1
- 244000291414 Vaccinium oxycoccus Species 0.000 description 1
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- 229920006221 acetate fiber Polymers 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 229920006397 acrylic thermoplastic Polymers 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- JZVFJDZBLUFKCA-FXIAWGAOSA-N alpha-Spinasterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)CC[C@H]33)C)C3=CC[C@H]21 JZVFJDZBLUFKCA-FXIAWGAOSA-N 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- JZVFJDZBLUFKCA-UTQQLQBSSA-N alpha-spinasterol Natural products CC[C@H](C=C[C@H](C)[C@H]1CC[C@H]2C3=CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C JZVFJDZBLUFKCA-UTQQLQBSSA-N 0.000 description 1
- 229920005603 alternating copolymer Polymers 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- HAMNKKUPIHEESI-UHFFFAOYSA-N aminoguanidine Chemical compound NNC(N)=N HAMNKKUPIHEESI-UHFFFAOYSA-N 0.000 description 1
- FQPFAHBPWDRTLU-UHFFFAOYSA-N aminophylline Chemical compound NCCN.O=C1N(C)C(=O)N(C)C2=C1NC=N2.O=C1N(C)C(=O)N(C)C2=C1NC=N2 FQPFAHBPWDRTLU-UHFFFAOYSA-N 0.000 description 1
- 229960003556 aminophylline Drugs 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical class C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- OCSIXPGPUXCISD-UHFFFAOYSA-N azane;2-[dodecanoyl(methyl)amino]acetic acid Chemical compound N.CCCCCCCCCCCC(=O)N(C)CC(O)=O OCSIXPGPUXCISD-UHFFFAOYSA-N 0.000 description 1
- OADXQALOSREDRB-UHFFFAOYSA-N azanium;hexadecyl sulfate Chemical compound N.CCCCCCCCCCCCCCCCOS(O)(=O)=O OADXQALOSREDRB-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229960005274 benzocaine Drugs 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 150000001277 beta hydroxy acids Chemical class 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- OUGIDAPQYNCXRA-UHFFFAOYSA-N beta-naphthoflavone Chemical compound O1C2=CC=C3C=CC=CC3=C2C(=O)C=C1C1=CC=CC=C1 OUGIDAPQYNCXRA-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000004420 brassicasterol Nutrition 0.000 description 1
- OILXMJHPFNGGTO-ZAUYPBDWSA-N brassicasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZAUYPBDWSA-N 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- UNYSKUBLZGJSLV-UHFFFAOYSA-L calcium;1,3,5,2,4,6$l^{2}-trioxadisilaluminane 2,4-dioxide;dihydroxide;hexahydrate Chemical compound O.O.O.O.O.O.[OH-].[OH-].[Ca+2].O=[Si]1O[Al]O[Si](=O)O1.O=[Si]1O[Al]O[Si](=O)O1 UNYSKUBLZGJSLV-UHFFFAOYSA-L 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940044199 carnosine Drugs 0.000 description 1
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229910052676 chabazite Inorganic materials 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000008294 cold cream Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- LUNQZVCDZKODKF-PFVVTREHSA-L copper acetic acid (2S)-6-amino-2-[[(2S)-2-[(2-aminoacetyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoate (2S)-6-amino-2-[[(2S)-2-[(2-amino-1-oxidoethylidene)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoate hydron Chemical compound [Cu+2].CC(O)=O.CC(O)=O.NCCCC[C@@H](C([O-])=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1.NCCCC[C@@H](C([O-])=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 LUNQZVCDZKODKF-PFVVTREHSA-L 0.000 description 1
- 235000004634 cranberry Nutrition 0.000 description 1
- 229940075482 d & c green 5 Drugs 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 229940073499 decyl glucoside Drugs 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 229960003949 dexpanthenol Drugs 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- FVCOIAYSJZGECG-UHFFFAOYSA-N diethylhydroxylamine Chemical compound CCN(O)CC FVCOIAYSJZGECG-UHFFFAOYSA-N 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 229940079881 disodium lauroamphodiacetate Drugs 0.000 description 1
- QKQCPXJIOJLHAL-UHFFFAOYSA-L disodium;2-[2-(carboxylatomethoxy)ethyl-[2-(dodecanoylamino)ethyl]amino]acetate Chemical compound [Na+].[Na+].CCCCCCCCCCCC(=O)NCCN(CC([O-])=O)CCOCC([O-])=O QKQCPXJIOJLHAL-UHFFFAOYSA-L 0.000 description 1
- FPAYXBWMYIMERV-UHFFFAOYSA-L disodium;5-methyl-2-[[4-(4-methyl-2-sulfonatoanilino)-9,10-dioxoanthracen-1-yl]amino]benzenesulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1S([O-])(=O)=O FPAYXBWMYIMERV-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- HEAHZSUCFKFERC-UHFFFAOYSA-N ecamsule Chemical class CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)C2=CC(C=C1)=CC=C1C=C1C(=O)C2(CS(O)(=O)=O)CCC1C2(C)C HEAHZSUCFKFERC-UHFFFAOYSA-N 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical class N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- 150000003620 farnesol derivatives Chemical class 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 210000004905 finger nail Anatomy 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 229940083124 ganglion-blocking antiadrenergic secondary and tertiary amines Drugs 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical class O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 239000013003 healing agent Substances 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 229910052677 heulandite Inorganic materials 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 150000001261 hydroxy acids Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 150000005165 hydroxybenzoic acids Chemical class 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- MQYXUWHLBZFQQO-QGTGJCAVSA-N lupeol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C MQYXUWHLBZFQQO-QGTGJCAVSA-N 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 210000000282 nail Anatomy 0.000 description 1
- 229910052674 natrolite Inorganic materials 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229960004738 nicotinyl alcohol Drugs 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 125000002801 octanoyl group Chemical class C(CCCCCCC)(=O)* 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical class C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 239000005026 oriented polypropylene Substances 0.000 description 1
- FJCFFCXMEXZEIM-UHFFFAOYSA-N oxiniacic acid Chemical compound OC(=O)C1=CC=C[N+]([O-])=C1 FJCFFCXMEXZEIM-UHFFFAOYSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000010419 pet care Methods 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 229940106026 phenoxyisopropanol Drugs 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 235000019175 phylloquinone Nutrition 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229960001898 phytomenadione Drugs 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001707 polybutylene terephthalate Polymers 0.000 description 1
- 229920006294 polydialkylsiloxane Polymers 0.000 description 1
- 229920005594 polymer fiber Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229940113171 polysorbate 85 Drugs 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 125000000946 retinyl group Chemical group [H]C([*])([H])/C([H])=C(C([H])([H])[H])/C([H])=C([H])/C([H])=C(C([H])([H])[H])/C([H])=C([H])/C1=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C1(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- YRWWOAFMPXPHEJ-OFBPEYICSA-K sodium L-ascorbic acid 2-phosphate Chemical compound [Na+].[Na+].[Na+].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1[O-] YRWWOAFMPXPHEJ-OFBPEYICSA-K 0.000 description 1
- 229940048058 sodium ascorbyl phosphate Drugs 0.000 description 1
- 229960002668 sodium chloride Drugs 0.000 description 1
- 229940079781 sodium cocoyl glutamate Drugs 0.000 description 1
- 229940079776 sodium cocoyl isethionate Drugs 0.000 description 1
- 229940045944 sodium lauroyl glutamate Drugs 0.000 description 1
- 229940077092 sodium myristoyl glutamate Drugs 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 229910052911 sodium silicate Inorganic materials 0.000 description 1
- IWIUXJGIDSGWDN-UQKRIMTDSA-M sodium;(2s)-2-(dodecanoylamino)pentanedioate;hydron Chemical compound [Na+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC(O)=O IWIUXJGIDSGWDN-UQKRIMTDSA-M 0.000 description 1
- FCBUGCHAVCFTHW-NTISSMGPSA-N sodium;(2s)-2-(tetradecanoylamino)pentanedioic acid Chemical compound [Na].CCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O FCBUGCHAVCFTHW-NTISSMGPSA-N 0.000 description 1
- AMJZVHHOVFFTOM-UHFFFAOYSA-M sodium;2-(2-hexanoyloxypropanoyloxy)propanoate Chemical compound [Na+].CCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O AMJZVHHOVFFTOM-UHFFFAOYSA-M 0.000 description 1
- HVFAVOFILADWEZ-UHFFFAOYSA-M sodium;2-[2-(dodecanoylamino)ethyl-(2-hydroxyethyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCC(=O)NCCN(CCO)CC([O-])=O HVFAVOFILADWEZ-UHFFFAOYSA-M 0.000 description 1
- CAVXVRQDZKMZDB-UHFFFAOYSA-M sodium;2-[dodecanoyl(methyl)amino]ethanesulfonate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CCS([O-])(=O)=O CAVXVRQDZKMZDB-UHFFFAOYSA-M 0.000 description 1
- CRPCXAMJWCDHFM-UHFFFAOYSA-M sodium;5-oxopyrrolidine-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1CCC(=O)N1 CRPCXAMJWCDHFM-UHFFFAOYSA-M 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940075554 sorbate Drugs 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000003687 soy isoflavones Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 229910052678 stilbite Inorganic materials 0.000 description 1
- DIORMHZUUKOISG-UHFFFAOYSA-N sulfoformic acid Chemical compound OC(=O)S(O)(=O)=O DIORMHZUUKOISG-UHFFFAOYSA-N 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 1
- 229960000368 sulisobenzone Drugs 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 229920001897 terpolymer Polymers 0.000 description 1
- RLNWRDKVJSXXPP-UHFFFAOYSA-N tert-butyl 2-[(2-bromoanilino)methyl]piperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCCCC1CNC1=CC=CC=C1Br RLNWRDKVJSXXPP-UHFFFAOYSA-N 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 229960004559 theobromine Drugs 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 210000004906 toe nail Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 229940048912 triethanolamine cocoyl glutamate Drugs 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 229940057400 trihydroxystearin Drugs 0.000 description 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical group CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 235000012711 vitamin K3 Nutrition 0.000 description 1
- 239000011652 vitamin K3 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 229940041603 vitamin k 3 Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/15577—Apparatus or processes for manufacturing
- A61F13/15707—Mechanical treatment, e.g. notching, twisting, compressing, shaping
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/51—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the outer layers of the pads
- A61F13/511—Topsheet, i.e. the permeable cover or layer facing the skin
- A61F13/51104—Topsheet, i.e. the permeable cover or layer facing the skin the top sheet having a three-dimensional cross-section, e.g. corrugations, embossments, recesses or projections
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/51—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the outer layers of the pads
- A61F13/511—Topsheet, i.e. the permeable cover or layer facing the skin
- A61F13/51113—Topsheet, i.e. the permeable cover or layer facing the skin comprising an additive, e.g. lotion or odour control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/51—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the outer layers of the pads
- A61F13/511—Topsheet, i.e. the permeable cover or layer facing the skin
- A61F13/51121—Topsheet, i.e. the permeable cover or layer facing the skin characterised by the material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/53—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium
- A61F13/538—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium characterised by specific fibre orientation or weave
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/84—Accessories, not otherwise provided for, for absorbent pads
- A61F13/8405—Additives, e.g. for odour, disinfectant or pH control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H11/00—Non-woven pile fabrics
- D04H11/08—Non-woven pile fabrics formed by creation of a pile on at least one surface of a non-woven fabric without addition of pile-forming material, e.g. by needling, by differential shrinking
-
- A—HUMAN NECESSITIES
- A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
- A47K—SANITARY EQUIPMENT NOT OTHERWISE PROVIDED FOR; TOILET ACCESSORIES
- A47K10/00—Body-drying implements; Toilet paper; Holders therefor
- A47K10/24—Towel dispensers, e.g. for piled-up or folded textile towels; Toilet paper dispensers; Dispensers for piled-up or folded textile towels provided or not with devices for taking-up soiled towels as far as not mechanically driven
- A47K10/32—Dispensers for paper towels or toilet paper
- A47K2010/3266—Wet wipes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00238—Wound bandages characterised by way of knitting or weaving
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00902—Plasters containing means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/51—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the outer layers of the pads
- A61F13/511—Topsheet, i.e. the permeable cover or layer facing the skin
- A61F13/51113—Topsheet, i.e. the permeable cover or layer facing the skin comprising an additive, e.g. lotion or odour control
- A61F2013/51117—Topsheet, i.e. the permeable cover or layer facing the skin comprising an additive, e.g. lotion or odour control the lotion having skin care properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/53—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium
- A61F13/538—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium characterised by specific fibre orientation or weave
- A61F2013/5386—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium characterised by specific fibre orientation or weave by the fibre orientation in the z plane or vertical direction
Definitions
- the present invention relates to disposable personal care articles that are cloth-like and are useful for cleansing and/or treating the skin, hair, and similar keratin-containing tissues of the body surfaces in need of such treatment and more particularly to a disposable, cleansing article comprising a fibrous non-woven web, together with a treatment composition and/or a cleansing composition applied to said non-woven fibrous web.
- Personal care products have traditionally been marketed in a variety of forms such as bar soaps, creams, lotions, and gels. These personal care products have attempted to satisfy a number of criteria to be acceptable to consumers. These criteria include cleansing effectiveness, skin feel, mildness to skin, hair and ocular mucosae, and sufficient lather volume. Ideal personal care products should gently cleanse, treat or condition the skin or hair, cause little or no irritation, and not leave the skin or hair overly dry after frequent use.
- Personal care products are frequently used with, or marketed in the form of articles employing a fibrous, non-woven web or other implement (e.g., washcloth, loofah, scrubbing towel, reticulated mesh, etc.) that carries a cleansing formulation or is used to deliver a separate cleansing, treatment or conditioning formulation to the skin or hair.
- a fibrous, non-woven web or other implement e.g., washcloth, loofah, scrubbing towel, reticulated mesh, etc.
- formulator adds emulsifiers, thickeners, and gellants to suspend the conditioning ingredients within a surfactant mixture. While the resulting composition is in an aesthetically pleasing, homogenous mixture, the conditioner is not effectively deposited onto skin or hair because the conditioners are emulsified and not efficiently released during cleansing. Also, many treatment agents have the disadvantage of suppressing lather generation. Lather suppression is a problem because many consumers seek cleansing articles that provide a rich, creamy, and generous lather.
- the personal care articles of the present invention are convenient to use because they are in the form of either a single, disposable personal care article or multiple disposable articles useful for cleansing as well as application of a therapeutic or aesthetic benefit agent.
- Disposable articles are convenient because they obviate the need to carry cumbersome bottles, bars, jars, tubes, and other forms of cleansing, treatment and conditioning articles.
- Disposable articles are also a more sanitary alternative to the use of a sponge, washcloth, or other cleansing implement intended for multiple reuse, because such implements develop bacterial growth, unpleasant odors, and other undesirable characteristics related to repeated use. Fibrous webs are well known in the art.
- fibrous, non-woven webs such as webs formed from polymer fibers are well known as materials useful for disposable products such as facing layers on absorbent articles such as diapers, for example.
- the articles are suitable for personal care applications and are useful for cleansing and/or therapeutically treating the skin, hair, and similar keratin-containing surfaces in need of such treatment.
- fibrous webs have a bulky texture and/or softness.
- textile wovens known as terry cloth have a bulky texture and softness and are often used for bath towels, wiping cloths, bibs, clothing, and upholstery fabric.
- Terry cloth is woven on specially made weaving machines, such as rapier weaving machines. Terry cloth is characterized by tufted loops of thread, and the tufts can be varied in number and density of loops.
- terry cloth is relatively expensive due to the relatively complex and expensive weaving machines necessary for its manufacture. The expense of terry cloth makes it commercially unfeasible for many applications, particularly for articles intended for limited use, such as disposable absorbent articles.
- the present invention relates to disposable, personal care articles especially useful for cleansing and, or treating the skin, hair, and similar keratin-containing tissues or other body surfaces in need of such treatment.
- Each such article comprises a fibrous nonwoven web having a first surface and a second surface and comprising a first region and a plurality of discrete integral second regions, the second regions having a discontinuity exhibiting a linear orientation and a deformation comprising a plurality of tufted fibers integral with but extending from the first region and a personal care composition associated with the web.
- these articles are suitable for use within or in conjunction with another personal care implement that is designed for more extensive use.
- the articles of the present invention are disposed within or attached to a separate personal care implement that is not readily disposable, e.g., a bath towel or washcloth.
- the disposable articles of the present invention may be removeably attached to a handle or grip suitable for moving the article over the surface to be cleansed and/or treated.
- the articles of the present invention are suitable for personal care applications, they may also be useful in a variety of other industries such as the automotive care, marine vehicle care, household care, animal care, etc., where surfaces or areas are in need of cleansing and/or application of a benefit agent, e.g., wax, conditioner, UV protectant and other similarly applied products.
- a benefit agent e.g., wax, conditioner, UV protectant and other similarly applied products.
- the articles are suitable for personal care applications and are useful for cleansing and/or treating the skin, hair, and similar keratin- containing surfaces of the body, primarily skin and hair, while producing adequate lather.
- the present invention also relates to personal care articles useful for cleansing and/or treating the skin, hair, and similar keratin-containing surfaces of the body, primarily skin and hair, that produce low lather to non-lathering.
- the present invention also relates to personal care articles useful for therapeutically treating the skin, hair, and similar keratin-containing surfaces of the body, primarily skin and hair, by delivering the benefit agent to the keratin-containing surface.
- the present invention also relates to methods for manufacturing personal care articles of the configuration described herein. Also, the present invention provides methods for cleansing, and treating the skin or hair and similar keratin -containing surfaces of the body, primarily skin and hair using the articles described herein.
- the present invention also covers kits containing a plurality of the fibrous, non-woven web that has a personal care composition associated with the web.
- the present invention also covers kits containing a plurality of the fibrous, non-woven web that has no treatment and, or cleansing composition on it wherein the web is packaged with certain types of compositions that during use effectuate cleansing and, or treating the skin, hair, and similar keratin-containing surfaces of the body
- FIG. 1 is a perspective view of a web of the present invention.
- FIG. 2 is an enlarged view of a portion of the web shown in FIG. 1.
- FIG. 3 is a cross-sectional view of section 3-3 of FIG. 2.
- FIG. 4 is a plan view of a portion of the web as indicated by 4-4 in FIG. 3.
- FIG. 5 is a photomicrograph of a portion of a web of the present invention.
- FIG. 6 is a photomicrograph of a portion of the web of FIG. 5.
- FIG. 7 is a perspective view of an apparatus for forming the web of the present invention.
- FIG. 8 is a cross-sectional depiction of a portion of the apparatus shown in FIG. 7.
- FIG. 9 is a perspective view of a portion of the apparatus for forming one embodiment the web of the present invention.
- FIG. 10 is an enlarged perspective view of a portion of the apparatus for forming the web of the present invention.
- FIG. 11 is a photomicrograph of a portion of a web of the present invention.
- FIG. 12 is a photomicrograph of a portion of a web of the present invention.
- FIG. 13 is a photomicrograph of a portion of a web of the present invention.
- FIG. 14 is a photomicrograph of a portion of a web of the present invention.
- FIG. 15 is a photomicrograph of a portion of a web of the present invention.
- FIG. 16 is a schematic representation of a portion of a web of the present invention.
- FIG. 17 is another schematic representation of a portion of a web of the present invention.
- FIG. 18 is another schematic representation of a portion of a web of the present invention.
- FIG. 19 is a photomicrograph of a portion of a web of the present invention.
- FIG. 20 is an enlarged photograph of a portion of the web shown in FIG. 16.
- FIG 21 is a perspective view of a web of the present invention.
- FIG 22 is a photomicrograph of a portion of a web of the present invention. DETAILED DESCRIPTION OF THE INVENTION
- the essential elements of personal care articles of the present invention i.e., a fibrous nonwoven web formed by selective mechanical deformation of a precursor web having a first surface and a second surface, and a personal care composition are described in detail as follows. All percentages and ratios used herein, unless otherwise indicated, are by total weight of the composition unless otherwise indicated and all measurements made are at 25° C, unless otherwise designated.
- the invention hereof can comprise, consist of, or consist essentially of, the essential as well as optional ingredients and components described therein.
- composition associated with the web means compositions that are applied to or inside of the individual fibers prior to forming the web, permeated into the web, coated onto, within or adjacent to the exposed surfaces of the web or releasably associated with the web.
- the presence of the “composition associated with the web” may interfere with the visibility of the tufts so that the "composition associated with the web” must either be removed mechanically or with a solvent (water, alcohol, isododecane), drying out the web, and then evaluating tufts with the "composition associated with the web” removed.
- randomly means, e.g., exhibits a general lack of orientation within a plane such as fibers in carded webs as compared to the well defined orientation of fibers in threads and threads in a weave. Fibrous webs with modest asymmetry, such as the small amount of orientation leading to enhanced MD web strength as compared to CD wed strength, are still considered to be essentially random in that the fibers are not placed in a specific location in the web such as a thread is placed within a weave.
- fluid means water, mono- and polyhydric alcohols (glycerin, propylene glycol, ethanol, isopropanol, etc.), hydrocarbon oils such as mineral oil, silicone oils having a viscosity, and can contain other components dissolved or dispersed within them, or in addition to them.
- lathering surfactant a surfactant, which when combined with a fluid and mechanically agitated generates a foam or lather.
- body cleansing composition means that the product or article contains enough of the surfactants described herein that it can generate at least 1400 ml of Steady Total Lather Volume, as described herein in the Steady Lather Volume Test.
- face cleansing composition means that the composition contains enough of the surfactant described herein that it can generate at least about 85 ml of Mechanical Lather Volume, as described in the Mechanical Lather Volume Test Test.
- low-lathering or “non-lathering”, as used herein, means that the composition generates from at the most 700ml of Steady Flash Lather Volume, as described in the Steady Lather Volume Test.
- treatment agent or composition means a formulation to deliver cosmetic and therapeutic benefit to keratin-containing surfaces of the body, primarily skin and hair.
- dispenser is used herein in its ordinary sense to mean an article that is disposed or discarded after a limited number of usage events, preferably less than 5, more preferably less than about 3, and even more preferably less than about 2 entire usage events.
- skin conditioning composition means a combination of the conditioning agents which can comprise a water soluble conditioning agent; an oil soluble conditioning agent; a conditioning emulsion; or any combination or permutation of the three.
- water-activated means that some of the articles of the present invention are presented to the consumer in a form to be used when wetted with a fluid. It is found that these articles produce a lather or are "activated” by either contacting them with a fluid or producing them with a fluid and then further subjecting the article to mechanical forces, such as rubbing.
- substantially dry means that prior to use the article is substantially free of fluid and generally feels dry to the touch.
- substantially dry means that the articles of the present invention exhibit a Moisture Retention of less than about 0.95 gms, preferably less than about 0.75 gms, even more preferably, less than about 0.5 gms, even more preferably less than about 0.25 gms, even still more preferably less than about 0.15 gms, and most preferably, less than about 0.1 gms. The determination of the Moisture Retention is discussed later.
- the "substantially dry" articles of the present invention will generally comprise less than about 20% by weight of fluid, preferably from 4% to about 20% by weight of fluid, and more preferably from about 4% to about 16% by weight of fluid.
- the term "moist,” as used herein, means that prior to use the article can feel relatively dry to the touch and still contain high fluid content.
- the “moist” articles of the present invention will generally comprise from about 20% to about 40% by weight of fluid.
- the term "wet” means that prior to use the article can feel wet to the touch and contain high fluid content.
- the weight percent of fluid in the "wet” article is based on the total weight of the composition. The weight is expressed as a weight of the total composition.
- the "wet" articles of the present invention will generally comprise from about greater than 40% by weight of fluid, preferably from 40% to about 95% by weight of fluid, and more preferably from about 50% to about 80% by weight of fluid.
- FIG. 1 shows a web 1 of the present invention.
- Web 1 is formed from a generally planar, two dimensional fibrous, non-woven precursor web 20, See FIG. 7, having a first surface 12 and a second surface 14, and having a machine direction (MD) and a cross machine direction (CD) as is commonly known in the art of fibrous, non-woven webs.
- First surface 12 corresponds to first "side” of web 1
- second surface 14 corresponds to the second "side” of web 1, the term “sides” being used in the common usage of generally two-dimensional webs, such as paper and films.
- precursor web 20 is a fibrous, non-woven web and is comprised of randomly oriented fibers, that is, essentially randomly oriented at least with respect to the MD and CD.
- Fibrous, non-woven web precursor webs 20 can be any known fibrous, non-woven webs comprising fibers having sufficient elongation or mobility of fibers properties to be formed into web 1 as described more fully below.
- Web 1 has a first region 2 defined on both sides of web 1 by the generally planar, two-dimensional configuration of the precursor web 20, and a plurality of discrete second regions 4 defined by spaced-apart deformations 6 and discontinuities 16 which are integral extensions of the fibers of the precursor web 20.
- the structure of second regions 4 is differentiated depending on which side of web 1 is considered. For the embodiment of web 1 shown in FIG. land FIG.
- second region 4 comprises deformations 6, each deformation 6 comprising a plurality of tufted, looped, aligned fibers 8 extending outwardly from first surface 12.
- Deformations 6 can be described as "tufts" of fibers, and each deformation 6 has a base 5 proximal to the first surface 12, and a distal portion 3 at a maximum distance from the first surface 12, as shown in FIG 3.
- second region 4 comprises discontinuities 16 corresponding to said deformations 6 of surface 12 that are defined by fiber orientation discontinuities on second surface 14 of web 1.
- the deformations 6 may be described as tufts, or tufted, but may not comprise looped or aligned fibers. Additionally, said deformations can be tufts that can comprise loop or non-looped areas.
- fibrous, non-woven web refers to a web having a structure of individual fibers or threads which are interlaid, but not in a repeating pattern as is the case with woven or knitted fabrics having oriented fibers. Fibrous, non-woven webs or fabrics have been formed from many processes including, but not necessarily limited to meltblowing processes, spunbonding processes, airlaying processes, hydroentangling processes, spunlacing processes, and bonded carded web processes.
- the basis weight of non-woven web fabrics is usually expressed in grams per square meter (gsm) and the fiber diameters are usually expressed in microns. Fiber size can also be expressed in denier.
- gsm to 500 gsm can range from 10 gsm to 500 gsm., preferably from about 16 gsm to 150 gsm, more preferably from about 25 gsm to about 120gsm, even more preferably from about 35 gsm. to about 100 gsm.
- a basis weight of between 125 gsm and 250 gsm may be appropriate.
- the constituent fibers of fibrous, non-woven web precursor web 20 can be comprised of polymer , and can be monocomponent, multicomponent, and/or multiconstituent, capillary channel fibers, hollow fibers, splittable fibers, shaped or lobed fibers and can have major cross-sectional dimensions (e.g., diameter for round fibers) ranging from 0.1-500 microns.
- one type of fibers suitable for the nonwoven web include nanofibers. Nanofibers are described as fibers having a mean diameter of less than 1 micron. Nanofibers can comprise all of the fibers in a nonwoven web or a portion of the fibers in a nonwoven web.
- the constitutent fibers of the precursor web may also be a mixture of different fiber types, differing in such features as chemistry, components, diameter, shape, and the like.
- the constituent fibers can range from about 0.1 denier to about 100 denier.
- the creped nonwoven layer may comprise a variety of both natural and synthetic fibers or materials.
- natural means that the materials are derived from plants, animals, insects or byproducts of plants, animals, and insects.
- the conventional base starting material is usually a fibrous web comprising any of the common synthetic or natural textile-length fibers, or combinations thereof.
- Nonlimiting examples of natural materials useful in the present invention include, but are not limited to, rayon fibers, silk fibers, keratin fibers and cellulosic fibers.
- Nonlimiting examples of keratin fibers include those selected from the group consisting of wool fibers, camel hair fibers and the like.
- Nonlimiting examples of cellulosic fibers include those selected from the group consisting of wood pulp fibers, cotton fibers, hemp fibers, jute fibers, flax fibers and combinations thereof.
- Cellulosic fiber materials are preferred in the present invention such as TencileTM.
- Nonlimiting examples of synthetic materials useful in the present invention include those selected from the group consisting of acetate fibers, acrylic fibers, cellulose ester fibers, modacrylic fibers, polyamide fibers, polyester fibers, polyolefin fibers, polyvinyl alcohol fibers, rayon fibers, polyethylene foam, polyurefhane foam, and combinations thereof.
- suitable synthetic materials include acrylics such as AcrilanTM, CreslanTM, and the acrylonitrile-based fiber, OrionTM; cellulose ester fibers such as cellulose acetate, ArnelTM, and AceleTM; polyamides such as nylons (e.g., nylon 6, nylon 66, nylon 610, and the like); polyesters such as FortrelTM, KodelTM, and the polyethylene terephthalate fiber, polybutylene terephthalate fiber, DacronTM; polyolefins such as polypropylene, polyethylene; polyvinyl acetate fibers; and combinations thereof.
- acrylics such as AcrilanTM, CreslanTM, and the acrylonitrile-based fiber, OrionTM
- cellulose ester fibers such as cellulose acetate, ArnelTM, and AceleTM
- polyamides such as nylons (e.g., nylon 6, nylon 66, nylon 610, and the like)
- polyesters such as FortrelTM, Kodel
- spunbond fibers refers to small diameter fibers which are formed by extruding molten thermoplastic material as filaments from a plurality of fine, usually circular capillaries of a spinneret with the diameter of the extruded filaments then being rapidly reduced. Spunbond fibers are generally not tacky when they are deposited on a collecting surface. Spunbond fibers are generally continuous and have average diameters (from a sample of at least 10) larger than 7 microns, and more particularly, between about 10 and 40 microns.
- meltblowing refers to a process in which fibers are formed by extruding a molten thermoplastic material through a plurality of fine, usually circular, die capillaries as molten threads or filaments into converging high velocity, usually heated, gas (for example air) streams which attenuate the filaments of molten thermoplastic material to reduce their diameter, which may be to microfiber diameter. Thereafter, the meltblown fibers are carried by the high velocity gas stream and are deposited on a collecting surface, often while still tacky, to form a web of randomly dispersed meltblown fibers. Meltblown fibers are microfibers which may be continuous or discontinuous and are generally smaller than 10 microns in average diameter.
- polymer generally includes, but is not limited to, homopolymers, copolymers, such as for example, block, graft, random and alternating copolymers, terpolymers, etc., and blends and modifications thereof.
- polymer includes all possible geometric configurations of the material. The configurations include, but are not limited to, isotactic, atactic, syndiotactic, and random symmetries.
- the term "monocomponent" fiber refers to a fiber formed from one or more extruders using only one polymer. This is not meant to exclude fibers formed from one polymer to which small amounts of additives have been added for coloration, antistatic properties, lubrication, hydrophilicity, etc. These additives, for example titanium dioxide for coloration, are generally present in an amount less than about 5 weight percent and more typically less than about 2 weight percent.
- bicomponent fibers refers to fibers which have been formed from at least two different polymers extruded from separate extruders but spun together to form one fiber.
- the polymers are arranged in substantially constantly positioned distinct regions across the cross-section of the bicomponent fibers and extend continuously along the length of the bicomponent fibers.
- the configuration of such a bicomponent fiber may be, for example, a sheath/core arrangement wherein one polymer is surrounded by another, or may be a side-by-side arrangement, a pie arrangement, or an "islands-in-the-sea" arrangement.
- Bicomponent fibers can be splittable fibers, such fibers being capable of being split lengthwise before or during processing into multiple fibers each having a smaller cross-sectional dimension than the original bicomponent fiber.
- Splittable fibers have been shown to produce softer nonwoven webs due to their reduced cross-sectional dimensions.
- Representative splittable fibers useful in the present invention include type T-502 and T-512 16 segment PET/nylon 6 2.5 denier fibers; and type T- 522 16 segment PET/PP splittable fibers, all available from Fiber Innovation Technology, Johnson City, TN.
- conjugate fibers refers to fibers which have been formed from at least two polymers extruded from separate extruders but spun together to form one fiber. Conjugate fibers are also sometimes referred to as multicomponent or bicomponent fibers.
- the polymers are usually different from each other though conjugate fibers may be monocomponent fibers.
- the polymers are arranged in substantially constantly positioned distinct zones across the cross section of the conjugate fibers and extend continuously along the length of the conjugate fibers.
- the configuration of such a conjugate fiber may be, for example, a sheath/core arrangement wherein one polymer is surrounded by another or may be a side-by-side arrangement, a segmented configuration ration or an "islands-in-the-sea" arrangement.
- the polymers may be present in ratios of 75/25, 50/50, 25/75 or any other desired ratios.
- multiconstituent fibers is used herein in accordance with its accepted meaning in the art, as is the term “domain”.
- the multiconstituent fibers are understood as including those fibers comprising at least two polymers dispersed in domains, as at least one discontinuous phase, throughout another polymer, provided in the form of a continuous phase.
- the multiconstituent fibers are further understood as including those fibers comprising at least two or more polymers inter dispersed in domains; such dispersion may be random.
- biconstituent fibers refers to fibers which have been formed from two polymers extruded from the same extruder as a blend. Biconstituent fibers do not have the various polymer components arranged in relatively constantly positioned distinct regions across the cross sectional area of the fiber and the various polymers are usually not continuous along the entire length of the fiber, instead usually forming fibrils which start and end at random. Biconstituent fibers are sometimes also referred to as multiconstituent fibers.
- capillary channel fibers refers to fibers having capillary channels. Such fibers can be hollow fibers, for example, but are preferably fibers having capillary channels on their outer surfaces.
- the capillary channels can be of various cross-sectional shapes such as "U-shaped”, “H-shaped”, “C-shaped” and "V-shaped”.
- the term "integral" as in “integral extension” when used of the second regions 4 refers to fibers of the second regions 4 having originated from the fibers of the precursor web 20 wherein the web comprises at least 4 discrete integral second regions per square centimeter. Therefore, the looped fibers 8 of deformations 6, for example, can be plastically deformed and extended fibers of the precursor web 20, and are, therefore, integral with first regions 2 of web 1.
- integral is to be distinguished from fibers introduced to or added to a separate precursor web for the purpose of making tufts, as is commonly done in conventional carpet making, for example.
- a suitable nonwoven web 20 should comprise fibers capable of experiencing sufficient plastic deformation and tensile elongation, or are capable of sufficient fiber mobility such that looped fibers 8 are formed.
- fibers capable of experiencing sufficient plastic deformation and tensile elongation, or are capable of sufficient fiber mobility such that looped fibers 8 are formed.
- loose fibers are referred to herein as "loose” or “broken” fibers 18 as shown in FIG. 3.
- Loose fiber ends 18 can also be the result of forming deformations 6 from nonwoven webs consisting of or containing cut staple fibers.
- Loose fiber ends 18 are not necessarily undesirable for the present invention, but it is believed that web 1 can retain its bulky and soft character more readily when deformation 6 comprises primarily looped fibers 8 up to about 100 weight percent. In a preferred embodiment at least 5 weight percent, preferably at least 10 weight percent, more preferably at least 20 weight percent, more preferably at least 30 weight percent, more preferably at least 40 weight percent, more preferably at least 50 weight percent, more preferably 70 weight percent and even still more preferably 90 weight percent of the fibers urged in the Z-direction are looped fibers 8.
- deformation 6 for the embodiment of web 1 shown in FIG. 1 is shown in a further enlarged view of region 2 in FIG. 2.
- deformation 6 comprises a plurality of looped fibers 8 that are substantially aligned such that deformation 6 has a distinct longitudinal orientation and a longitudinal axis L.
- the term "longitudinal”, as used herein, refers to a line, axis or direction in the plane of the deformations 6 that is aligned with the longest dimension of the deformation 6.
- Deformations 6 also have a transverse axis T, See FIG 4., generally orthogonal to longitudinal axis L in the MD-CD plane. In the embodiment shown in FIGS. 1 and 2, longitudinal axis L is parallel to the MD.
- all the spaced apart deformations 6 have generally parallel longitudinal axes L.
- the number of deformations 6 per unit area of web 1, i.e., the area density of deformations 6, can comprise at least 1 deformations 6 per square centimeter, preferably at least 4 deformations 6 per square centimeter, more preferably at least 10 deformations 6 per square centimeter, even more preferably at least 20 deformations 6 per square centimeter, still more preferably at least 30 deformations 6 per square centimeter.
- the area density of deformations 6 need not be uniform across the entire area of web 1, but deformations 6 can be only in certain regions of web 1, such as in regions having predetermined shapes, such as lines, stripes, bands, circles, and the like.
- one characteristic of the fibers 8 of deformations 6 in one embodiment of web 1 is the predominant directional alignment of the looped fibers 8 that are within the loop.
- the looped fibers 8 have a substantially uniform alignment with respect to transverse axis T when viewed in plan view, such as in FIG. 4.
- looped fibers 8 is meant fibers 8 that begin and end in web 1.
- alignd with respect to looped fibers 8 of deformations 6 is meant that looped fibers 8 are all generally oriented such that, if viewed in plan view as in FIG.
- each of the looped fibers 8 has a significant vector component parallel to the transverse axis T, and preferably a major vector component parallel to the transverse axis T.
- a looped fiber 8 oriented at an angle of greater than 45 degrees from the longitudinal axis L when viewed in plan view, as in FIG. 4 has a significant vector component parallel to the transverse axis T.
- a looped fiber 8 oriented at an angle of greater than 60 degrees from longitudinal axis L when viewed in plan view, as in FIG. 4 has a major vector component parallel to the transverse axis T.
- Deformation can comprises a major vector component parallel to transverse axis T up to about 100%).
- At least 1 weight percent, preferably at least 5 weight percent, more preferably at least 10 weight percent, still more preferably at least 20 weight percent, still more preferably at least 30 weight percent, even still more preferably at least 40weight percent, still even more preferably at least 50 weight percent, still even more preferably at least 70 weight percent, and even more preferably at least 90 weight percent of fibers 8 of deformation 6 have a significant, and more preferably, a major vector component parallel to transverse axis T. Fiber orientation can be determined by use of magnifying means if necessary, such as a microscope fitted with a suitable measurement scale.
- a straight-line approximation for both longitudinal axis L and the looped fibers 8 can be used for determining the angle of looped fibers 8 from longitudinal axis L.
- the orientation of looped fibers 8 in the deformations 6 of second region 4 is to be contrasted with the fiber composition and orientation of the first region 2, which, for fibrous, non- woven web precursor webs 20, is best described as having an essentially randomly-oriented fiber alignment.
- the longitudinal axes L of deformations 6 are generally aligned in the MD.
- Deformations 6 and, therefore, longitudinal axes L can, in principle, be aligned in any orientation with respect to the MD or CD. Therefore, in general, it can be said that for each deformation 6, the looped aligned fibers 8 are aligned generally orthogonal to the longitudinal axis L such that they have a significant vector component parallel to transverse axis T, and more preferably a major vector component parallel to transverse axis T.
- FIG. 5 is a scanning electron microscope (SEM) photo of a web 1 similar to that described with respect to FIG. 1.
- the web 1 of FIG. 5 is a 70 gsm spunbond fibrous, non-woven web comprising polyethylene/polypropylene (sheath core) bicomponent fibers.
- the perspective of FIG. 5 is essentially a side view of the first surface 2 and deformations 6 of web 1.
- side view is meant that the photo of FIG. 5 is taken generally in the CD direction as indicated in FIGS. 1-4, such that the MD and longitudinal axes L of each deformation 6 are oriented across (e.g., from right to left) in FIG. 5.
- deformations 6 comprising looped aligned fibers 8 are aligned generally orthogonal to the longitudinal axis L and have at least a significant vector component parallel to transverse axis T.
- deformations 6 due to the preferred method of forming deformations 6, as described below, another characteristic of deformations 6 is their generally open structure characterized by open void area 10, See FIG 2 and 3, defined interiorly of deformations 6.
- the void area 10 may have a shape that is wider or larger at the distal 3 end of deformation 6 and narrower at the base 5 of the deformation 6. This shape is opposite to the shape of the tooth which is used to form the deformation 6.
- void area is not meant completely free of any fibers, but is meant as a general description of its general appearance. Therefore, it may be that in some deformations 6 a loose fiber 8 or a plurality of loose fibers 8 may be present in the void area 10.
- FIG. 6 is a close-up SEM view of one deformation 6 of the web 1 shown in FIG. 5.
- the looped aligned fibers 8 there is a distinct open void area 10 defined by a plurality of looped aligned fibers 8. Very few broken fibers 18 are visible.
- the base 5 of the deformation 6 may be closed (as in the fibers forming the deformation 6 are close enough together to touch) or may remain open. Generally, any opening at the base 6 is narrow.
- the second regions 4 associated with second surface 14 are discontinuities 16 characterized by a generally linear indentation defined by formerly random fibers of the second surface 14 having been urged directionally (i.e., the "Z-direction" as is commonly understood in the fibrous, non-woven web art to indicate an "out-of-plane” direction generally orthogonal to the MD-CD plane as shown in FIGS. 1 and 3) into deformation 6 by the teeth of the forming structure, described in detail below.
- the abrupt change of orientation exhibited by the previously randomly oriented fibers of precursor web 20 defines the discontinuity 16, which exhibits a linearity such that it can be described as having a longitudinal axis generally parallel to longitudinal axis L of the deformation 6.
- discontinuity 16 may not be as distinctly noticeable as deformations 6, for example. For this reason, the discontinuities 16 on the second side of web 1 can go unnoticed and may be generally undetected unless web 1 is closely inspected.
- web 1 has the look and feel of terry cloth in some embodiments, web 1 has the look and feel of terry cloth on a first side, and a relatively smooth, soft look and feel on a second side.
- each precursor web exhibits a pronounced linearity at or near the first and second surfaces 12, and 14, respectively, of web 1.
- the deformations 6 and their corresponding discontinuities 16 of second regions 4 of precursor web 20 each have a linear orientation associated therewith. This linear orientation is an inevitable consequence of the method of making web 1 as described herein.
- One way of understanding this linear orientation is to consider the linear orientation of discontinuities 16 on the second surface 14 of web 1.
- the second region 4 would appear as a linear discontinuity on the first surface 12 of web 1, e.g., as if a linear slit or cut had been made in precursor web 20 at the location of deformation 6.
- This linear web discontinuity corresponds directionally to longitudinal axis L.
- the looped fibers 8 of deformation 6 can originate and extend from either the first surface 12 or the second surface 14 of web 1.
- the fibers 8 of deformation 6 can also extend from the interior 18 of web 1.
- the fibers 8 of deformations 6 extend due to having been urged out of the generally two-dimensional plane of precursor web 20 (i.e., urged in the "Z-direction" as shown in FIG. 3).
- the fibers of the second regions 4 comprise fibers that are integral with and extend from the fibers of the fibrous web first regions 2.
- web 1 can be described as being a fibrous web 1 having a first surface 12 and a second surface 14, the fibrous web 1 comprising a first region 2 and a plurality of discrete integral second regions 4, the second regions 4 having at least one portion being a discontinuity 16 exhibiting a linear orientation and defining a longitudinal axis L and at least another portion being a deformation 6 comprising a plurality of tufted fibers integral with but extending from the first region 2.
- the extension of looped fibers 8 is can be accompanied by a general reduction in fiber cross sectional dimension (e.g., diameter for round fibers) due to plastic deformation of the fibers and the effects of Poisson's ratio. Therefore, the fibers 8 of deformation 6 can have an average fiber diameter less than the average fiber diameter of the fibers of precursor web 20 as well as the fibers of first regions 2, specifically; it is the portion of the fibers in the loop, between the distal and proximal portions, which exhibits the reduction in fiber diameter. The same fiber also exists in the first region, and has at that point the original fiber diameter.
- this reduction in fiber diameter can contribute to a perceived softness or texture of the web 1, a softness that can be comparable to cotton terry cloth, depending on the material properties of the precursor web 20. It has been found that the reduction in fiber cross-sectional dimension is greatest intermediate the base 5 and the distal portion 3. This is believed to be due to the method of making, as disclosed more fully below. Briefly, portions of fibers at the base 5 and distal portion 3 of deformations 6 are adjacent the tip of teeth 110 of roll 104, described more fully below, and are frictionally locked and immobile during processing. Thus, the intermediate portions of deformations 6 are more free to stretch, or elongate, and accordingly more free to experience a corresponding fiber cross sectional dimension reduction.
- a suitable preferred precursor web 20 for a web 1 of the present invention should comprise fibers capable of experiencing sufficient plastic deformation and tensile elongation such that looped fibers 8 are formed.
- a certain percentage of fibers urged out of the plane of the first surface 12 of precursor web 20 will not form a loop, but instead will break and form loose ends.
- Such fibers are shown as loose fiber ends 18 in FIGS. 2 and 3.
- FIG. 7 there is shown in an apparatus and method for making web 1 of the present invention.
- the apparatus 100 comprises a pair of intermeshing rolls 102, rotating around Axis A, and 104, rotating around axis B, the axes A being parallel in the same plane.
- Roll 102 comprises a plurality of ridges 106 and corresponding grooves 108 which extend unbroken about the entire circumference of roll 102.
- Roll 104 is similar to roll 102, but rather than having ridges that extend unbroken about the entire circumference, roll 104 comprises a plurality of rows of circumferentially-extending ridges that have been modified to be rows of circumferentially-spaced teeth 110 that extend in spaced relationship about at least a portion of roll 104.
- the individual rows of teeth 110 of roll 104 are separated by corresponding grooves 112.
- rolls 102 and 104 intermesh such that the ridges 106 of roll 102 extend into the grooves 112 of roll 104 and the teeth 110 of roll 104 extend into the grooves 108 of roll 102.
- the intermeshing is shown in greater detail in the cross sectional representation of FIG. 8, discussed below. Both by means or either of rolls 102 and 104 can be heated known in the art such as hot oil filled rollers, or electrically-heated the roller
- the apparatus 100 is shown in a preferred configuration having one patterned roll, e.g., roll 104, and one non-patterned grooved roll 102. However, in certain embodiments it may be preferable to use two patterned rolls 104 having either the same or differing patterns, in the same or different corresponding regions of the respective rolls. Such an apparatus can produce webs with deformations protruding from both sides of the web 1.
- FIG. 7 The method of making a web 1 of the present invention in a commercially viable continuous process is depicted in FIG. 7.
- Web 1 is made by mechanically deforming a precursor web 20 that can be described as generally planar and two dimensional.
- planar and two dimensional is meant simply that the web is flat relative to the finished web 1 that has distinct, out-of-plane, Z-direction three-dimensionality imparted due to the formation of second regions 4.
- “Planar” and “two-dimensional” are not meant to imply any particular flatness, smoothness or dimensionality.
- Precursor web 20 is provided either directly from a web making process or indirectly from a supply roll (neither shown) and moved in the machine direction to the nip 116 of counter- rotating intermeshing rolls 102 and 104.
- Precursor web can be a nonwoven web comprising any of known fiber types, including monocomponent, bicomponent, and/or biconstituent, capillary channel fibers, hollow fibers, shaped or lobed fibers and can have major cross-sectional dimensions (e.g., diameter for round fibers) ranging from 5-500 microns.
- Precursor web 20 can be preheated by means known in the art, such as by heating over oil-heated rollers.
- precursor web can be a fibrous, non-woven web made by known processes, such as meltblown, spunbond, and bonded carded web processes.
- precursor web 20 goes through the nip 116 the teeth 110 of roll 104 enter grooves 108 of roll 102 and simultaneously urge fibers out of the plane of plane of precursor web 20 to form deformations 6.
- teeth 110 "push” or "punch” through precursor web 20.
- the tip of teeth 110 push through precursor web 20 the portions of fibers that are oriented predominantly in the CD and across teeth 110 are urged by the teeth 110 out of the plane of precursor web 20 in the Z-direction until the fibers either stretch or plastically deform or break, resulting formation of second region 4, including the looped fibers 8 of deformations 6 of web 1.
- Fibers that are predominantly oriented generally parallel to the longitudinal axis L, i.e., in the machine direction of precursor web 20 as shown in FIG. 1, are simply spread apart by teeth 110 and remain substantially in the first region 2 of web 1.
- the looped fibers 8 can exhibit the unique fiber orientation which is a high percentage of fibers having a significant or major vector component parallel to the transverse axis T of deformation 6, as discussed above with respect to FIGS. 3 and 4.
- at least some of the fibers of deformation 6 are looped, aligned fibers 8 which can be described as having a significant or major vector component parallel to a Z-oriented plane orthogonal to transverse axis T.
- the number, spacing, and size of deformations 6 can be varied by changing the number, spacing, and size of teeth 110 and making corresponding dimensional changes as necessary to roll 104 and/or roll 102.
- This variation together with the variation possible in precursor webs 20 and line speeds, permits many varied webs 1 to be made for many purposes.
- FIG 8 shows in cross section a portion of the intermeshing rolls 102 and 104 and ridges 106 and teeth 110.
- teeth 110 have a tooth height TH (note that TH can also be applied to ridge height; in a preferred embodiment tooth height and ridge height are equal), and a tooth-to- tooth spacing (or ridge-to-ridge spacing) referred to as the pitch P.
- depth of engagement E is a measure of the level of intermeshing of rolls 102 and 104 and is measured from tip of ridge 106 to tip of tooth 110.
- the depth of engagement E, tooth height TH, and pitch P can be varied as desired depending on the properties of precursor web 20 and the desired characteristics of web 1. For example, in general, the greater the level of engagement E, the greater the necessary elongation characteristics the fibers of precursor web 20 should possess if predominantly looped deformations are desired. Also, the greater the density of second regions 4 desired (second regions 4 per unit area of web 1), the smaller the pitch should be, and the smaller the tooth length TL and tooth distance TD should be, as described below.
- FIG. 9 shows one embodiment of a roll 104 having a plurality of teeth 110 useful for making a terry cloth-like web 1 of spunbond fibrous, non- woven web material from a precursor web 20 having a basis weight of between about 60 gsm and 100 gsm, preferably about 80 gsm.
- An enlarged view of teeth 110 is shown in FIG. 10.
- teeth 110 have a uniform circumferential length dimension TL measured generally from the leading edge LE to the trailing edge TE at the tooth tip 111 of about 1.25 mm and are uniformly spaced from one another circumferentially by a distance TD of about 1.5 mm.
- teeth 110 of roll 104 preferably have a length TL ranging from about 0.5 mm to about 3 mm and a spacing TD from about 0.5 mm to about 3 mm, a tooth height TH ranging from about 0.5 mm to about 10 mm, and a pitch P between about 1 mm (0.040 inches) and 2.54 mm (0.100 inches).
- Depth of engagement E can be from about 0.5 mm to about 5 mm (up to a maximum equal to tooth height TH).
- E, P, TH, TD and TL can be varied independently of each other to achieve a desired size, spacing, and area density of deformations 6 (number of deformations 6 per unit area of web 1).
- each tooth 110 has a tip 111, a leading edge LE and a trailing edge TE.
- the tooth tip 111 is elongated and has a generally longitudinal orientation, corresponding to the longitudinal axes L of second regions 4. It is believed that to get the tufted, looped deformations 6 of the web 1 that can be described as being terry cloth-like, the LE and TE should be very nearly orthogonal to the local peripheral surface 120 of roll 104. As well, the transition from the tip 111 and LE or TE should be a sharp angle, such as a right angle, having a sufficiently small radius of curvature such that teeth 110 push through precursor web 20 at the LE and TE.
- line speed that is, the rate at which precursor web 20 is processed through the nip of rotating rolls 102 and 104, and the resulting rate of formation of deformations 6, impacts the structure of the resulting deformations 6.
- the deformations 6 shown in FIGS. 5 and 6 were made at a relatively low rate of approximately 3 meters per minute (m min) (about 10 feet per minute). Three m/min is considered a relatively slow rate for commercial production for many consumer applications, but for the spun bond, bicomponent fibers used in the fibrous, non- woven web shown in FIGS. 5 and 6 this relatively slow speed results in very uniform, looped, aligned fibers in deformations 6.
- FIGS. 11 and 12 show representative deformations 6 for webs 1 made from the same material with the same process conditions, the only difference being the rotational speed of the rolls 102 and 104, i.e., line speed (in units of length/time) of the precursor web 20 being processed into web 1.
- the web shown in FIGS. 11 and 12 is a 25 gsm available from BBA Fibrous, non-woven webs, Simpsonville, SC, and sold under the trade name Softspan 200®.
- the web 11 was processed through the nip 116 of rolls 102 and 104 having a depth of engagement E of about 3.4 mm (about 0.135 inch), a pitch P of 0.060 in., a tooth height TH of 0.154 in, a tooth distance of TD of 0.0625 in., and a tooth length of TL of 0.050 in.
- the web was run at a line speed of about 15 meters/minute (about 50 feet per minute).
- the web shown in FIG. 12 is identical to the web shown in FIG. 11, and was processed under identical conditions except for the line speed, which was about 150 meters per minute (about 500 feet per minute).
- the deformation 6 shown in FIG. 11 is similar in structure to the deformations shown in FIGS. 1-6. That is, it exhibits substantially aligned, looped fibers 8 with very few broken fibers, e.g., fibers 18 as shown in FIG 3.
- the deformation 6 shown in FIG. 12 exhibits a very different structure, a structure that appears to be typical of spunbond fibrous, non-woven web materials processed to form deformations 6 at relatively high speeds.
- Mat 7 comprises and is supported at the top of deformations 6 by unbroken, looped fibers 8, and also comprises portions of broken fibers 11, that are no longer integral with precursor web 20. That is, mat 7 comprises fiber portions which were formerly integral with precursor web 20 but which are completely detached from precursor web 20 after processing at sufficiently high line speeds in the process described with reference to FIGS. 7 and 8.
- web 1 can be described as being a fibrous web 1 having a first surface 12 and a second surface 14, the fibrous web 1 comprising a first region 2 and a plurality of discrete second regions 4, the second regions 4 having at least one portion being a discontinuity 16 exhibiting a linear orientation and defining a longitudinal axis L and at least another portion being a deformation 6, the deformation 6 comprising fibers integral with but extending from first region 2 and fibers neither integral with nor extending from first region 2.
- FIGS. 13 and 14 Another example of webs 1 being identical in material and processing except for line speed is shown with respect to FIGS. 13 and 14.
- the precursor web 20 for each web 1 shown in FIGS. 13 and 14 was a 60 gsm DAPP (Ductile Oriented Polypropylene) available from BBA Fibrous, non-woven web s, Simpsonville, SC, and sold under the trade name Softspan 200®.
- the web 13 was processed through the nip 116 of rolls 102 and 104 having a depth of engagement E of about 3.4 mm (about 0.135 inch), a pitch P of 0.060 in., a tooth height TH of 0.145 in., a tooth distance of TD of 0.0625 in., and a tooth length of TL of 0.050 in.
- the web was run at a line speed of about 15 meters/minute (about 50 feet per minute).
- the web shown in FIG. 14 is identical to the web shown in FIG. 13, and was processed under identical conditions except for the line speed, which was about 150 meters per minute (about 500 feet per minute).
- the web 1 shown in FIG. 13 was processed at a line speed of about 15 meters per minute (about 50 feet per minute). As shown, even at this relatively moderate line speed, some amount of matting at the distal end of deformation 6 is noticed. This matting, which appears to be a higher density of flattened, compressed fiber portions, occurs on the portion of deformation 6 associated with the tip of tooth 110 of roll 104. As line speed is increased, this matting, i.e., mat 7, becomes more distinct, as shown in FIG. 14, which shows a web processed under identical conditions as the web shown in FIG. 13, but was processed at a line speed of about 150 meters per minute (about 500 feet per minute). The deformations 6 shown in FIG. 14 exhibit a more distinct mat 7 and can be described as comprising fibers integral with but extending from first region 2 and fibers neither integral with nor extending from first region 2.
- the distinct fiber orientation observed at the distal portion of deformations 6, e.g., mat 7, is due primarily to processing rates, it is also believed to be affected by other parameters, such as fiber type, basis weight of the precursor web 20 as well as processing temperatures that can affect the of fiber-to-fiber bonding
- other parameters such as fiber type, basis weight of the precursor web 20 as well as processing temperatures that can affect the of fiber-to-fiber bonding
- matting of fibers occurs on the portion of deformation 6 associated with the tip of tooth 110 of roll 104. It is believed that frictional engagement of the fibers at the tip of the teeth "lock" the fibers in place, thereby limiting fiber elongation and/or fiber mobility, two mechanisms believed to permit formation of deformations 6.
- fibers adjacent tooth 110 tip can be broken, and, due to the random entanglement of the precursor web as well as possible cold fusion of fibers due to pressure and friction, the broken fibers become and remain lodged in mat 7 at the distal end of deformations 6.
- Precursor webs 20 having relatively higher basis weights generally have relatively more fiber portions in mat 7. In one sense, it appears as is as if most of the fiber content of the precursor web is simply displaced in the Z-direction to the distal portion of deformations 6, resulting in mat 7.
- Precursor webs 20 comprising relatively low elongation fibers, or fibers with relatively low fiber-to-fiber mobility (e.g., fiber reptation) appear to result in relatively few fibers becoming and remaining lodged in mat 7 at the distal end of deformations 6. Fiber-to-fiber mobility can be increased reducing or eliminating the fiber-to-fiber bonds. Thermal bonds can be completely eliminated, or significantly reduced in certain nonwoven webs to increase fiber-to- fiber mobility.
- hydroentangled web can be less entangled to increase fiber-to-fiber mobility.
- any precursor web 20 lubricating it prior to processing as disclosed herein can also increase fiber-to-fiber mobility.
- a surfactant or mineral oil lubricant can be applied to precursor web 20 prior to it entering the nip 116 of rolls 102 and 104.
- mats 7 The result of the presence of mats 7 is a slightly rougher, textured web 1 useful, for example, for wipes in which more scrubbing texture is desirable.
- a web having soft terry cloth-like tactile impression under relatively low-speed processing can have the feel of a cheap hotel towel when processed under identical, but relatively higher speed conditions.
- This rough, textured tactile impression can be useful for some applications, such as for a hard surface cleaning wipe, an exfoliating facial wipe, and a skin cleansing wipe.
- carded fibrous, non-woven webs can produce deformations 6 having few, if any, looped, aligned fibers 8, and many, if not all, non-aligned fibers and/or broken fibers 18.
- the web of the present invention need not have looped, aligned fibers, and in one embodiment can be described as being a fibrous web 1 formed by selective mechanical deformation of a precursor web 20 having a first surface 12 and a second surface 14 and comprising substantially randomly-oriented fibers, the fibrous web comprising a first region of substantially randomly-oriented fibers being substantially free of deformation by the selective mechanical deformation, and a plurality of discrete integral second regions, the second regions 4 comprising spaced-apart deformations 6 of the precursor web 20, each of the second regions 4 having at least one portion being a discontinuity 16 exhibiting a linearity and defining a longitudinal axis L and at least another portion comprising a plurality of tufted fibers integral with but extending from said first region.
- Webs 1 of the present invention offer many opportunities for producing engineered materials having selected characteristics.
- a web 1 can be made by selecting the length of staple fibers in a carded precursor web 20 so that the probability of having fiber ends exposed in deformations 6 can be reliably predicted.
- a carded web of staple fibers can be blended or laminated with a spunbond fibrous, non-woven web to produce a hybrid, such that the deformations 6 of second regions 4 comprise primarily looped spunbond fibers and the first regions 2 comprise both carded and spunbond fibers.
- the type of fibers, the length of staple fibers, the layering of fibers, and other variations of precursor web 20 can be varied as desired to produce desired functional characteristics of the web 1.
- precursor web 20 is a fibrous, non-woven web in which there are minimal fiber-to-fiber bonds.
- the precursor web can be a fibrous, non-woven web having a pattern of discrete thermal point bonds, as is commonly known in the art for fibrous, non-woven webs.
- Preferred carded thermal bonded webs for the present invention are lightly bonded.
- lightly bonded means that the nonwoven web has been thermally bonded sufficiently to melt the fusible fibers and provide web integrity for easy handling and transporting, but not enough to heavily bond the web such that the web losses its softness and flexibility.
- lightly bonding is preferred for making tufts and loops.
- web 1 is disclosed in preferred embodiments as a single layer web made from a single layer precursor web 20, it is not necessary that it be so.
- a laminate or composite precursor web 20 having two or more layers or plies can be used.
- looped aligned fibers 8 for example, formed from a laminate precursor web may be comprised of fibers from both (or all) layers of the laminate.
- fibers from all the layers of the laminate may contribute to the tufted deformations 6.
- the fibers of the different webs may be mixed or intermingled in the deformation 6. The fibers do not protrude through but combine with the fibers in an adjacent web. This is often observed when the webs are processed at very high speeds.
- Multilayer webs 1 can have significant advantages over single layer webs 1.
- a deformation 6 from a multilayer web 1 using two precursor webs 20A and 20B is shown schematically in FIGS. 16-18.
- both precursor webs 20A and 20B contribute fibers to deformations 6 in a "nested" relationship that "locks" the two precursor webs together, forming a laminate web without the use or need of adhesives or thermal bonding between the layers.
- an adhesive, chemical bonding, resin or powder bonding, or thermal bonding between the layers can be selectively utilized to certain regions or all of the precursor webs.
- the deformations 6 retain the layered relationship of the laminate precursor web, as shown in FIG. 16, and in all preferred embodiments the upper layer (specifically layer 20A in FIGS. 16-18, but in general the top layer with reference to the Z- direction as shown in FIGS. 16-18) remains substantially intact and forms looped fibers 8 shown in FIG. 2.
- each precursor web can have different properties.
- web 1 can comprise two (or more) precursor webs, e.g., first and second precursor webs 20A and 20B.
- First precursor web 20A can form an upper layer exhibiting high elongation and significant elastic recovery which enables the web 20A to spring back.
- the spring back helps to laterally squeeze the base portion 5 of the deformation 6 of both webs as shown in FIG. 16.
- the spring back or lateral squeeze also helps to secure and stabilize the Z-oriented fibers in the deformation 6.
- the lateral squeeze provided by precursor web 20A can also increase the stability of the second precursor web 20B.
- An example of a multilayer web 1 includes a first precursor web 20A comprised of spunbond PE/PP sheath/core nonwoven web made by BBA, Washougal WA.
- the second precursor web 20B is comprised of a thermal point bonded carded PET/Co-PET nonwoven web (50% 6dpf PET Wellman Type 204 made in Charlotte NC and 50% 6 dpf Co-PET Kanematsu Type LM651 made in Gastonia NC.
- the second precursor web 20B can be loosely bonded to enable tufting so the lateral squeeze of the first precursor web 20A can also increase the stability of the second precursor web 20B.
- the multilayer web 1 can be utilized as a body- contacting layer when used as a topsheet on a disposable absorbent article or can be utilized as a lower layer which is disposed between the topsheet and an absorbent core.
- the multilayer web could also be utilized as an absorbent core.
- each precursor web can have different material properties, thereby providing web 1 with beneficial properties.
- web 1 comprising two (or more) precursor webs, e.g., first and second precursor webs 20A and 20B can have beneficial fluid handling properties for use as a topsheet on a disposable absorbent article, as described more fully below.
- first precursor web 20A can form an upper layer (i.e., a body-contacting when used as a topsheet on a disposable absorbent article) and be comprised of relatively hydrophobic fibers.
- Second precursor web 20B can form a lower layer (i.e., disposed between the topsheet and an absorbent core when used on a disposable absorbent article) comprised of relatively hydrophilic fibers.
- Fluid deposited upon the upper, relatively hydrophobic layer is quickly transported to the lower, relatively hydrophilic, layer.
- One reason for the observed rapid fluid transport is the capillary structures formed by the generally aligned fibers 8, 18 of deformations 6.
- the fibers 8, 18 form directionally-aligned capillaries between adjacent fibers, and the capillary action is enhanced by the general convergence of fibers near proximal portion 5 of deformations 6.
- first precursor web 20 A can be comprised of relatively soft fibers (e.g., polyethylene), while second precursor web 20B can be comprised of relatively stiff fibers (e.g., polyester).
- first precursor web 20 A can be comprised of relatively soft fibers (e.g., polyethylene)
- second precursor web 20B can be comprised of relatively stiff fibers (e.g., polyester).
- deformations 6 can retain or recover a certain amount of height h, even after applied pressure.
- web 1 of the present invention can exhibit a wide range of physical properties.
- the web 1 can exhibit a range of texture subjectively experienced as ranging from softness to roughness; an absorbency ranging from non-absorbent to very absorbent; a bulkiness ranging from relatively low bulk to relatively high bulk; a tear strength ranging from low tear strength to high tear strength; an elasticity ranging from non-elastic to at least 100% elastically extensible; a chemical resistance ranging from relatively low resistance to high resistance; depending on the chemical considered, and many other variable parameters generally described as shielding performance, alkali resistance, opacity, wiping performance, water absorptivity, oil absorptivity, moisture permeability, heat insulating properties, weatherability, high strength, high tear force, abrasion resistance, electrostatic controllability, drape, dye-affinity, safety and the like.
- the dimensions of apparatus 100 can be varied to produce a web 1 having a wide range of dimensions associated with second regions 4, including the height h (as shown in FIG. 20), and spacing (including area density of discrete second regions 4).
- FIG. 19 is a photomicrograph of a terry cloth-like fibrous, non-woven web fabric web 1 made by the process of the present invention using a roll 104 as shown in FIGS 9 and 10 and useful as a component of a disposable, absorbent article.
- the precursor web 20 used for the web 1 shown in FIG. 19 was a spunbond fibrous, non- woven web having a basis weight of about 80 gsm, and comprising polyethylene/polypropylene (sheath core) polyethylene/polypropylene (sheath core) polyethylene/polypropylene (sheath/core) bicomponent fibers having an average diameter of about 33 microns.
- 19 has about 24 deformations 6 per square centimeter and is folded with the folded edge visible to show more clearly a plurality of spaced apart, tufted, looped deformations 6 having a plurality of looped, aligned fibers 8, each of which has an average fiber diameter of about 18 microns.
- a single deformation 6 is shown in FIG. 20 with dimensions indicated.
- the void area 10 tufted, looped, deformation 6 is typically generally circular or oblong in shape, having a major dimension, referred to as height h, that can be at least 1 mm.
- the height is not considered to be critical to the operation of the web, but can be varied depending on the desired end use of web 1.
- the height h can be from 0.1 mm to about 10 mm or more.
- a web 1 formed from a fibrous, non-woven web precursor web 20 and having a look and feel of terry cloth should have a height h of about 1 mm to about 3 mm.
- second region 4 can comprise deformations 6, each deformation 6 comprising a plurality of tufted, aligned fibers 8 extending outwardly from first surface 12.
- Deformations 6 can be described as "tufts" of fibers, and each deformation 6 has a base 5 proximal to the first surface 12, and a distal portion 3 at a maximum distance from the first surface 12.
- a second region 4 can comprise discontinuities 16 which are defined by fiber orientation discontinuities on the first surface 12 of web 1.
- second region 4 can comprise deformations 6, each deformation 6 comprising a plurality of tufted, looped, aligned fibers 8 extending outwardly from second surface 14.
- Deformations 6 can be described as "tufts" of fibers, and each deformation 6 has a base 5 proximal to the second surface 14, and a distal portion 3 at a maximum distance from the second surface 14.
- a second region can comprise discontinuities 16 which are defined by fiber orientation discontinuities on second surface 14 of web 1. Therefore, web 1 can comprise deformation 6 and discontinuities 16 on first surface 12 and second surface 14.
- Table 1 below shows representative dimensions for representative apparatus and webs made thereon.
- a representative portion of a side of a web is selected and a sample of the web is prepared suitable for evaluation by scanning electron microscope (SEM) imaging, which produces an image or photomicrograph, by standard procedures well known to those skilled in the art.
- SEM scanning electron microscope
- Imaging first at a relatively low magnification, about, 1 Ox, a field is chosen having tufts. Within the field, several representative tufts are selected and images taken at several viewing angles in order to augment the ability to count fibers contained in the selected tufts. At least a first image is taken of each selected tuft facing in the machine direction at a low angle from the surface, viewing through the open ends of the tuft. At least a second image is obtained at an angle rotated close to 90 degrees from the first image.
- Magnification is selected to enhance the ability to accurately count and measure the diameter of fibers within the tuft. If a representative portion of the bulk is not visible in the images already obtained, an image of the bulk surface, away from the tuft, is also obtained for comparison. Suitable magnifications typically range from about lOx to about lOOx when the images are printed out in 8 in. x 10 in. size and measurements taken with a 6 inch caliper. Print the images in 8 in. x 10 in. size or larger, which is a photomicrograph. Include a scale bar on each printed image. Fiber Count
- Count all the visible fiber ends in the tuft Use a pencil, pen or marker to identify each end as it is counted. This minimizes the risk of counting the same end more than once. Carefully examine the tuft images, looking for ends that missed being counted. Adjust the count accordingly. The result obtained is the Number of Fiber Ends per Tuft. Note that some fibers may pull out of the web surface, exposing only one end, in which case the Number of Fiber Ends per Tuft can be an odd value, not an even value. It is reported as counted regardless of whether the value obtained is odd or even.
- N Total Number of Fibers per Tuft - (Number of Fiber Ends per Tuft)/2 Express the Number of Fibers per Tuft Not Broken as a percentage according to Equation 2.
- N/% 100 x N/Total Number of Fibers per Tuft
- Tuft Height is H
- Tuft Maximum Width is W
- Tuft Minimum Width is B.
- To measure the Tuft Maximum Width set the caliper spacing to the width of that tuft at the widest point. Most tufts will have a few random stray fibers that protrude dramatically from the bulk of the tuft. Do not include these fibers within the caliper gap. Compare the caliper spacing with several additional tufts (5 - 10). Average the results, and use the scale bar to adjust the result to actual dimensions.
- Personal care articles of the present invention require, in addition to the fibrous web of the present invention, at least one cleansing and, or treatment composition associated with the fibrous, non-woven web that are useful for cleansing and, or treating the skin, hair, and similar keratinous surfaces of the body.
- Inventors have discovered that the combined action of the tufted web and the treatment/cleansing component (i.e., composition as part of another composition) associated with the web of the current invention provides an unexpected level of benefits in personal care articles. Without being limited by theory, it is believed that the multitude of fibers oriented orthogonal to the plane of the web, in addition to providing a surface which can advantageously feel soft or textured, provide unique cleansing, exfoliating, treating and/or lathering benefits when combined with treatment compositions of the present invention.
- Personal care articles of the present invention may comprise volatile and non-volatile fluids selected from the group consisting of water, mono- and polyhydric alcohols (glycerin, propylene glycol, ethanol, isopropanol, etc.), hydrocarbon oils such as mineral oil, silicone fluids, also triglyceride oils, also fluid resins such as silicone MQ resins, esters and ethers of hydrocarbons, alcohols, perfume, fragrance oils, natural oils such as terpenes, various tree and plant oils, as well as mixtures of the above and can contain other components dissolved or dispersed within them, or in addition to them.
- volatile and non-volatile fluids selected from the group consisting of water, mono- and polyhydric alcohols (glycerin, propylene glycol, ethanol, isopropanol, etc.), hydrocarbon oils such as mineral oil, silicone fluids, also triglyceride oils, also fluid resins such as silicone MQ resins, esters and ethers of hydrocarbons, alcohol
- the articles may also be useful without the addition of fluids or the fluid may be activated, or both. Because of the interaction of the tufted web with the treatment composition, low levels of the treatment component can provide substantial benefit. For example, only about 0.25 grams to about 10 grams of dried surfactant component per square meter of web surface area (0.25 - 10.0 gsm) can provide a lather benefit useful for facial cleansing. Because of the low density nature of the tufted web, the web is also capable of holding at least about 10 times the weight of the fibrous, non-woven web of a liquid treatment component, useful for wiping onto or delivering to the designated surface a treatment composition. Other uses of the articles of the present invention will become apparent from the examples disclosed herein.
- personal care articles of the present invention may appear to not contain deformations, for example in the presence of treatment compositions contained thereon, if a large amount of opaque composition is added to the web of the invention, masking the presence of deformations.
- a stack of 30 folded, interleaved personal care articles of the current invention each article containing 500 weight percent by weight of the substrate of a viscous, opaque, therapeutic, semi-solid emulsion may not readily exhibit the tufts and loops contained therein.
- Masking the presence of deformations in no way diminishes the benefits obtained thereby, and the presence of deformations, i.e., tufts and/or loops, can be verified by first removing the personal care composition from the web of the invention.
- the present invention is for personal care articles used by individuals primarily for cleansing and, or treatment of skin, hair or other and similar keratin-containing surfaces including skin, hair and finger and toe nails. These personal care articles encompass the use of personal care compositions that are embedded or impregnated onto the surface of the fibrous nonwoven web of the present invention.
- the personal care compositions of the present invention are selected from the group consisting of cleansing compositions and treatment agents and mixtures thereof.
- the present invention can comprise articles that combine both cleansing compositions and treatment agents into a single article.
- the articles of the present invention also comprise one or more lathering surfactants that are associated with the fibrous, non-woven web or substrate fibrous, non- woven web.
- the lathering surfactants can be added onto or impregnated into the fibrous, non- woven web. Generally this will be done prior to the point of use of the article, i.e., the surfactants will be combined with the article before the article is ultimately wetted for use.
- the body cleansing compositions of the present invention comprise a sufficient amount of one or more lathering surfactants such that the articles are capable of generating at least 1400ml of Total Steady Lather Volume according to the Steady Lather Volume Test described below.
- the face cleansing compositions of the present invention of the present comprises a sufficient level of surfactant described herein that it generates at least 85 ml of Mechanical Lather Volume, as described in the Mechanical Lather Volume Test described below.
- the shampoo articles of the present invention comprise sufficient level of a shampoo composition dried on the fibrous, non- woven web.
- the body cleansing compositions are characterized as having lather that lasts for an extended time period, and are most useful for washing a larger surface, i.e. such as washing the entire body during showering.
- the body cleansing composition will preferably comprise no more than about 1600 weight percent by weight of the web of the lathering surfactant, preferably comprise no more than about 1000 weight percent, more preferably no more than about 800 weight percent, and still more preferably no more than about 600 weight percent by weight of the web of a lathering surfactant.
- the body cleansing composition will preferably comprise at least 15 weight percent by weight of the web of the lathering surfactant, preferably at least 25 weight percent, more preferably at least 50 weight percent, and still more preferably at least 60 weight percent by weight of the web of a lathering surfactant.
- the body cleansing compositions of the present invention comprise a sufficient amount of one or more lathering surfactants such that the compositions are capable of generating at least 1400 ml of Steady Total Lather Volume according to the Steady Lather Volume Test described below.
- the body cleansing composition Preferably the body cleansing composition generates at least 1900ml of Steady Total Lather Volume, even more preferably at least 2500ml of Steady Total Lather Volume, and even more preferably at least 3000ml of Steady Total Lather Volume, and still more preferably at least 3500 ml of Total Steady Lather Volume.
- lathering surfactant means a surfactant, that when combined with a fluid and mechanically agitated generates foam or lather sufficient to cause the article that it's associated with to form a lather.
- these lathering surfactants and, or their combination with other surfactants should be mild, which means that these surfactants provide sufficient cleansing or detersive benefits but do not overly dry the skin or hair, and yet meet the lathering criteria described in the Steady Lather Volume Test.
- the face cleansing compositions create a lather which is used to wash a small portion of the skin generally using lower amounts of fluid. Face cleansing compositions are particularly useful for facial cleansing at a sink.
- the face cleansing compositions will preferably comprise no more than about 250 weight percent by weight of the web of a lathering surfactant.
- the compositions of the present invention comprises no more than about 100 weight percent, more preferably no more than about 75 weight percent, and still more preferably no more than about 50 weight percent by weight of the web of a lathering surfactant.
- the face cleansing compositions will preferably comprise at least 0.5 weight percent by weight of the web of a lathering surfactant.
- the compositions of the present invention comprises at least 0.6 weight percent, more preferably at least .75 weight percent, and still more preferably at least 1 weight percent by weight of the web of a lathering surfactant.
- the face cleansing compositions of the present invention comprise a sufficient amount of one or more lathering surfactants such that the compositions are capable of generating at least 85ml of Mechanical Lather Volume according to the Mechanical Lather Volume Test described below.
- the face cleansing composition generates at least 150 ml of Mechanical Lather Volume, even more preferably at least 220ml of Mechanical Lather Volume, and still more preferably at least 350ml of Mechanical Lather Volume.
- a lathering surfactant is meant a surfactant, which when combined with a fluid and mechanically agitated generates a foam or lather sufficient to cause the article, as a whole, to lather.
- these surfactants or combinations of surfactants should be mild, which means that these surfactants provide sufficient cleansing or detersive benefits but do not overly dry the skin or hair, and yet meet the lathering criteria described above.
- lathering surfactants are useful for both the body cleansing compositions and the face cleansing compositions described herein and include those selected from the group consisting of anionic lathering surfactants, nonionic lather surfactants, amphoteric lathering surfactants, and mixtures thereof.
- lathering surfactants useful in the compositions of the present invention are disclosed in U.S. Pat. No. 6,280,757, to McAtee et al., issued Aug. 28, 2001.
- the lathering surfactants do not strongly interfere with deposition of any conditioning agents that are present, e.g., are fairly water soluble, and usually have an HLB value of above 10.
- Cationic surfactants can also be used as optional components, provided they do not negatively impact the overall lathering characteristics of the required lathering surfactants.
- the shampoo article comprises shampoo compositions that are applied to the fibrous, non-woven web.
- Said article may be a dry, moist or wet article as previously disclosed. This article is suitable for shampoo and the body.
- Suitable Surfactants for the lathering cleansing compositions described above include the following surfactants:
- Non-limiting examples of anionic lathering surfactants useful in the compositions of the present invention are disclosed in McCutcheon's, Detergents and Emulsifiers, North American edition (1986), published by allured Publishing Corporation; McCutcheon's, Functional Materials, North American Edition (1992); and U.S. Pat. No. 3,929,678, to Laughlin et al., issued Dec. 30, 1975.
- anionic lathering surfactants include those selected from the group consisting of sarcosinates, sulfates, isethionates, taurates, phosphates, lactylates, glutamates, and mixtures thereof.
- anionic lathering surfactants include those selected from the group consisting of sarcosinates, sulfates, isethionates, taurates, phosphates, lactylates, glutamates, and mixtures thereof.
- the alkoyl isethionates are preferred, and amongst the sulfates, the alkyl and alkyl ether sulfates are preferred.
- fatty acid soaps i.e., alkali metal salts, e.g., sodium or potassium salts
- fatty acid soaps typically having from a fatty acid having about 8 to about 24 carbon atoms, preferably from about 10 to about 20 carbon atoms.
- These fatty acids used in making the soaps can be obtained from natural sources such as, for instance, plant or animal- derived glycerides (e.g., palm oil, coconut oil, soybean oil, castor oil, tallow, lard, etc.)
- the fatty acids can also be synthetically prepared. Soaps and their preparation are described in detail in U.S. Pat. No. 4,557,853.
- anionic materials include phosphates such as monoalkyl, dialkyl, and trialkylphosphate salts.
- preferred anionic lathering surfactants useful herein include those selected from the group consisting of sodium lauryl sulfate, ammonium lauryl sulfate, ammonium laureth sulfate, sodium laureth sulfate, sodium trideceth sulfate, ammonium cetyl sulfate, sodium cetyl sulfate, ammonium cocoyl isethionate, sodium lauroyl isethionate, sodium lauroyl lactylate, triethanolamine lauroyl lactylate, sodium caproyl lactylate, sodium lauroyl sarcosinate, sodium myristoyl sarcosinate, sodium cocoyl sarcosinate, sodium lauroyl methyl taurate, sodium cocoyl methyl taurate, sodium lauroyl glutamate, sodium myristoyl glutamate,
- ammonium lauryl sulfate ammonium laureth sulfate, sodium lauroyl sarcosinate, sodium cocoyl sarcosinate, sodium myristoyl sarcosinate, sodium lauroyl lactylate, and triethanolamine lauroyl lactylate.
- Non-limiting examples of nonionic lathering surfactants for use in the compositions of the present invention are disclosed in McCutcheon's, Detergents and Emulsifiers, North American edition (1986), published by allured Publishing Corporation; and McCutcheon's, Functional Materials, North American Edition (1992);
- Nonionic lathering surfactants useful herein include those selected from the group consisting of alkyl glucosides, alkyl polyglucosides, polyhydroxy fatty acid amides, alkoxylated fatty acid esters, lathering sucrose esters, amine oxides, and mixtures thereof.
- Non-limiting examples of preferred nonionic surfactants for use herein are those selected form the group consisting of C 8 -C ⁇ 4 glucose amides, C 8 -C ⁇ 4 alkyl polyglucosides, sucrose cocoate, sucrose laurate, lauramine oxide, cocoamine oxide and mixtures thereof.
- amphoteric lathering surfactant is also intended to encompass zwitterionic surfactants, which are well known to formulators skilled in the art as a subset of amphoteric surfactants.
- amphoteric lathering surfactants can be used in the compositions of the present invention. Particularly useful are those which are broadly described as derivatives of aliphatic secondary and tertiary amines, preferably wherein the nitrogen is in a cationic state, in which the aliphatic radicals can be straight or branched chain and wherein one of the radicals contains an ionizable water solubilizing group, e.g., carboxy, sulfonate, sulfate, phosphate, or phosphonate.
- an ionizable water solubilizing group e.g., carboxy, sulfonate, sulfate, phosphate, or phosphonate.
- amphoteric surfactants useful in the compositions of the present invention are disclosed in McCutcheon's, Detergents and Emulsifiers, North American edition (1986), published by allured Publishing Corporation; and McCutcheon's, Functional Materials, North American Edition (1992).
- Non-limiting examples zwitterionic surfactants are those selected from the group consisting of betaines. sultaines, hydroxysultaines, alkyliminoacetates, imninodialkanoates, aminoalkanoates, and mixtures thereof.
- Preferred lathering surfactants for use herein are the following, wherein the anionic lathering surfactant is selected from the group consisting of ammonium lauroyl sarcosinate, sodium trideceth sulfate, sodium lauroyl sarcosinate, ammonium laureth sulfate, sodium laureth sulfate, ammonium lauryl sulfate, sodium lauryl sulfate, ammonium cocoyl isethionate, sodium cocoyl isethionate, sodium lauroyl isethionate, sodium cetyl sulfate, sodium lauroyl lactylate, triethanolamine lauroyl lactylate, and mixtures thereof, wherein the non-ionic lathering surfactant is selected from the group consisting of lauramine oxide, cocoamine oxide, decyl polyglucose, lauryl polyglucose, sucrose cocoate, glucosamides, sucrose laurate, and
- compositions of the present invention also comprise one or more non-lathering surfactants that are associated with the fibrous, non-woven web.
- Preferred articles of the present invention are either wet or moist and the compositions comprise a sufficient amount of one or more non-lathering surfactants such that the compositions do not generate a lather as disclosed in the Steady Lather Volume Test.
- the non-lathering cleansing compositions of the present invention comprise a sufficient amount of one or more non- lathering surfactants such that the compositions are capable of generating from at the most 700ml of Steady Flash Lather Volume according to the Steady Lather Volume Test described below.
- the non-lathering cleansing composition generates less than 400ml of Steady Flash Lather Volume, even more preferably less than 300ml of Steady Flash Lather Volume, and still even more preferably less than 250ml of Steady Flash Lather Volume.
- the non-lathering cleansing composition will preferably comprise no more than about 1600 weight percent by weight of the web of the non-lathering surfactant, preferably comprise no more than about 1000 weight percent, more preferably no more than about 800 weight percent, and still more preferably no more than about 600 weight percent by weight of the web of a non-lathering surfactant.
- the non-lathering cleansing composition will preferably comprise at least 15 weight percent by weight of the web of the non-lathering surfactant, preferably at least 25 weight percent, more preferably at least 50 weight percent, and still more preferably at least 60 weight percent by weight of the web of a non-lathering surfactant.
- Non-lathering articles will be used for exfoliation, wiping clothes (e.g., wet wipes, refreshment wipes) where lather is not desirable and to lie on skin.
- wiping clothes e.g., wet wipes, refreshment wipes
- Nonlimiting examples of these are skin wiping compositions and refreshing compositions.
- Nonlimiting examples of these non-lathering surfactants are: polyethylene glycol 20 sorbitan monolaurate (Polysorbate 20), polyethylene glycol 5 soya sterol, Steareth-20, Ceteareth- 20, PPG-2 methyl glucose ether distearate, Ceteth-10, Polysorbate 80, cetyl phosphate, potassium cetyl phosphate, diethanolamine cetyl phosphate, Polysorbate 60, glyceryl stearate, PEG- 100 stearate, polyoxyethylene 20 sorbitan trioleate (Polysorbate 85), sorbitan monolaurate, polyoxyethylene 4 lauryl ether sodium stearate, polyglyceryl-4 isostearate, hexyl laurate, PPG-2 methyl glucose ether distearate, ceteth-10, diethanolamine cetyl phosphate, glyceryl stearate, PEG- 100 stearate, and mixtures thereof.
- Polysorbate 20 polyethylene glycol
- the skin, nail or hair wipe consists of an article that includes face make-up removal, baby wipes, skin refreshing wipes, incontinent patient bathing wipes, masks and hand cleaning wipes.
- the articles of the present invention also comprise one or more treatment compositions that are associated with the fibrous, non-woven web.
- these articles are generally considered non-lathering and such articles can be wet, moist or dry as previously defined.
- the treatment compositions associated with the fibrous, non-woven web of the present invention are skin conditioning agents and skin treatment agents for skin, hair and similar keratinous regions.
- the treatment compositions of the present invention comprise a sufficient amount of one or more non-lathering surfactants such that the compositions are capable of generating from at the most 700ml of Steady Flash Lather Volume according to the Steady Lather Volume Test described below.
- the treatment composition generates less than 400ml of Steady Flash Lather Volume, even more preferably less than 300ml of Steady Flash Lather Volume, and still even more preferably less than 250ml of Steady Flash Lather Volume.
- the articles of the present invention can comprise a skin conditioning agent that is useful for providing a conditioning benefit to the skin, hair and other parts of the body with keratin- containing tissue.
- the skin conditioning agent can comprise no more than about 1600 weight percent, preferably no more than about 1000 weight percent, more preferably no more than about 800 weight percent, and most preferably no more than about 600 weight percent by weight of the web of a skin conditioning agent.
- the skin conditioning agent can comprise at least 0.05 weight percent, preferably at least 15 weight percent, more preferably at least 15 weight percent, and most preferably no more than about 60 weight percentby weight of the web of a skin conditioning agent.
- the skin conditioning agent useful in the present invention can comprise: a water soluble conditioning agent; an oil soluble conditioning agent; a conditioning emulsion; or any combination or permutation of the three.
- the oil soluble conditioning agent is selected from one or more oil soluble conditioning agents such that the weighted arithmetic mean solubility parameter of the oil soluble conditioning agent is less than or equal to 10.5.
- the water soluble conditioning agent is selected from one or more water soluble conditioning agents such that the weighted arithmetic mean solubility parameter of the water soluble conditioning agent is greater than 10.5. It is recognized, based on this mathematical definition of solubility parameters, that it is possible, for example, to achieve the required weighted arithmetic mean solubility parameter, i.e.
- Solubility parameters are well known to the formulation chemist of ordinary skill in the art and are routinely used as a guide for determining compatibilities and solubilities of materials in the formulation process. See “Solubility Effects in Product, Package, Penetration, and Preservation", Cosmetics and Toiletries vol. 103, p 47-69, (October 1988).
- Non-limiting examples of useful conditioning agents include those selected from the group consisting of petrolatum, fatty acids, esters of fatty acids, fatty alcohols, ethoxylated alcohols, polyol polyesters, glycerine, glycerin mono-esters, glycerin polyesters, epidermal and sebaceous hydrocarbons, lanolin, straight and branched hydrocarbons, silicone oil, silicone gum, vegetable oil, vegetable oil adduct, hydrogenated vegetable oils, nonionic polymers, natural waxes, synthetic waxes, polyolefinic glycols, polyolefinic monoester, polyolefmic polyesters, cholesterols, cholesterol esters, triglycerides and mixtures thereof.
- the conditioning agent may be selected from the group consisting of paraffin, mineral oil, petrolatum, stearyl alcohol, cetyl alchohol, cetearyl alcohol, behenyl alcohol, C 10-30 polyesters of sucrose, stearic acid, palmitic acid, behenic acid, oleic acid, linoleic acid, myristic acid, lauric acid, ricinoleic acid, steareth-1-100, cetereath 1-100, cholesterols, cholesterol esters, glyceryl tribehenate, glyceryl dipalmitate, glyceryl monostearate, trihydroxystearin, ozokerite wax, jojoba wax, lanolin wax, ethylene glycol distearate, candelilla wax, carnauba wax, beeswax, and silicone waxes.
- Mineral oil which is also known as petrolatum liquid, is a mixture of liquid hydrocarbons obtained from petroleum. See The Merck Index, Tenth Edition, Entry 7048, p. 1033 (1983) and International Cosmetic Ingredient Dictionary, Fifth Edition, vol, 1, p.415-417 (1993).
- Petrolatum which is also known as petroleum jelly, is a colloidal system comprising nonstraight-chain solid hydrocarbons and high-boiling liquid hydrocarbons. See The Merck Index, Tenth Edition, Entry 7047, p. 1033 (1983); Schindler, Drug. Cosmet. Ind., p. 89, 36-37, 76, 78-80, 82 (1961); and International Cosmetic Ingredient Dictionary, Fifth Edition, Vol. 1, p. 537 (1993).
- Nonvolatile silicones such as polydialkylsiloxanes, polydiarylsiloxanes, and polyalkarylsiloxanes are also useful skin conditioning agents. These silicones are disclosed in U.S. Pat. No. 5,069,897, to Orr, issued Dec. 3, 1991.
- the skin conditioning agent preferably used in the present invention may also comprise a conditioning emulsion that is useful for providing a conditioning benefit to the skin, hair and similar keratin-containing surfaces during the use of the article.
- the term "conditioning emulsion” as used herein can either mean the combination of an internal phase comprising a water soluble conditioning agent that is enveloped by an external phase comprising an oil soluble agent or the term “conditioning emulsion” as used herein means the combination of an internal phase comprising an oil soluble agent that is enveloped by an external phase comprising a water soluble agent.
- the conditioning emulsion would further comprise an emulsifier.
- the conditioning emulsion comprises from about 15% to about 1600%, preferably from about 25% to about 1000%, more preferably from about 50% to about 800%, and most preferably from about 60% to about 600% by weight of said water insoluble fibrous, non-woven web.
- the conditioning emulsion comprises (i) an internal phase comprising water soluble conditioning agents as described above, and (ii) an external phase comprising oil soluble agents as described hereinbefore in the oil soluble conditioning agent section or hereinafter in the "Materials Used to Increase Lipid Hardness Value" section.
- the conditioning emulsion further comprises an emulsifier capable of forming an emulsion of said internal and external phases.
- a water soluble conditioning agent can be enveloped by an oil soluble agent without an emulsifier. As long as the water soluble conditioning agent is enveloped by the oil soluble agent, thereby protected from being rinsed away during the cleansing process, the composition would be within the scope of the present invention.
- the articles of the present invention can comprise a skin treatment agent that is useful for providing a therapeutic benefit and/or cosmetic benefit to the skin, hair and similar keratin- containing surfaces during the use of the article.
- the skin treatment agents are suitable for application to keratin-containing tissue, that is, they are suitable for use in contact with human keratin-containing tissue without undue toxicity, incompatibility, instability, allergic response, and the like within the scope of sound medical judgment.
- the CTFA Cosmetic Ingredient Handbook, Second Edition (1992) describes a wide variety of nonlimiting cosmetic and pharmaceutical ingredients commonly used in the personal care industry, which are suitable for use in the compositions of the present invention.
- the skin treatment agent can comprise no more than about 1600 weight percent, preferably no more than about 1000 weight percent, more preferably no more than about 800 weight percent, and most preferably no more than about 600 weight percent by weight of the web of a skin treatment agent.
- the skin treatment agent can comprise at least 0.05 weight percent, preferably at least 15 weight percent, more preferably at least 15 weight percent, and most preferably no more than about 60 weight percent by the weight of the web of a skin treatment agent.
- the skin treatment agents useful in the present invention can comprise compositions described herein. Vitamins
- the present articles can comprise vitamin compounds, precursors, and derivatives thereof. These vitamin compounds may be in either natural or synthetic form. Suitable vitamin compounds include, but are not limited to, Vitamin A (e.g., beta carotene, retinoic acid, retinol, retinoids, retinyl palmitate, retinyl proprionate, etc.), Vitamin B (e.g., niacin, niacinamide, riboflavin, pantothenic acid, etc.), Vitamin C (e.g., ascorbic acid, etc.), Vitamin D (e.g., ergosterol, ergocalciferol, cholecalciferol, etc.), Vitamin E (e.g., tocopherol acetate, etc.), and Vitamin K (e.g., phytonadione, menadione, phthiocol, etc.) compounds.
- Vitamin A e.g., beta carotene, retinoic acid, retin
- the articles of the present invention may comprise a safe and effective amount of a vitamin B3 compound.
- Vitamin B 3 compounds are particularly useful for regulating skin condition as described in co-pending U. S. Application Serial No. 08/834,010, filed April 11, 1997 (corresponding to international publication WO 97/39733 Al, published October 30, 1997) which is incorporated by reference herein in its entirety.
- the therapeutic component of the present invention preferably comprise from about 0.0001% to about 50%, more preferably from about 0.1% to about 10%, even more preferably from about 0.5% to about 10%, and still more preferably from about 1% to about 5%, most preferably from about 2% to about 5%, of the vitamin B3 compound.
- vitamin B3 compound means a compound having the formula:
- R is - CONH2 (i.e., niacinamide), - COOH (i.e., nicotinic acid) or - CH2OH (i.e., nicotinyl alcohol); derivatives thereof; and salts of any of the foregoing.
- CONH2 i.e., niacinamide
- COOH i.e., nicotinic acid
- CH2OH i.e., nicotinyl alcohol
- Exemplary derivatives of the foregoing vitamin B3 compounds include nicotinic acid esters, including non-vasodilating esters of nicotinic acid, nicotinyl amino acids, nicotinyl alcohol esters of carboxylic acids, nicotinic acid N-oxide and niacinamide N-oxide.
- vitamin B3 compounds are well known in the art and are commercially available from a number of sources, e.g., the Sigma Chemical Company (St. Louis, MO); ICN Biomedicals, Inc. (Irvin, CA) and Aldrich Chemical Company (Milwaukee, WI).
- the vitamin compounds may be included as the substantially pure material, or as an extract obtained by suitable physical and/or chemical isolation from natural (e.g., plant) sources.
- Non-limiting examples of zeolites useful herein include natural zeolites such as analcite, chabazite, heulandite, natrolite, stilbite, and thomosonite; and synthetic zeolites such as those made by the gel process (sodium silicate and alumina) or a clay process (kaolin), which forms a matrix to which the zeolite is added.
- natural zeolites such as analcite, chabazite, heulandite, natrolite, stilbite, and thomosonite
- synthetic zeolites such as those made by the gel process (sodium silicate and alumina) or a clay process (kaolin), which forms a matrix to which the zeolite is added.
- Peptides including but not limited to, di-, tri-, tetra-, and pentapeptides and derivatives thereof, may be included in the compositions of the present invention in amounts that are safe and effective.
- Non-limiting examples of peptides and peptide derivatives useful herein include; Carnosine® (beta-ala-his), gly-his-lys, arg-lys-arg, his-gly-gly, palmitoyl-gly-his-lys (which may be purchased as Biopeptide CL®, lOOppm commercially available from Sederma, France), Peptide CK (arg-lys-arg), PEPTIDE CK+ (ac-arg-lys-arg-NH2), and a copper derivative of his- gly-gly sold commercially as IAMIN, from Sigma (St. Louis, Missouri). Tetrapeptides and pentapeptides (such as palmitoyl-lys-thr-thr-lys-ser commercially
- peptides are preferably included in amounts of from about lxl0 "6 % to about 10%, more preferably from about lxl0 "6 % to about 0.1%, by weight of the composition.
- compositions of the subject invention may contain a sunscreen active.
- sunscreen active includes both sunscreen agents and physical sunblocks.
- Inorganic sunscreens useful herein include the following metallic oxides; titanium dioxide having an average primary particle size of from about 15 nm to about 100 nm, zinc oxide having an average primary particle size of from about 15 nm to about 150 nm, iron oxide having an average primary particle size of from about 15 nm to about 500nm, and mixtures thereof.
- the inorganic sunscreens are present in the amount of from about 0.1% to about 20%, preferably from about 0.5% to about 10%, by weight of the composition.
- organic sunscreen actives are suitable for use herein. Sagarin, Vol. 102 pages 21 et seq., of Cosmetics and Toiletries (1987). discloses numerous suitable actives.
- Nonlimiting examples of organic sunscreen actives useful herein include octylsalicylate, 2-phenylbenzimidazole-5-sulphonic acid salts, salts of terephthalylidene dicamphor sulfonic acid, octocrylene, octylmethoxycinnamate, avobenzone, and mixtures thereof.
- compositions of the present invention When present in compositions of the present invention, a safe and effective amount of the organic sunscreen active is used, typically from about 1% to about 20%, more typically from about 2% to about 10% by weight of the composition.
- compositions of the present invention may, in some embodiments, contain a safe and effective amount of a terpene alcohol such as farnesol, farnesol derivatives, and mixtures thereof.
- a terpene alcohol such as farnesol, farnesol derivatives, and mixtures thereof.
- the terpene alcohol is preferably is included in an amount from about 0.001% to about 50% by weight of the composition, more preferably from about 0.01% to about 20%, by weight of the composition.
- a safe and effective amount of a desquamation active may be added to the compositions of the present invention, preferably from about 0.1% to about 10%, more preferably from about 0.2% to about 5%, by weight of the composition.
- desquamation systems useful herein include; a combination of sulfhydryl compounds and zwitterionic surfactants; and a combination of salicylic acid and zwitterionic surfactants.
- compositions of the present invention may contain a safe and effective amount of one or more anti-acne actives.
- useful anti-acne actives include resorcinol, sulfur, salicylic acid, benzoyl peroxide, erythromycin, zinc, etc.
- compositions of the present invention may further contain a safe and effective amount of one or more anti-wrinkle actives or anti-atrophy actives.
- anti-wrinkle actives or anti-atrophy actives suitable for use in the compositions of the present invention include hydroxy acids (e.g., alpha-hydroxy acids such as lactic acid and glycolic acid or beta-hydroxy acids such as salicylic acid and salicylic acid derivatives such as the octanoyl derivative), phytic acid, lipoic acid; lysophosphatidic acid, and skin peel agents.
- a safe and effective amount of an anti-oxidant/radical scavenger may be added to the compositions of the subject invention, preferably from about 0.1% to about 10%, more preferably from about 1% to about 5%, of the composition.
- Non-limiting examples of anti-oxidants/radical scavengers useful herein include; ascorbic acid (vitamin C) and derivatives thereof; tocopherol (vitamin E) and derivatives thereof (e.g. tocopherol sorbate, tocopherol acetate); butylated hydroxy benzoic acids and their salts, 6- hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid; sorbic acid and its salts; lipoic acid, amines (e.g., N,N-diethylhydroxylamine, amino-guanidine); tea extracts; grape skin/seed extracts; and mixtures thereof.
- vitamin C ascorbic acid
- vitamin E tocopherol sorbate, tocopherol acetate
- butylated hydroxy benzoic acids and their salts 6- hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
- sorbic acid and its salts lipoic acid, amines (e
- compositions of the present invention may optionally contain a flavonoid compound.
- Flavonoids are broadly disclosed in U.S. Patents 5,686,082 and 5,686,367.
- Non-limiting examples of flavonoids useful herein include unsubstituted flavone, 7,2'-dihydroxy flavone, 3',4'- dihydroxy naphthoflavone, 4'-hydroxy flavone, 5,6-benzoflavone, and 7,8-benzoflavone, unsubstituted isoflavone, daidzein (7,4'-dihydroxy isoflavone), 5,7-dihydroxy-4'-methoxy isoflavone, soy isoflavones (a mixture extracted from soy), and mixtures thereof.
- the flavonoid compounds are preferably present in concentrations of from about 0.01%) to about 20%, more preferably from about 0.1 % to about 10%, by weight of the composition.
- a safe and effective amount of an anti-inflammatory agent may be added to the compositions of the present invention, preferably from about 0.1% to about 10%, more preferably from about 0.5% to about 5%, of the composition.
- "natural" anti-inflammatory agents include candelilla wax, bisabolol (e.g., alpha bisabolol), aloe vera, plant sterols (e.g., phytosterol), and mixtures thereof.
- Additional anti-inflammatory agents useful herein include glycyrrhizinate compounds such as dipotassium glycyrrhizinate.
- compositions of the present invention may also contain a safe and effective amount of an anti-cellulite agent.
- anti-cellulite agents useful herein include xanthine compounds (e.g., caffeine, theophylline, theobromine, and aminophylline).
- compositions of the present invention may also contain a safe and effective amount of a topical anesthetic.
- topical anesthetic drugs include benzocaine, lidocaine, pharmaceutically acceptable salts thereof, and mixtures thereof.
- compositions of the present invention may contain a tanning active.
- a tanning active When present, it is preferable that the compositions contain from about 0.1% to about 20%, more preferably from about 2% to about 7%, by weight of the composition, of the artificial tanning active.
- a non-limiting example of a tanning active useful herein is dihydroxyacetone.
- chelator or “chelating agent” means an active agent capable of removing a metal ion from a system by forming a complex so that the metal ion cannot readily participate in or catalyze chemical reactions.
- the inclusion of a chelating agent is especially useful for providing protection against UV radiation which can contribute to excessive scaling or skin texture changes and against other environmental agents which can cause skin damage.
- oil-soluble chelators that are useful herein are disclosed in U.S. Patent No. 5,487,884, issued 1/30/96 to Bissett et al.; International Publication No. 91/16035, Bush et al., published 10/31/95; and International Publication No. 91/16034, Bush et al., published 10/31/95.
- Preferred oil-soluble chelators useful in compositions of the subject invention are furildioxime, furilmonoxime, and derivatives thereof.
- compositions of the present invention may contain a skin lightening agent.
- the compositions preferably contain from about 0.1% to about 10%, more preferably from about 0.2% to about 5%, by weight of the composition, of a skin lightening agent.
- skin lightening agents useful herein include those known in the art, including niacinamide, kojic acid, arbutin, glucosamine and derivatives, phytosterol derivatives (e.g.
- ascorbic acid and derivatives thereof e.g sodium ascorbyl phosphate
- extracts e.g., mulberry extract, placental extract.
- actives useful herein include those selected from glycolic acid, lactic acid, phytic acid, N-acetyl-L-cysteine, phenoxyethanol, phenoxypropanol, phenoxyisopropanol, and mixtures thereof.
- compositions of the present invention may include a skin soothing or skin healing active.
- Skin soothing or skin healing actives suitable for use herein includes panthenoic acid derivatives (including panthenol, dexpanthenol, ethyl panthenol), aloe vera, allantoin, bisabolol, and dipotassium glycyrrhizinate.
- a safe and effective amount of a skin soothing or skin healing active may be added to the present composition, preferably, from about 0.1% to about 30%, more preferably from about 0.5% to about 20%, by weight of the composition.
- Preferred embodiments include: therapeutic treatment (e.g., acne articles), sunscreen application articles, anti-cellulite articles, anti-wrinkle articles, masks, self tanner articles, foot scrubbing articles, cosmetic application articles and perfume/fragrance articles.
- therapeutic treatment e.g., acne articles
- sunscreen application articles e.g., sunscreen application articles
- anti-cellulite articles e.g., sunscreen application articles
- anti-wrinkle articles e.g., sunscreen application articles
- masks e.g., self tanner articles
- foot scrubbing articles e.g., cosmetic application articles
- perfume/fragrance articles e.g., perfume/fragrance articles.
- compositions can be added separately or the compositions can be mixed together prior to being associated with the fibrous, non-woven web. Additional Ingredients
- the articles of the present invention can comprise a wide range of other optional components. These additional components should be pharmaceutically acceptable.
- CTFA Cosmetic Ingredient Handbook Second Edition, 1992, which is incorporated by reference herein in its entirety, describes a wide variety of nonlimiting cosmetic and pharmaceutical ingredients commonly used in the skin care industry, which are suitable for use in the compositions of the present invention. Nonlimiting examples of functional classes of ingredients are described at page 537 of this reference.
- Examples of these and other functional classes include: abrasives, absorbents, anticaking agents, antioxidants, vitamins, binders, biological additives, buffering agents, bulking agents, chelating agents, chemical additives, colorants, cosmetic astringents, cosmetic biocides, denaturants, drug astringents, external analgesics, film formers, fragrance components, humectants, opacifying agents, pH adjusters, preservatives, propellants, reducing agents, skin bleaching agents, and sunscreening agents.
- aesthetic components such as fragrances, pigments, colorings, essential oils, skin sensates, astringents, skin soothing agents, and skin healing agents.
- compositions used in the present invention may also contain a "fluid” such as water, mono- and polyhydric alcohols (glycerin, propylene glycol, ethanol, isopropanol, etc.), hydrocarbon oils such as mineral oil, silicone oils having a viscosity, and can contain other components dissolved or dispersed within them, or in addition to them.
- a "fluid” such as water, mono- and polyhydric alcohols (glycerin, propylene glycol, ethanol, isopropanol, etc.), hydrocarbon oils such as mineral oil, silicone oils having a viscosity, and can contain other components dissolved or dispersed within them, or in addition to them.
- compositions used in the present invention may also contain an organic cationic deposition polymer.
- Concentrations of the cationic deposition polymer preferably range from about 0.025% to about 3%, more preferably from about 0.05% to about 2%, even more preferably from about 0.1% to about 1%, by weight of the personal care composition.
- Suitable cationic deposition polymers for use in the present invention contain cationic nitrogen-containing moieties such as quaternary ammonium or cationic protonated amino moieties.
- the cationic protonated amines can be primary, secondary, or tertiary amines (preferably secondary or tertiary), depending upon the particular species and the selected pH of the personal cleansing composition.
- the average molecular weight of the cationic deposition polymer is between about 5,000 to about 10 million, preferably at least about 100,000, more preferably at least about 200,000, but preferably not more than about 2 million, more preferably not more than about 1.5 million.
- the polymers also have a cationic charge density ranging from about 0.2 meq/gm to about 5 meq/gm, preferably at least about 0.4 meq/gm, more preferably at least about 0.6 meq/gm., at the pH of intended use of the personal cleansing composition, which pH will generally range from about pH 4 to about pH 9, preferably between about pH 5 and about pH 8.
- Nonlimiting examples of cationic deposition polymers for use in the personal care composition include polysaccharide polymers, such as cationic cellulose derivatives.
- Preferred cationic cellulose polymers are the salts of hydroxyethyl cellulose reacted with trimethyl ammonium substituted epoxide, referred to in the industry (CTFA) as Polyquaternium 10 which are available from Amerchol Corp. (Edison, N.J., USA) in their Polymer KG, JR and LR series of polymers with the most preferred being KG-30M.
- Suitable cationic deposition polymers include synthetic cationic polymers.
- the cationic polymers suitable for use in the cleansing composition herein are water soluble or dispersible, non crosslinked, cationic polymers having a cationic charge density of from about 4 meq/gm to about 7 meq/gm, preferably from about 4 meq/gm to about 6 meq/gm, more preferably from about 4.2 meq/gm to about 5.5 meq/gm.
- the select polymers also must have an average molecular weight of from about 1,000 to about 1 million, preferably from about 10,000 to about 500,000, more preferably from about 75,000 to about 250,000.
- the concentration of the cationic polymer in the personal care composition ranges from about 0.025% to about 5%, preferably from about 0.1% to about 3%, more preferably from about 0.2%) to about 1%, by weight of the composition.
- a non limiting example of a commercially available synthetic cationic polymer for use in the cleansing compositions is polymethyacrylamidopropyl trimonium chloride, available under the trade name POLYCARETM 133, from Rhodia, Cranberry, N.J., U.S.A. Steady Lather Volume Test
- Articles of the present invention can provide a steady lather profile as described hereafter.
- the body cleansing compositions have high Total Steady Lather Volumes, whereas the non- lathering articles have low Steady Flash Lather Volumes.
- the personal care article can be cleansing or non-cleansing, and can be lathering or non-lathering with different lather profiles as described below.
- the Steady Lather Volume Test provides a measure of the lather profile of an article in the presence of a renewed water supply, a condition such as naturally exists during bathing or showering.
- the lather profile described herein is a combination of the Steady Flash Lather Volume and the Steady Total Lather Volume, both of which are determined in accordance with the following Steady Lather Volume Test.
- Eight 1,000 ml graduated cylinders are chosen which are marked in 10 ml increments and have a height of 14.5 inches at the 1,000 ml mark from the inside of the base (for example, Pyrex No. 2982). 100 grams of distilled water (+/- 0.3 grams, at 23°C) is added to each graduated cylinder.
- the cylinders numbered sequentially from the first cylinder (Cylinder 1) to the last cylinder (Cylinder 8) are clamped in a rotating apparatus which clamps the cylinders with an axis of rotation which transects the center of the graduated cylinder in an axis parallel to the ground with the cylinder standing upright. Stopcocks are added to Cylinder 2 through Cylinder 8.
- the article is prepared by cutting it into four equal width strips in the longest dimension. If the article contains entrapped contents that spill if the article is cut into strips, the article is instead folded into four equal strips. If folding and inserting into the graduated cylinders is not possible due to size of the article, the article is cut into strips that can be inserted, and any contents which may spill out during this procedure are caught and added separately into the first graduated cylinder described hereinafter.
- These strips are stacked and clipped at one end with a simple binder clip, which is selected to be narrow enough to fit inside the neck of the graduated cylinders.
- a thin polymer thread such as a thin fishing line is tied to the clip so that when the thread is held aloft, the strips hang vertically from the clip and thread.
- the strips are inserted into the first graduated cylinder (Cylinder 1) so that they hang vertically inside the graduated cylinder with the top ends of the stack of strips hanging evenly with the 1,000 ml mark on the side of Cylinder 1.
- the stopcock is then inserted into the neck of Cylinder 1, fixing the strips of the article relative to the graduated cylinder. If necessary, the overhanging thread can be taped to the outside of Cylinder 1 before inserting the stopcock. Also, to prevent leaking, Teflon® tape can be used to effect a waterproof seal.
- the cylinders are automatically rotated by the rotating apparatus 50 rotations at a steady rate of 50 rotations in 88 seconds in order to generate a lather, which is comprised of foam cells, and stopped in a vertical position to complete a first rotation sequence.
- a timer is set to allow 30 seconds for the lather thus generated to drain.
- the first lather volume designated Lather in Cylinder 1
- the lather height is measured to the nearest 10 ml mark by recording the lather height in ml up from the base in Cylinder 1 (said height includes water that has drained to the bottom, on top of which the lather is floating). If the top surface of the lather is uneven, the lowest height at which it is possible to see halfway across the first graduated cylinder is the Lather in Cylinder 1 (ml).
- lather e.g., about 60 ml of volume or more
- the lather on the top and sides is urged to the bottom part of the graduated cylinder to meet the other lather prior to measuring volume (during the 30 second drainage period) using a semi-circular shaped flexible plow attached to a rod, for example a 2 inch diameter plug cut from a sponge, cut again in half, and secured to a long threaded rod.
- the maximum lather volume possible is 1,000 ml (even if the total foam height exceeds the 1,000 ml mark on the graduated cylinder).
- the minimum lather volume possible is 100 ml (even if there is no foam, the height of the water in the graduated cylinder is designated the top of the lather and is measured as the Lather in Cylinder 1).
- the thread is held and stopcock removed, and the strips are removed from the first graduated cylinder, which is then re-cocked. Holding the strips of article only by the thread, the strips are lightly touched for a few seconds to a stack of absorbent paper towels to remove water drops from the bottom of the strips. Then, in the same manner as previously described, the strips of the article are fixed inside the second graduated cylinder, which is numbered as previously described as Cylinder 2, its stopcock is added, and a second rotation sequence is completed, the lather volume being measured in the second cylinder in the same manner as described for the first graduated cylinder, and is recorded as the Lather in Cylinder 2.
- the lather volume in each graduated cylinder being recorded as the lather volume in that cylinder. That is, the lather volume in Cylinder 1, Cylinder 2, Cylinder 3, Cylinder 4, Cylinder 5, Cylinder 6, Cylinder 7 and Cylinder 8 is designated, respectively, as the Lather in Cylinder 1, Lather in Cylinder 2, Lather in Cylinder 3, Lather in Cylinder 4, Lather in Cylinder 5, Lather in Cylinder 6, Lather in Cylinder 7, and Lather in Cylinder 8.
- the Steady Flash Lather Volume is obtained by adding together the Lather in Cylinder 1 and the Lather in Cylinder 2.
- the Steady Total Lather Volume is obtained by adding together the lather obtained in all eight graduated cylinders. Mechanical Lather Volume Test
- Personal care articles of the present invention provide a Mechanical Lather Volume as described hereafter.
- the personal care articles can be cleansing or non-cleansing, and can be lathering or non-lathering with different Mechanical Lather Volumes as described below.
- the Mechanical Lather Volume Test provides a measure of the mechanical lather of an of an article in the presence of a restricted water supply, a condition such as naturally exists during washing at a sink, for example washing the face at a sink, especially removing makeup at a sink using a lathering cloth, cloth-like article, or fibrous, non-woven web.
- a 1,000 ml graduated cylinder is chosen which is marked in 10 ml increments and has a height of 14.5 inches at the 1,000 ml mark from the inside of the base (for example, Pyrex No. 2982). 25 grams of distilled water (+/- 0.1 grams, at 23°C) is added to the graduated cylinder.
- the article is prepared by cutting it into four equal width strips, by cutting lengthwise in the longest dimension.
- the strips are stacked and clipped at one end with a binder clip, designated the top clip, which is selected to be narrow enough to fit inside the neck of the graduated cylinders. If the article contains entrapped contents that spill if the article is cut into strips, the article is instead folded into four equal strips. If folding and inserting into the graduated cylinders is not possible due to size of the article, the article is cut into strips that can be inserted, and any contents which may spill out during this procedure are caught and added separately into the first graduated cylinder described hereinafter.
- the strips are inserted into the graduated cylinder so that they hang vertically inside the graduated cylinder with the top end of the stack of strips hanging evenly with the 1,000 ml mark on the side of the cylinder.
- a stopcock is inserted into the neck, fixing the strips of the article relative to the graduated cylinder.
- the cylinder is rotated for 25 rotations at a steady rate of 25 rotations in 44 seconds in order to generate a mechanical lather, which is comprised of foam cells, and is stopped in a vertical position.
- the strips are observed during the rotations, each rotation causing the strips to cycle through a maximum compression as they are inverted to a maximum extension in the original vertical position. The extent of compression is based on the wet compliance of the strips, and thus varies.
- the rotation speed of the apparatus is slowed down until the strips are observed to compress with each inversion and extend in the vertical position. It is important to complete a full 25 compression-extension cycles of the strips, to the extent that they compress and extend, based on their compliance. If the strips do not compress and extend, the rate of rotation is slowed to as low as 15 rotations per minute (rpm) to accomplish the intended compression- extension of the strips. If the strips still do not compress and/or extend because of interfering factors listed above, the cylinders are shaken by hand at each vertical position, being held there momentarily during each rotation, to allow the strips to compress and extend.
- interfering factors such as (1) too rapid rate of rotation of the cylinders, (2) interference by lather produced, (3) sticking of strips to the walls of the cylinder, or (4) a combination of factors
- the plow is also used to ensure large (> 1 inch) air voids within the collapsed fibrous, non-woven web are filled with lather as it is lowered, before reading the lather volume. If the top of the lather surface does not extend beyond the article, the lather is urged with the plow to the lowest level possible in the cylinder without destroying it or compressing it.
- the Mechanical Lather Volume is the height of the lather, inclusive of the underlying fibrous, non-woven web if the height is above the top level of the fibrous, non-woven web.
- the lather height is measured within 15 seconds of stopping. If the height is lower than the top level of the fibrous, non-woven web, the Mechanical Lather Volume is the height of the topmost portion of the lather surface that extends across the graduated cylinder. If the article expands during the test, such as a sponge might expand when first wetted, the plow is used to urge lather off the surface of the expanded fibrous, non-woven web, which is not lowered to the cylinder bottom and not included in the lather height.
- the Mechanical Lather Volume is the lather height with the scored or punctured article.
- the maximum lather volume possible is 1,000 ml (even if the total foam height exceeds the 1,000 ml mark on the graduated cylinder).
- the minimum lather volume possible is 0 ml (the height of the water, which may be absorbed into the article). If no lather is visible inside the graduated cylinder, it is not necessary to lower the article and measure a height: the Mechanical Lather Volume is designated as the height of the water in the bottom of the graduated cylinder.
- the articles of the present invention can be “substantially dry”.
- substantially dry means that the articles of the present invention exhibit a Moisture Retention of less than about 0.95 gms, preferably less than about 0.75 gms, even more preferably, less than about 0.5 gms, even more preferably less than about 0.25 gms, even still more preferably less than about 0.15 gms, and most preferably, less than about 0.1 gms.
- the Moisture Retention is indicative of the dry feel that users perceive upon touching the articles of the present invention as opposed to the feel of "wet" wipes.
- Articles of the present invention which have a dry feel will exhibit a Moisture Retention of less than about 0.95 gms, preferably less than about 0.75 gms, even more preferably, less than about 0.5 gms, even more preferably less than about 0.25 gms, even still more preferably less than about 0.15 gms, and most preferably, less than about 0.1 gms.
- the articles of the present invention can be manufactured by separately or simultaneously adding onto the surface of said web and, onto or impregnating into said web, before or after it has undergone selective mechanical deformation, a cleansing and, or a treatment composition.
- a cleansing and, or a treatment composition By “separately” is meant that the cleansing and treatment compositions can be added sequentially, in any order without first being combined together.
- simultaneously is meant that the cleansing and treatment compositions can be added with or without first being combined together.
- the cleansing and/or the treatment composition can be embedded onto or impregnated into the fibrous, non-woven web using any means known to those skilled in the art. These components can be applied using various spraying, soaking, coating or dipping techniques. Excess surfactant and/or conditioning component can be removed (e.g., by a nipping process). The resulting article can remain as wet or can be further processed to be moist or dry using conventional methods known in the art.
- the present invention also relates to a method of cleansing and, or treating the skin, hair or other keratin-containing tissues of the body with a personal care article of the present invention that is soft due to the structure of the fibrous, fibrous, non-woven web.
- These methods comprise the steps of wetting with fluid a disposable, personal care article comprising a fibrous, non-woven web, wiping the article across the area to be cleansed and, or treated with the cleansing and, or a treatment composition.
- the articles of the present invention can be wetted with fluid prior to use, already contain fluid prior to use, or not require any fluid in order to use the article.
- the substantially dry article is wetted by immersion in fluid or by placing it under a stream of fluid. Lather is generated from the article by mechanically agitating and/or deforming the article either prior to or during contact of the article with the skin, hair or other keratin-containing surfaces.
- the resulting lather is useful for cleansing and treating the skin, hair or other keratin- containing surfaces.
- the treatment agents and active ingredients are contacted with the skin, hair or other keratin- containing surfaces.
- Deposition of treatment compositions and active ingredients are enhanced by the physical contact of the fibrous, non-woven web with the skin, hair or other keratin-containing tissues of the body.
- the fibrous, non-woven web significantly contributes to generation of lather and deposition of treatment compositions and any other active ingredients. It is believed that this lathering and deposition is the result of the surface action of the fibrous, non-woven web.
- milder and significantly lower amounts of surfactants may be employed.
- the decreased amount of required surfactant is believed to relate to a decrease in the drying effect of the skin or hair by the surfactants.
- the diminished amount of surfactant lowers any inhibitory action (e.g., via emulsification or direct removal by the surfactants) which surfactants exhibit regarding deposition of treatment compositions.
- the fibrous, non-woven web also enhances deposition of treatment compositions and active ingredients. Furthermore, because the treatment compositions and active ingredients are embedded onto or impregnated into the fibrous, non- woven web, they are transferred directly to the skin, hair or other keratin-containing surfaces by surface contact of the wet, moist or wetted article to the skin.
- the height x maximum width of the loop is about 0.80 mm x 1.1 mm, and the loops have a minimum width proximal to the surface of the web of about 0.60 mm.
- a tufted fibrous, non-woven web is prepared.
- the same polypropylene fibrous, non- woven web of Example 1 is used, and the same toothed roll and setup, excepting the line speed is increased to 500 feet per minute. Deformations are observed to be less loop-like.
- Example 3
- a tufted fibrous, non-woven web is prepared which is dual zoned (i.e., one area of the web defines a zone having tufts; and a second area of the same web defines a second zone, having no tufts), having both tufted and untufted portions.
- the tufted portions appear mostly looped.
- the same polypropylene fibrous, non-woven web of Example 1 is used.
- a toothed roll is used which has the same pattern as the previous example, but is hand cranked (line speed only a few feet per minute, using an arm attached to the toothed roll, the toothed roll being geared to the grooved roll, so that when the arm is rotated using force applied by hand, the rolls rotate, drawing the web through the nip between the rolls, where tufting occurs).
- the toothed roll has portions of the rolls which do not have teeth, but instead have voids, the voids being in rows oriented in both the machine direction and cross machine direction, the rows having a width of about 0.85cm. and spaced at 7.5cm between rows (center to center distance) in both directions.
- Portions of the tufted web, in first regions, are tufted.
- Other portions of the web, in second regions, which is in rows and corresponding to the portions of the toothed roll which contains no teeth, are unmodified. Thickness of the web is measured using a Mitutoyo model ID-C112CEB micrometer.
- the thickness of the tufted portions in the first region is about 0.39 mm.
- the thickness of the tufted web in the second, untufted region is about 0.14 mm.
- a tufted fibrous, non-woven web is prepared.
- the fibrous, non-woven web is comprised of fibers which are DAPP fibers (Deeply Activated Polypropylene), which are multiconstituent fibers comprising polypropylene, polyethylene, and at least another copolymer.
- the basis weight of the fibrous, non- woven web is about 30 gsm +/5 gsm.
- the fibrous, non-woven web is obtained from BBA Fibrous Nonwovens, Simpsonville, NC, and produced by Fiberweb, Inc, of France and marketed as Sofstpan 200 ®.
- the web is tufted using the toothed roll and setup in Example 1, at a line speed of 50 fpm, and the tufted web is examined in the same manner.
- Example 4 The same polypropylene fibrous, non- woven web of Example 4 is used to prepare a tufted fibrous, non-woven web.
- a toothed roll is used which has the same pattern as the previous example, but is hand cranked, as described in Example 3, (line speed only a few feet per minute).
- the toothed roll has portions of the rolls which do not have teeth, but instead have voids, voids being defined by the absence of teeth, in rows extending in the MD and in the CD.
- Portions of the tufted web, in first region are tufted.
- Other portions of the web, in second regions, which is in rows and around the edges, as defined in Example 3, are unmodified. Thickness of the web is measured using a Mitutoyo model ID-C112CEB micrometer.
- the thickness of the tufted web in the first region is about 0.92 mm.
- the thickness of the tufted web in the second, untufted region is about 0.21 mm.
- a fibrous, non-woven web is tufted utilizing the same toothed roll and equipment settings and line speed as Example 4, and using the same material from the same supplier as Example 4 but at a higher basis weight, 60 gsm.
- the web is evaluated microscopically.
- Representative tufts comprise an average of 32 fibers of which about 75% are unbroken, looped fibers.
- the diameter of individual looped fibers is about 13 microns in the loops, and about 18 microns in the bulk (0.72 diameter ratio).
- the height x maximum width of the loop is about 1.35 mm x 1.03 mm, and the loops have a minimum width of about 0.45 mm. Assuming elliptical dimensions, as described in Example 1, the loop area is calculated as 1.09 mm 2 .
- the line speed is increased to 500 fpm with no other changes.
- the web is evaluated microscopically.
- the diameter of individual looped fibers is about 17.5 microns in the loops that are formed, and about 21 microns in the bulk (0.83 diameter ratio).
- the height x maximum width of the loop is about 1.20 mm x 1.20 mm, and the loops have a minimum width of about 0.60 mm.
- the loop area is calculated as 1.13 mm 2 .
- Representative tufts comprise an average of about 25 fibers of which about 68% are unbroken, looped fibers.
- a fibrous, non-woven web is tufted.
- the web is T260 HEC (High Elongation Carded), which is a lightly bonded, high elongation carded fiber web comprised of 100% polypropylene carded fibers, manuctured by BBA Fibrous, non-woven webs, Simpsonville, SC, and has a basis weight of 40 gsm.
- the web is processed in the same manner as Example 4.
- the web is evaluated microscopically.
- Representative tufts comprise an average of 18 fibers of which about 44% are unbroken, looped fibers.
- the diameter of individual looped fibers is about 18.5 microns in the loops, and about 20 microns in the bulk (0.93 diameter ratio).
- the height x maximum width of the loop is about 1.30 mm x 1.15 mm, and the loops have a minimum width of about 0.55 mm. Assuming elliptical dimensions, as described in Example 1, the loop area is calculated as 1.17 mm 2 .
- the line speed is increased to 500 fpm with no other changes.
- the web is evaluated microscopically.
- Representative tufts comprise an average of 22 fibers of which about 36% are unbroken, looped fibers.
- the diameter of individual looped fibers is about 15 microns in the loops, and about 15 microns in the bulk.
- the height x maximum width of the loop is about 1.20 mm x 0.85 mm, and the loops have a minimum width of about 0.60 mm. Assuming elliptical dimensions, as described in Example 1, the loop area is calculated as 0.80 mm 2 .
- a fibrous, non-woven web is tufted.
- the web is 100% polypropylene prepared by a spunbond/spunlace process, has a basis weight of 50 gsm, and is manufactured by Avgol Nonwovens, Greensboro, NC.
- the same toothed roll as the previous example was used, with a line speed of 10 fpm.
- the depth of engagement of the toothed and grooved rolls is set at an engagement (E) of 0.100 in.
- the web is evaluated microscopically.
- Representative tufts comprise an average of about 29 fibers of which about 50% are unbroken, looped fibers.
- the diameter of individual looped fibers is about 16 microns in the loops, and about 16 microns in the bulk.
- the height x maximum width of the loop is about 0.90 mm x 0.70 mm, and the loops have a minimum width of about 0.60 mm. Assuming elliptical dimensions, as described in Example 1, the loop area is calculated as 0.49 mm 2 .
- Example 12 A fibrous, non-woven web is tufted using a heated press. The web is the same as Example 11. A pneumatic toothed roll is used with top and bottom metal plates having the same tooth and groove measurements as the rolls of Example 1. The plates are 1.5 cm thick and 30 cm square in the x and y dimensions, the toothed top plate and grooved bottom plate being milled to the aforementioned tooth and groove dimension specifications.
- the pneumatic toothed roll is an AIRAM ATP-1585 pneumatic press made by Airam, Inc, Aiken, SC, USA.
- the web is tufted using a 1 second dwell time (contact time).
- the web is evaluated microscopically.
- Representative tufts comprise an average of about 50 fibers of which about 100% are unbroken, looped fibers.
- the diameter of individual looped fibers is about 7 microns in the loops, and about 15 microns in the bulk.
- the height x maximum width of the loop is about 0.55 mm x 0.50 mm, and the loops have a minimum width of about 0.50 mm. Assuming elliptical dimensions, as described in Example 1, the loop area is calculated as 0.22 mm 2 .
- a fibrous, non- woven web is tufted at a line speed of 10 fpm using the toothed roll described in Example 1, with the same 0.135 in. engagement (E).
- the web is comprised of 5 denier spunbond Polyethylene (PE)/Polypropylene (PP) bicomponent fibers in a core-sheath configuration and has a basis weight of 70 gsm, and is manufactured and sold by BBA Nonwovens, Simpsonville, SC, USA under the trade name Softex ®.
- the tufted, looped web has a thickness of 1.09 mm measured by the Mitutoyo micrometer.
- the web is evaluated microscopically.
- Representative tufts comprise an average of about 44 fibers of which about 100% are unbroken, looped fibers.
- the diameter of individual looped fibers is about 17 microns in the loops, and about 27 microns in the bulk.
- the height x maximum width of the loop is about 1.55 mm x 1.20 mm, and the loops have a minimum width of about 0.65 mm. Assuming elliptical dimensions, as described in Example 1, the loop area is calculated as 1.46 mm 2 .
- Example 15 The same material as Example 13 at a higher basis weight, 80 gsm, is tufted in the same manner as described in Example 13.
- the web is evaluated microscopically.
- Representative tufts comprise an average of about 61 fibers of which about 100% are unbroken, looped fibers.
- the diameter of individual looped fibers is about 19 microns in the loops, and about 32 microns in the bulk.
- the height x maximum width of the loop is about 1.05 mm x 1.25 mm, and the loops have a minimum width of about 0.625 mm. Assuming elliptical dimensions, as described in Example 1, the loop area is calculated as 1.03 mm 2 .
- Example 15 Example 15
- Example 16 Using the same process and material as Example 13, the line speed is increased to 300 ⁇ m.
- the web is evaluated microscopically.
- Representative tufts comprise an average of about 67 fibers of which about 100% are unbroken, looped fibers.
- the diameter of individual looped fibers is about 16 microns in the loops, and about 26 microns in the bulk.
- the height x maximum width of the loop is about 1.00 mm x 1.10 mm, and the loops have a minimum width of about 0.60 mm. Assuming elliptical dimensions, as described in Example 1, the loop area is calculated as 0.86 mm 2 .
- Example 16 Example 16
- a baby wipe is prepared.
- a chemical component is prepared from the following ingredients by mixing until homogeneous and buffering the pH to 5.5.
- Example 7 The looped web of Example 7 is cut into individual wipes having dimensions 18 cm by 20 cm, and Z-folded in an interleaving configuration with an overlapping portion and stacked in groups of 40 wipes with the tufted side facing out.
- the chemical component is added to the stacks at an add-on rate of 350% based on the cloth weight, and cloths are packaged in a "pop-up" wipes dispenser, in which upon pulling a wipe out of the tub, an edge of the next wipe is presented for easy dispensing.
- Example 17 Example 17
- a tufted fibrous, non-woven web is prepared from a spunbond web having a basis weight of about 18 gsm.
- the web is comprised of fibers which are 100%) white polyester (PET), and is manufactured by Freudenberg Fibrous Nonwovens, 3440 Industrial Dr., Durham, NC 27704.
- PET white polyester
- the web is tufted using the equipment and setup and hand cranking procedure as Example 6.
- the web produced is tufted with a low proportion of looped fibers.
- the web has a thickness of 0.36 mm in the tufted zone, and a thickness of 0.13 mm in the untufted zone.
- a fibrous, non- woven web is prepared which is tufted and has a high proportion of looped fibers.
- the web is a core-sheath bicomponent fiber (PE/PP) spunbond web having a basis weight of 46 gsm, manufactured by BBA Fibrous Nonwovens.
- the tufts are prepared using a toothed roll having teeth with TL of 0.25 in. and pitch (P) of 0.25 in.
- the teeth are arranged in rows, every other row offset by Vi pitch to create a staggered pattern.
- the depth of engagement (E) is 0.1,35 in.
- the apparatus is cranked by hand as described previously.
- the web has tufts which appear as tunnel-like loops, seen to be open at two ends by careful examination, which measure about 6 mm length x 1.25 mm width.
- the web has a thickness of 0.91 mm in tufted regions and 0.37 mm in untufted regions.
- a fibrous, non-woven web is prepared utilizing the apparatus and procedure of Example 18.
- the web is the same as Example 11. Tunnel-like tufts are evident, which have looped fibers.
- Example 20
- a fibrous, non-woven web is prepared utilizing the apparatus and procedure of Example 18.
- the web is the same as Example 1. Tunnel-like tufts are evident, which have looped fibers.
- Example 21
- a tufted fibrous, non-woven web having looped fibers is prepared from two precursor webs. Two identical webs are mated physically, which are 34 gsm webs comprising core-sheath bicomponent fibers which are dark blue in color. The mated webs are fed into the toothed roll, using conditions of Example 3 to create tufts, which have fibers originating and ending in both precursor webs. The tufting procedure with the two webs creates what is essentially a single web by interlocking the webs at the tufts.
- the tufted web has a thickness of 1.18 mm in the tufted regions, and 0.42 mm in the untufted regions. In a cloth measuring 8.375 in. long x 6.75 in.
- the cloth has the appearance and feel of a high quality, terry cloth washcloth or small towel with a hemmed edge. Examples 22 - 28
- Spunbond webs are prepared using a process with multiple (sequential) spinnerets, producing webs which have mixtures of PP and PE/PP bicomponent fibers. Some of the webs are prepared with mixtures of fibers that are not organized. Other webs are prepared with sequential spinnerets using different fibers to layer the fibers from the top to the bottom of the web. The webs are each tufted to prepare a tufted web using the process and conditions of Example 4. The webs are prepared according to the following compositions:
- a web is obtained from Tredegar Corp., Terre Haute, IN, USA which is a large hex pattern (8.75 hex) formed film comprising a polyethylene blend (HDPE/LDPE).
- the web has a basis weight of about 36 gsm and a thickness of 0.04 in.
- the formed film is a film containing hexagonally shaped pores formed from a precursor film by drawing the film across the surface of a forming screen, the forming screen being a drum shaped, hollow frame with a screen on the surface of the drum, the screen having a hexagonal pattern corresponding to the resulting land area of the film and open area corresponding to the pores.
- the formed film is formed from the precursor film by rotating the drum with the film in contact with the drum and applying water jets which impinge upon the film at a pressure of about 3,000 psi, said jets rupturing the film in the open area of the screen, creating pores in the film.
- a web is obtained from the Tredegar Corp., Terre Haute, IN, USA which is a formed film having a basis weight of 25 gsm and a thickness of about 0.017 in., comprising low density polyethylene polymer.
- a web is obtained commercially which is 100% polyester, adhesive bonded using a latex adhesive and a dip & nip process, which dips the unbonded web through a trough filled with adhesive and uses two rubber rolls with a nip to squeeze excess adhesive, the web having a basis weight of 2 oz/yd 2 (68gsm), as is available commercially by many manufacturers, such as Stearns Textiles, Cincinnati, OH, USA.
- the web is a batting and has a thickness of about 5.8 mm.
- a web is obtained which is a closed cell polyethylene foam.
- the web has a thickness of about 1/8 in., a basis weight of 93 gsm, and a density of about 30 kg/m 3 .
- the web is slit in the machine direction in rows, the slits 3 ⁇ in. long with l A in. between slits within a row, and 1/8 in. between rows of slits. Slits in alternating rows are offset in the MD by l A the length of a slit, so that when the slitted web is pulled apart in the CD, the web opens to a lattice pattern.
- Such a web is supplied by Kevron LLC, Portland, Oregon, U.S.A.
- a batting is obtained which is an airlaid blend of carded fibers (50% PET, 50% PE/PP core-sheath bicomponent) having a basis weight of 65 gsm and a thickness of 2.7mm, from Libeltex NV, Belgium.
- carded fibers 50% PET, 50% PE/PP core-sheath bicomponent
- a composite web is prepared, which is a web formed from two precursor webs.
- a single ply sheet of a cellulose absorbent paper towel (Bounty towel, marketed by Procter & Gamble Co., Cincinnati, OH, USA) is attached to a sheet of 0.25 oz/yd 2 spunbond polypropylene using point bonds which are ultrasonic welds spaced at about 5 mm between points in offset rows.
- a polypropylene web is available from BBA Fibrous Nonwovens is marketed as Celestra ®.
- a dual textured lathering cloth or article (terms used interchangeable to mean the same thing in these Examples) for cleansing the body in a shower is prepared.
- a lathering surfactant component is prepared from the following ingredients:
- the ingredients are prepared by mixing the cationic polymer with the glycol and surfactants under heat with continuous stirring to avoid lumps.
- the perfume is added during cooling.
- the lathering surfactant component melts upon heating to about 60 degrees C or more, and solidifies upon cooling to a hard solid.
- the percentages added in this and subsequent examples are of the ingredient including water it may contain.
- a layered, laminated article is prepared using two layers of the tufted web of Example 20 with the deformations facing away from the cloth interior (same direction for all following examples also), and two layers of the batting of Example 33.
- the lathering surfactant component is heated until liquid, and slot coated in 3 rows between the batting layers at a rate of 4 grams per finished article.
- the layers are sealed using an ultrasonic sealer such as a Branson Model 9000 Ultrasonic Sealer, which seals a dot pattern comprising a grid of 4 mm diameter sealing points spaced evenly across the article at 3 cm intervals.
- the sealed web is cut into 11.9 cm x 9.0 cm rectangles to create the finished article.
- a dual textured lathering cloth for cleansing the body in a shower is prepared.
- a lathering surfactant component is prepared from the following ingredients:
- Example 35 The ingredients are processed in the same manner as Example 35.
- a layered, laminated article is prepared using a first layer of the tufted web of Example 19, an interior layer which is the formed film of Example 30 with the male side facing toward the batting layer, and a layer of the batting of Example 33.
- the lathering surfactant component is slot coated in a thin layer between the first layer and the interior batting layer at a rate of 5.0 grams per finished article and is finished in the same manner as Example 35.
- Example 37 A layered, laminated article is prepared using a first layer of the tufted web of Example 19, an interior layer which is the formed film of Example 30 with the male side facing toward the batting layer, and a layer of the batting of Example 33.
- the lathering surfactant component is slot coated in a thin layer between the first layer and the interior batting layer at a rate of 5.0 grams per finished article and is finished in the same manner as Example 35.
- Example 37
- a dual textured lathering cloth for cleansing the body in the bath is prepared.
- a lathering surfactant component is prepared from the following ingredients:
- a sodium soap is prepared from an excess amount of the tallow fatty acid, coconut fatty acids, ricinoleic acid in the relative proportions indicated by the component amounts, and half the amount of glycerin and water necessary in the final component batch.
- Sodium hydroxide is added in the stoichiometric amount necessary to neutralize the fatty acids with no excess to make the soap.
- a triethanolamine (TEA) soap is prepared in the same manner with the stearic acid and oleic acid, neutralizing with a 10% excess of TEA.
- the sodium and TEA soaps are blended with the other ingredients except fragrance and heated to 85 degrees C. When homogeneous, the mixture is cooled, fragrance is added during cooling.
- the mixture is a hard soap at room temperature, and is a liquid above 80°C with a viscosity of only about 19 cP at 85 degrees C and 2.5 1/seconds shear rate on a cone & plate viscometer.
- a layered, laminated article is prepared using a first layer of the tufted web of Example 18, an interior layer which is the web of Example 33, and two layers of the creped web of Example 30.
- the lathering surfactant component is heated to 80°C and sprayed onto the center layer at a rate of 3 grams per finished article on the side facing the batting, prior to sealing the layers together.
- the layers are then sealed through the surfactant component, and cut into a square about 150 cm 2 to finish the article.
- a dual textured lathering cloth for cleansing the body in a shower is prepared.
- a lathering surfactant component is prepared from the following ingredients:
- Example 35 The ingredients are processed in the same manner as Example 35.
- a layered, laminated article is prepared using a first layer of the tufted web of Example 19, an interior layer which is the batting of Example 37, and an exterior layer of the same batting.
- the lathering surfactant component is slot coated in stripes between the batting layers at a rate of 4.0 grams per finished article and is finished in the same manner as Example 35.
- Example 39
- a dual textured lathering cloth for cleansing the body in a shower is prepared.
- a lathering surfactant component comprising 33.1% active surfactants is prepared from the following ingredients.
- a web is prepared by sealing together two layers of the tufted web of Example 20, and a layer of the web of Example 33, with the side formed at the highest temperature facing away from the cloth interior.
- the lathering surfactant component which has a low viscosity, is sprayed onto the web at a rate of 12 grams per finished article and the web is dried using forced hot air to a water content of about 5%.
- the web is cut into rectangular shapes having an area of about 270 cm 2 to create finished articles.
- Examples 40-43 Lathering surfactant components are prepared for Examples 40-43 having the following percentages.
- webs are laminated according to the following table, without the surfactant component.
- the layers are sealed together using point bonds in a grid pattern with a heat sealing die utilizing a pressure- platen heat sealing device such as a Sentinel Model 808 heat sealer available from Sencorp, Hyannis, Mass.
- the point bonds measure about 4 mm diameter each and are spaced at 2 cm intervals in a hexagonal array.
- the laminates are cut into rectangles having an area of about 270 cm 2 .
- the examples are finished by coating the surfactant components onto the laminated webs.
- the surfactant components are heated to reduce viscosity and, drawn into a syringe, and coated through the rougher side of the web (Examples 40-42) or onto the surface of the rougher side (Example 43) at a rate of 3.8 grams per finished article.
- Examples 44-47 are finished by coating the surfactant components onto the laminated webs.
- the surfactant components are heated to reduce viscosity and, drawn into a syringe, and coated through the rougher side of the web (Examples 40-42) or onto the surface of the rougher side (Example 43) at a rate of 3.8 grams per finished article. Examples 44-47
- the following chemical components are prepared and used for Examples 44-47 articles, which are useful for cleaning the face, especially removing makeup, at the sink.
- the component phase B is prepared in water and the petrolatum emulsified into the component phase B at 75 °C to make a 25% solids aqueous mixture of phase A + B, which is the surfactant component for these examples.
- the formula shown does not include the added water.
- Component phase C is prepared by mixing the ingredients separately.
- Articles are prepared by dipping webs into a trough of the surfactant component, running the webs through a nip roll to meter the surfactant to the appropriate add-on rate, spraying on component phase C, and drying the cloth in a forced air oven to a moisture content of about 11%.
- the surfactant component is added at a rate of 86 grams per square meter of web (gsm).
- Component C is added at the rate of 6.6 gsm.
- the webs used for Examples 44-47 are as follows:
- the webs are cut into rectangles having rounded corners and a surface area of about 275 cm 2 .
- Lathering, face cleansing articles are prepared.
- the surfactant component of Examples 44-47 is prepared in the same manner except the petrolatum is left out, and the surfactant component is prepared at 25% solids.
- Articles are prepared by spraying the surfactant component onto the webs at a rate of 39 gsm, drying the web to about 11% moisture content, and spraying petrolatum onto the web at a rate of 4.5 gsm (Example 48), 9.1 gsm (Example 49) and 13.5 gsm (Example 50).
- Component C is added at the same rate as Examples 46-49.
- the webs used for Examples 48-50 are as follows.
- Example 51 The webs are cut into rectangles having rounded corners and a surface area of about 275 cm 2 .
- Example 51
- a fragrance free cloth is prepared useful for washing the face and removing makeup.
- the surfactant component of Examples 48-50 is prepared and sprayed onto a web at the rate of 30 gsm (i.e., about 7.5 gsm chemicals). No petrolatum or fragrance is added to the web.
- the web used is the web of Example 28. The web is dried and cut in the manner of the previous example.
- Example 52
- a wet lathering cloth is prepared, useful for washing the face and removing makeup.
- the cloth of Example 21 is prepared having a surface area of about 365 cm 2 .
- the surfactant component (25% solids) of Example 48 is sprayed onto the cloth at the rate of 63 gsm.
- Thirty cloths are prepared identically, folded in half, stacked, and packaged in a hermetically sealed wrap having good vapor barrier properties. The wrap is placed in a tub with a snap lid. The article can be used as a wipe or activated with additional fluid to produce lather.
- Example 53
- a dual textured lathering cloth for cleansing the body in a shower is prepared.
- a lathering surfactant component is prepared.
- Shave 53.0 gm of a bar soap which includes the following components:
- Example 54 Mix the bar soap shavings with 37.0 gm glycerin (99.7% pure), 9.5 gm water, and 0.5 gm perfume. Heat mixture to 200°F while stirring continuously. Cold-mill mixture on a standard 3- roll mill to make a homogeneous surfactant paste.
- An article of the present invention is prepared using the web of Example 15 on one side, two center webs which are the web of Example 30, and the web of Example 11 on the other exterior side. 3.5 grams of the surfactant paste of the current example is extruded in 3 stripes between the webs of Example 30. The article is sealed using the Sentinel Model 808 sealer with point bonds in rows, the rows avoiding the surfactant stripes.
- Example 54 Example 54
- a dual textured lathering cloth for cleansing the body in a shower is prepared.
- a dry, powdered lathering surfactant component is prepared by dry blending the following ingredients in a high speed shearing mixer. Perfume is added last, spraying onto the powder once the powder is homogeneous.
- Example 55 The tufted webs of Example 14 and Example 12 are cut to matching 150 cm 2 ovals and bonded at the edges and in the center point using the Sencorp Model 808 heat sealer with 3.0 grams of the surfactant component in the center, and stored in a sealed container.
- Example 55
- Example 5 The spunbond, tufted webs of Examples 7 and 13 are bonded in the same manner as the previous example, with 3 grams of the same surfactant component in the center. Petrolatum is sprayed onto one side of the web of Example 7 at the rate of 2 grams per cloth.
- Example 56
- a cleansing article useful for cleansing the face is prepared.
- the tufted webs of Examples 8 and 11 are bonded in the same manner as the previous example, with 0.5 grams of the same surfactant component in the center.
- Lanolin, wax (Rita Corp) is sprayed onto one side of the web of Example 11 at the rate of 2 grams per cloth.
- Example 57
- the surfactant component of Example 54 is prepared.
- the surfactant component is mixed with a 50/50 mixture of Lanolin wax and Petrolatum in a ratio of 2 parts surfactant component to 1 part lipid mixture by melting the lipid mixture and adding to the surfactant component as it is being agitated in a high shear mixer.
- a layered article is prepared with the web of Example 4 on one side and the web of Example 17 on the other exterior side, and the webs of Example 5 and 9 layered in the center. 5 grams of the surfactant component is spread between the two center webs, and the webs are bonded at the edges and center using the Sencorp sealer.
- the lipid ingredients added help the dry ingredients to keep from migrating around the cloth, and also serve to extend the duration of lathering activity of the surfactant component.
- a commercial body wash is obtained which has about 16%> active surfactants.
- the body wash is distributed by Bath & Body Works and comprises water, sodium laureth sulfate, lauraminde DEA, TEA cocoyl glutamate, cocamidopropyl betaine, fragrance, sodium PCA, aloe leaf juice, carica papaya fruit extract, propylene glycol, polyquaternium-10, preservatives, fragrance, PEG-150 distearate, sodium chloride and colors.
- a layered article is prepared by bonding with ultrasonic point bonds the web of Example 6 on one side, the foam of Example 32 in the center, and the batting of Example 33 on the bottom.
- the bonded webs are soaked in the commercial body wash, which is added to the webs at the rate of 1100 gsm.
- the webs are dried in a forced air oven, turning them over when partially dry and wiping excess body wash back onto the web as it is turned. After drying to about 16% moisture, the web is cut into rectangles measuring 11.9 cm x 9.0 cm.
- a combination shampoo and skin cleansing article is prepared.
- the following ingredients are blended together, heated to 60°C, the pH is adjusted to 6.5, and the mixture cooled to room temperature.
- Example 5 The web of Example 5 is bonded to the web of Example 33 using point bonds, and is cut into 192 cm 2 rectangles. Fourteen grams of the ingredient mixture is added to the article and the article is dried to a water content of less than 10%. The article is useful for cleansing the hair and skin and is tear-free composition, not irritating to the eyes and mucosae.
- Example 60 The web of Example 5 is bonded to the web of Example 33 using point bonds, and is cut into 192 cm 2 rectangles. Fourteen grams of the ingredient mixture is added to the article and the article is dried to a water content of less than 10%. The article is useful for cleansing the hair and skin and is tear-free composition, not irritating to the eyes and mucosae.
- Example 60 Example 60
- a skin conditioning article with sunscreen is prepared comprising the following chemical components.
- the Sepigel is mixed with the CD 9040 until homogeneous.
- the titanium dioxide is milled into the water then slowly added to the Sepigel phase with stirring.
- the sunscreens are mixed together at 40°C until homogeneous, and added to the other ingredients with stirring.
- the fragrance is added and the mixture cooled to ambient.
- a cloth is prepared having deformations on both sides of a web.
- the web is comprised of 5 denier spunbond Polyethylene (PE)/Polypropylene (PP) bicomponent fibers in a core-sheath configuration and has a basis weight of 80 gsm, and is manufactured and sold by BBA Fibrous Nonwovens, Simpsonville, SC, USA under the trade name Softex ®.
- a top plate is prepared having rows of teeth with a tooth height (TH) of 0.145 in., a Tooth Length (TL) of 0.050 in., an in-row spacing between teeth (TD) of 0.0625 in., and a pitch (P) of 0.060 in.
- a bottom plate is prepared having offset rows which interlock with the top plate, the teeth of the bottom row having TL of 0.25 in.
- the teeth of the bottom row are arranged to form a macroscopic pattern of rectangular arrays, three parallel arrays forming a square, with adjacent squares having alternating, orthogonal direction of the long axis of the array, in order to give the article the appearance of an embroidered cloth.
- the chemical components are loaded onto the cloth at the rate of 400 gsm. Cloths are stacked and packaged. The article is useful for transferring the sunscreen composition to skin, and gives the skin a soft feel.
- a conditioning article is prepared for application of emollient material to dry skin.
- the webs of Example 9 and Example 10 are thermally bonded using point bonds using a Sentinel Model 808 heat sealer from Sencorp. Petrolatum is heated to 90 degrees C and sprayed onto the side of Example 9 web with a paint sprayer at an add-on rate of 280 gsm. Rectangular articles measuring 124 cm 2 area are cut. The articles are useful for moisturizing dry skin and can be used in the shower, or on dry skin.
- a water-free skin wiping article is prepared which comprises a water-free emulsion component useful for moisturizing and cleansing the skin comprising the following ingredients.
- Example 63 The web of Example 14 is prepared, and the emulsion component added to the web at an add-on rate of 240 gsm. The web is cut into rectangular articles 275 cm 2 in size.
- Example 63 The web of Example 14 is prepared, and the emulsion component added to the web at an add-on rate of 240 gsm. The web is cut into rectangular articles 275 cm 2 in size.
- a facial treatment mask that is either wet or dry.
- the web is dried.
- the web is wet.
- the facial treatment mask is prepared by mixing Phase A until homogeneous, then combining Phase B and adding the combination to Phase A and, additionally add a preservative. Stir in slowly the Salcare, mixing until uniform.
- the mixture is coated onto a web at the rate of 800 gsm add-on, the web comprised of 5 denier spunbond Polyethylene (PE)/Polypropylene (PP) bicomponent fibers in a core-sheath configuration with a basis weight of 80 gsm, manufactured and sold by BBA Fibrous Nonwovens, Simpsonville, SC, USA under the trade name Softex®.
- the web is dried by convection to a water content of 8%.
- the coated web is tufted at a line speed of 10 ⁇ m using the toothed roll and rolls described in Example 1, with the same 0.135 in. engagement (E). Articles are cut measuring 15 cm square. Articles are used by wetting with warm water and placing them as a mask on the face with the looped side against the skin.
- Example 64 Example 64
- the component is prepared using a standard emulsion procedure and milling the pigments into the water phase with the Polysorbate 80 as the first step, being careful not to aerate the component.
- the pH is adjusted to 7.5 as a final step.
- the foundation component is applied to the web of Example 14 at the rate of 400 gsm and cut into 2.5 in. diameter circles and packaged in a hermetically sealed package.
- the articles are used to apply colored cosmetics to the skin and as an antiwrinkle treatment.
- a baby wipe is prepared from the following chemical component. 500 grams of the chemical component is prepared.
- Example 66 The mixture is sprayed onto the looped web of Example 14 at an add-on rate of 600%.
- the treated cloths are packaged in a conventional plastic tub with a lid and are useful for wiping the skin, removing soil from baby bottoms effectively while being very soft to the skin during wiping.
- Example 66
- a wipe is prepared which is useful for removing makeup, which does not require additional water.
- a chemical component is prepared from the following ingredients:
- Example 67 The chemical component is sprayed onto the looped web of Example 14 at an add-on rate of 300%.
- the treated wipes of this example are packaged in a hermetically sealed flexible package with a fitment snap opening closure.
- Example 67
- a skin sanitizing wiping article is prepared.
- a chemical component is prepared from the following ingredients by dispersing the Carbopol in water, sequentially adding each ingredient while stirring to maintain a homogeneous mixture. The pH is adjusted to 6.5.
- Example 68 The chemical component is added to the looped web of Example 7 at an add-on rate of 550%) and cloths are packaged in a flexible wipes package. The article is useful for cleansing and sanitizing the skin.
- Example 68 The chemical component is added to the looped web of Example 7 at an add-on rate of 550%) and cloths are packaged in a flexible wipes package. The article is useful for cleansing and sanitizing the skin.
- An applicator wipe which is a self tanning skin care composition is prepared comprising a chemical component prepared from the following ingredients:
- Phase A is heated to 75 °C
- Phase B is heated separately and added to Phase A while mixing until uniform. Fragrance is added during cooling.
- the chemical component is added to the looped web of Example 7 at an add-on rate of 600% and cloths are packaged in a flexible wipes package.
- a wet wipe is prepared which is useful for incontinent patient bathing, requiring no rinsing.
- a chemical component is prepared, comprising the following ingredients:
- a body cleansing kit is prepared.
- the tufted web of Example 14 is prepared and cut into 300 cm 2 square cloths with rounded corners.
- the cloths are stacked and shrink wrapped in groups of 30 cloths.
- a commercial body wash is obtained, for example Oil of Olay Moisturizing Body Wash 700 ml size, manufactured and distributed by The Procter & Gamble Co, Cincinnati, OH, USA.
- Three stacks of cloths are shrink wrapped a second time with a single bottle of body wash, constituting a kit comprising about 3 months supply of body wash with disposable washcloths.
- a face cleansing kit is prepared.
- the tufted web of Example 7 is prepared and cut into 270 cm 2 square cloths.
- a kit is prepared comprising a 200 ml jar of a cold cream banded to a group of 30 cloths. No water is required when using the kit to cleanse makeup from the face.
- a body cleansing kit is prepared.
- the tufted web of Example 7 is prepared and cut into 275 cm 2 cloths.
- a kit is prepared comprising a bar of soap and a group of 30 cloths, which are shrink wrapped together as a unit. The kit constitutes about a 1 month supply of individual, disposable washcloths and soap.
- a pet care kit is prepared.
- the tufted web which is disclosed in Example 60 is prepared and cut to 270 cm 2 size. Fifteen cloths are banded together and shrink wrapped to a 350 ml bottle of pet shampoo comprising the following ingredients: water, sodium laureth sulfate, cocamidopropyl betaine, decyl glucoside, polyuquaternium-7, fragrance, DMDM hydantoin, tetrasodium EDTA, sodium chloride, citric acid, benzophenone-4, D&C Green No. 5 and FD&C Yellow No. 5.
- the kit is useful for lathering and cleaning pets, and is used with an external water supply.
- a dual textured lathering article is prepared using the webs of Example 39 and the surfactant component of Example 36. Five grams of the surfactant component is, melted and applied in 4 stripes to the center of the layers prior to sealing the FQN web layers to the Avgol polypropylene layer. A rectangular article measuring 270 cm 2 is cut. The article has a Steady Flash Lather Value of about 1,330 ml and a Steady Total Lather Value of about 4,020 ml. The article is useful for producing a steady stream of lather when used in an environment where the supply of water is steady, i.e., a shower.
- a dual textured lathering article is prepared using the webs of Example 39, which are bonded together in the absence of a chemical component and cut to the same size as the previous example.
- a chemical component is prepared comprising the following ingredients:
- Example 77 The ingredients are stirred, the cationic polymer added last and stirred until homogeneous with no lumps present.
- the chemical component is added to the bonded web at a rate of 12.4 grams per article.
- the article is dried overnight in still air at 125°F until it has lost 6.3 grams of water per article.
- the article has a Steady Flash Lather Value of about 1,530 ml and a Steady Total Lather Value of about 3,570 ml.
- Example 77 The ingredients are stirred, the cationic polymer added last and stirred until homogeneous with no lumps present.
- the chemical component is added to the bonded web at a rate of 12.4 grams per article.
- the article is dried overnight in still air at 125°F until it has lost 6.3 grams of water per article.
- the article has a Steady Flash Lather Value of about 1,530 ml and a Steady Total Lather Value of about 3,570 ml.
- a dual textured lathering article is prepared using the webs of Example 39 and the surfactant component of Example 36. Five grams of the surfactant component is melted and applied in 4 stripes to the center of the layers prior to sealing the FQN web layers to the Avgol polypropylene layer. A rectangular article measuring 270 cm 2 is cut. The article has a Steady Flash Lather Value of about 1,330 ml and a Steady Total Lather Value of about 4,020 ml. The article is useful for producing a steady stream of lather when used in an environment where the supply of water is steady, i.e., a shower.
- a dual textured lathering article is prepared using the webs of Example 39, which are bonded together in the absence of a chemical component and cut to the same size as the previous example.
- a chemical component is prepared comprising the following ingredients:
- the ingredients are stirred, the cationic polymer added last and stirred until homogeneous with no lumps present.
- the chemical component is added to the bonded web at a rate of 12.4 grams per article.
- the article is dried overnight in still air at 125°F until it has lost 6.3 grams of water per article.
- the article has a Steady Flash Lather Value of 1,530 ml and a Steady Total Lather Value of 3,570 ml. Examples 79-84
- Facial cleansing cloths are prepared.
- a surfactant component is prepared from the following ingredients, which is 25% active in surfactant:
- Webs are prepared as indicated below using the webs from previous examples and the surfactant component sprayed onto the web at the indicated amounts.
- the webs are dried using forced air until dry to the touch, about 5% moisture content based on the total weight.
- Petrolatum is striped onto the web in two one-inch wide stripes at the rate of 0.167 grams per linear inch (gli) per stripe.
- a perfume phase comprising a mixture of polyethylene glycol 4600, beta cyclodexfrin, fragrance, menthol and water & sodium MA/Diisobutylene Copolymer is added to the web at a rate of 6.6 gsm.
- the web is cut into 7.5 inch x 6.25 inch cloths and packaged.
- the cloths have the following Mechanical Lather Volume.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Mechanical Engineering (AREA)
- Manufacturing & Machinery (AREA)
- Birds (AREA)
- Textile Engineering (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
- Nonwoven Fabrics (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005509994A JP4058073B2 (ja) | 2002-12-20 | 2003-12-16 | 布状のパーソナルケア用品 |
MXPA05006592A MXPA05006592A (es) | 2002-12-20 | 2003-12-16 | Articulos tipo tela para el cuidado personal. |
EP03814118A EP1572147A1 (fr) | 2002-12-20 | 2003-12-16 | Article d'hygiene personnelle du type tissu |
AU2003301011A AU2003301011A1 (en) | 2002-12-20 | 2003-12-16 | Cloth-like personal care articles |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32466102A | 2002-12-20 | 2002-12-20 | |
US10/324,661 | 2002-12-20 | ||
US46964303P | 2003-05-12 | 2003-05-12 | |
US43599603A | 2003-05-12 | 2003-05-12 | |
US60/469,643 | 2003-05-12 | ||
US10/435,996 | 2003-05-12 | ||
US61029903A | 2003-06-30 | 2003-06-30 | |
US10/610,299 | 2003-06-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004058214A1 true WO2004058214A1 (fr) | 2004-07-15 |
Family
ID=32686256
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/040232 WO2004058214A1 (fr) | 2002-12-20 | 2003-12-16 | Article d'hygiene personnelle du type tissu |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1572147A1 (fr) |
JP (1) | JP4058073B2 (fr) |
AU (1) | AU2003301011A1 (fr) |
MX (1) | MXPA05006592A (fr) |
WO (1) | WO2004058214A1 (fr) |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004112734A2 (fr) * | 2003-06-13 | 2004-12-29 | The Procter & Gamble Company | Article de nettoyage presentant une maniabilite amelioree |
WO2005063192A1 (fr) * | 2003-12-22 | 2005-07-14 | Unilever Plc | Dispositifs de soin d'hygiene personnelle contenant une composition de nettoyage et de soin de la peau, cette composition etant stable et reactive |
WO2006009997A2 (fr) * | 2004-06-21 | 2006-01-26 | The Procter & Gamble Company | Voile non tisse boucle |
WO2006038965A1 (fr) * | 2004-09-30 | 2006-04-13 | Kimberly-Clark Worldwide, Inc. | Compositions rafraichissantes pour la peau |
JP2006188514A (ja) * | 2004-12-28 | 2006-07-20 | Johnson & Johnson Consumer Co Inc | 皮膚手入れ用物品および皮膚手入れ方法 |
WO2010141309A1 (fr) * | 2009-06-03 | 2010-12-09 | The Procter & Gamble Company | Voile de fibres structuré |
WO2010141642A1 (fr) * | 2009-06-03 | 2010-12-09 | The Procter & Gamble Company | Nappe fibreuse structurée perméable au fluide |
WO2010141578A1 (fr) * | 2009-06-03 | 2010-12-09 | The Procter & Gamble Company | Réseau fibreux structuré |
EP2386672A3 (fr) * | 2010-04-21 | 2011-11-23 | Johnson & Johnson Consumer Companies, Inc. | Plaquette poreuse en mousse pour une utilisation avec un dispositif motorisé |
US8168550B2 (en) | 2006-11-30 | 2012-05-01 | The Procter & Gamble Company | Extensible nonwoven webs containing monocomponent nanocomposite fibers |
US8173559B2 (en) | 2006-11-30 | 2012-05-08 | The Procter & Gamble Company | Extensible nonwoven webs containing multicomponent nanocomposite fibers |
WO2013035072A1 (fr) * | 2011-09-08 | 2013-03-14 | Vile Glenn | Nanofibres bioactives |
GB2495109A (en) * | 2011-09-29 | 2013-04-03 | Gama Healthcare Ltd | A wet wipe impregnated with an aqueous alkyl glucoside and /or alkyl polyglucoside mixture |
WO2016040101A1 (fr) * | 2014-09-12 | 2016-03-17 | The Procter & Gamble Company | Matériau non tissé présentant des déformations tridimensionnelles distinctes à larges ouvertures au niveau de la base |
WO2016040104A1 (fr) * | 2014-09-12 | 2016-03-17 | The Procter & Gamble Company | Matériau non tissé comportant des déformations tridimensionnelles discrètes formant des protubérances ayant une largeur variable et des ouvertures de base larges |
WO2016040115A1 (fr) * | 2014-09-12 | 2016-03-17 | The Procter & Gamble Company | Matériau de non-tissé comportant des déformations tridimensionnelles distinctes avec de larges ouvertures de base et des concentrations de fibre spécifiques |
US9359585B2 (en) | 2003-12-08 | 2016-06-07 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Stable nonaqueous reactive skin care and cleansing compositions having a continuous and a discontinuous phase |
US10064766B2 (en) | 2014-09-12 | 2018-09-04 | The Procter & Gamble Company | Nonwoven material having discrete three-dimensional deformations that are configured to collapse in a controlled manner |
US10076898B2 (en) | 2014-09-12 | 2018-09-18 | The Procter & Gamble Company | Apparatus having forming members with surface texture for making nonwoven material having discrete three-dimensional deformations with wide base openings |
US10610423B2 (en) | 2016-03-08 | 2020-04-07 | The Procter & Gamble Company | Absorbent article comprising a topsheet/acquisition web laminate |
EP3288512B1 (fr) | 2015-04-27 | 2022-01-19 | Medtrade Products Limited | Pansement |
WO2022073601A1 (fr) * | 2020-10-07 | 2022-04-14 | Essity Hygiene And Health Aktiebolag | Tampon nettoyant pour la peau traité avec une lotion nettoyante auto-émulsifiante appropriée pour le démaquillage |
WO2022073602A1 (fr) * | 2020-10-07 | 2022-04-14 | Essity Hygiene And Health Aktiebolag | Tampon de nettoyage de la peau traité avec une lotion de nettoyage appropriée pour le démaquillage |
US11696856B2 (en) | 2017-03-09 | 2023-07-11 | The Procter & Gamble Comoany | Three-dimensional materials having apertures and voids |
US11839531B2 (en) | 2014-09-10 | 2023-12-12 | The Procter And Gamble Company | Nonwoven webs with hydrophobic and hydrophilic layers |
WO2024026088A1 (fr) * | 2022-07-29 | 2024-02-01 | Kimberly-Clark Worldwide, Inc. | Procédé de formation de matériaux non tissés multicouches avec des projections topographiques par retrait différentiel |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0520319B1 (pt) * | 2005-06-21 | 2015-11-03 | Procter & Gamble | manta fibrosa com tufos, artigo absorvente descartável, manta multicamada com tufos, aparelho para formação de uma manta fibrosa de material e método para fabricação de uma manta com tufos |
US20100312208A1 (en) * | 2009-06-03 | 2010-12-09 | Eric Bryan Bond | Fluid Permeable Structured Fibrous Web |
US20100310810A1 (en) * | 2009-06-03 | 2010-12-09 | Eric Bryan Bond | Structured Fibrous Web |
JP5999754B2 (ja) * | 2012-02-28 | 2016-09-28 | 大王製紙株式会社 | 吸収性物品用シート状素材及びこれを用いた吸収性物品、並びに吸収性物品用シート状素材の製造方法 |
WO2014045680A1 (fr) * | 2012-09-20 | 2014-03-27 | 株式会社エバメール化粧品 | Feuille cosmétique d'essuyage et son procédé de fabrication |
JP5946487B2 (ja) * | 2013-04-01 | 2016-07-06 | 花王株式会社 | 毛髪化粧品並びにそれを用いた毛髪処理方法及び頭皮の清拭方法 |
JP5828490B2 (ja) * | 2014-03-28 | 2015-12-09 | 花王株式会社 | シート状毛髪化粧品及びそれを用いた毛髪処理方法 |
JP5828491B2 (ja) * | 2014-03-28 | 2015-12-09 | 花王株式会社 | シート状毛髪化粧品及びそれを用いた毛髪処理方法 |
US10271997B2 (en) * | 2014-04-08 | 2019-04-30 | The Procter & Gamble Company | Absorbent articles having substrates having zonal treatments |
US9872543B2 (en) * | 2015-05-29 | 2018-01-23 | Velcro BVBA | Loop fastening material |
US10010142B2 (en) * | 2015-05-29 | 2018-07-03 | Velcro BVBA | Loop fastening material |
GB2579948B (en) * | 2017-08-31 | 2021-04-14 | Kao Corp | Nonwoven fabric |
GB2577821B (en) * | 2017-08-31 | 2021-01-06 | Kao Corp | Nonwoven fabric |
CN110832129B (zh) * | 2017-08-31 | 2022-03-22 | 花王株式会社 | 无纺布 |
JP6623206B2 (ja) * | 2017-12-26 | 2019-12-18 | 花王株式会社 | 不織布の製造方法 |
Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3695270A (en) * | 1970-01-22 | 1972-10-03 | Int Playtex Corp | Sanitary tampon |
US3929678A (en) | 1974-08-01 | 1975-12-30 | Procter & Gamble | Detergent composition having enhanced particulate soil removal performance |
US4035881A (en) * | 1974-03-12 | 1977-07-19 | Josef Zocher | Method and apparatus for producing non-woven textile product |
US4379799A (en) | 1981-02-20 | 1983-04-12 | Chicopee | Nonwoven fabric having the appearance of apertured, ribbed terry cloth |
US4465726A (en) | 1983-06-23 | 1984-08-14 | Chicopee | Ribbed terry cloth-like nonwoven fabric and process and apparatus for making same |
US4557853A (en) | 1984-08-24 | 1985-12-10 | The Procter & Gamble Company | Skin cleansing compositions containing alkaline earth metal carbonates as skin feel agents |
WO1991016034A1 (fr) | 1990-04-26 | 1991-10-31 | The Procter & Gamble Company | Compositions chelatrices comprenant des composes d'oxime |
WO1991016035A1 (fr) | 1990-04-26 | 1991-10-31 | The Procter & Gamble Company | Compositions chelatrices comprenant des composes d'alpha-diamine |
US5069897A (en) | 1987-10-16 | 1991-12-03 | The Proctor & Gamble Company | Antiperspirant creams |
WO1994002674A1 (fr) * | 1992-07-27 | 1994-02-03 | The Procter & Gamble Company | Compresses de traitement a plusieurs couches et a deux textures |
US5487884A (en) | 1987-10-22 | 1996-01-30 | The Procter & Gamble Company | Photoprotection compositions comprising chelating agents |
WO1997039733A1 (fr) | 1996-04-23 | 1997-10-30 | The Procter & Gamble Company | Methodes de traitement et d'amelioration de l'aspect de la peau au moyen d'un compose a la vitamine b¿3? |
US5686082A (en) | 1992-12-24 | 1997-11-11 | L'oreal | Cosmetic or pharmaceutical composition containing a combination of a polyphenol and a ginkgo extract |
US5686367A (en) | 1995-02-14 | 1997-11-11 | Tdk Corporation | Semiconducting ceramic composition having positive temperature coefficient of resistance and production process thereof |
WO1999025318A1 (fr) | 1997-11-19 | 1999-05-27 | The Procter & Gamble Company | Articles de type serviettes d'hygiene corporelle, dotes d'une douceur amelioree |
US6217889B1 (en) | 1999-08-02 | 2001-04-17 | The Proctor & Gamble Company | Personal care articles |
US6280757B1 (en) | 1997-05-22 | 2001-08-28 | The Procter & Gamble Company | Cleansing articles for skin or hair |
EP1136050A1 (fr) * | 2000-03-22 | 2001-09-26 | McNEIL-PPC, INC. | Films microporeux comprenant des fibres floquées |
US20020029445A1 (en) * | 1997-07-02 | 2002-03-14 | Karlheinz Stein | Structure textile material made of at least two base nonwoven fabrics and method for its manufacture |
GB2384789A (en) * | 2002-01-30 | 2003-08-06 | Modetex Fiber Textile Ind Corp | Method for making a cosmetic sheet product |
EP1350456A1 (fr) * | 2002-04-06 | 2003-10-08 | Accantia Holdings Limited | Tissu et application de ce tissu |
-
2003
- 2003-12-16 AU AU2003301011A patent/AU2003301011A1/en not_active Abandoned
- 2003-12-16 MX MXPA05006592A patent/MXPA05006592A/es unknown
- 2003-12-16 WO PCT/US2003/040232 patent/WO2004058214A1/fr active Application Filing
- 2003-12-16 EP EP03814118A patent/EP1572147A1/fr not_active Withdrawn
- 2003-12-16 JP JP2005509994A patent/JP4058073B2/ja not_active Expired - Fee Related
Patent Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3695270A (en) * | 1970-01-22 | 1972-10-03 | Int Playtex Corp | Sanitary tampon |
US4035881A (en) * | 1974-03-12 | 1977-07-19 | Josef Zocher | Method and apparatus for producing non-woven textile product |
US3929678A (en) | 1974-08-01 | 1975-12-30 | Procter & Gamble | Detergent composition having enhanced particulate soil removal performance |
US4379799A (en) | 1981-02-20 | 1983-04-12 | Chicopee | Nonwoven fabric having the appearance of apertured, ribbed terry cloth |
US4465726A (en) | 1983-06-23 | 1984-08-14 | Chicopee | Ribbed terry cloth-like nonwoven fabric and process and apparatus for making same |
US4557853A (en) | 1984-08-24 | 1985-12-10 | The Procter & Gamble Company | Skin cleansing compositions containing alkaline earth metal carbonates as skin feel agents |
US5069897A (en) | 1987-10-16 | 1991-12-03 | The Proctor & Gamble Company | Antiperspirant creams |
US5487884A (en) | 1987-10-22 | 1996-01-30 | The Procter & Gamble Company | Photoprotection compositions comprising chelating agents |
WO1991016034A1 (fr) | 1990-04-26 | 1991-10-31 | The Procter & Gamble Company | Compositions chelatrices comprenant des composes d'oxime |
WO1991016035A1 (fr) | 1990-04-26 | 1991-10-31 | The Procter & Gamble Company | Compositions chelatrices comprenant des composes d'alpha-diamine |
WO1994002674A1 (fr) * | 1992-07-27 | 1994-02-03 | The Procter & Gamble Company | Compresses de traitement a plusieurs couches et a deux textures |
US5686082A (en) | 1992-12-24 | 1997-11-11 | L'oreal | Cosmetic or pharmaceutical composition containing a combination of a polyphenol and a ginkgo extract |
US5686367A (en) | 1995-02-14 | 1997-11-11 | Tdk Corporation | Semiconducting ceramic composition having positive temperature coefficient of resistance and production process thereof |
WO1997039733A1 (fr) | 1996-04-23 | 1997-10-30 | The Procter & Gamble Company | Methodes de traitement et d'amelioration de l'aspect de la peau au moyen d'un compose a la vitamine b¿3? |
US6280757B1 (en) | 1997-05-22 | 2001-08-28 | The Procter & Gamble Company | Cleansing articles for skin or hair |
US20020029445A1 (en) * | 1997-07-02 | 2002-03-14 | Karlheinz Stein | Structure textile material made of at least two base nonwoven fabrics and method for its manufacture |
WO1999025318A1 (fr) | 1997-11-19 | 1999-05-27 | The Procter & Gamble Company | Articles de type serviettes d'hygiene corporelle, dotes d'une douceur amelioree |
US6217889B1 (en) | 1999-08-02 | 2001-04-17 | The Proctor & Gamble Company | Personal care articles |
EP1136050A1 (fr) * | 2000-03-22 | 2001-09-26 | McNEIL-PPC, INC. | Films microporeux comprenant des fibres floquées |
GB2384789A (en) * | 2002-01-30 | 2003-08-06 | Modetex Fiber Textile Ind Corp | Method for making a cosmetic sheet product |
EP1350456A1 (fr) * | 2002-04-06 | 2003-10-08 | Accantia Holdings Limited | Tissu et application de ce tissu |
Non-Patent Citations (11)
Title |
---|
"International Cosmetic Ingredient Dictionary", vol. 1, 1993, pages: 415 - 417 |
"International Cosmetic Ingredient Dictionary", vol. 1, 1993, pages: 537 |
"McCutcheon's, Detergents and Emulsifiers", 1986, ALLURED PUBLISHING CORPORATION |
"McCutcheon's, Functional Materials", 1992, NORTH AMERICAN EDITION |
"Solubility Effects in Product, Package, Penetration, and Preservation", COSMETICS AND TOILETRIES, vol. 103, October 1988 (1988-10-01), pages 47 - 69 |
"The CTFA Cosmetic Ingredient Handbook", 1992 |
"The Merck Index", vol. 7047, 1983, pages: 1033 |
"The Merck Index", vol. 7048, 1983, pages: 1033 |
RIEDEL: "The Encyclopedia Americana", vol. 11, 1987, NONWOVEN WORLD, article "Nonwoven Bonding Methods and Materials", pages: 147 - 153 |
SAGARIN, COSMETICS AND TOILETRIES, vol. 102, 1987, pages 21 |
SCHINDLER, DRUG. COSMET. IND., 1961, pages 89 |
Cited By (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004112734A3 (fr) * | 2003-06-13 | 2005-03-03 | Procter & Gamble | Article de nettoyage presentant une maniabilite amelioree |
WO2004112734A2 (fr) * | 2003-06-13 | 2004-12-29 | The Procter & Gamble Company | Article de nettoyage presentant une maniabilite amelioree |
US9359585B2 (en) | 2003-12-08 | 2016-06-07 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Stable nonaqueous reactive skin care and cleansing compositions having a continuous and a discontinuous phase |
US7846462B2 (en) | 2003-12-22 | 2010-12-07 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Personal care implement containing a stable reactive skin care and cleansing composition |
WO2005063192A1 (fr) * | 2003-12-22 | 2005-07-14 | Unilever Plc | Dispositifs de soin d'hygiene personnelle contenant une composition de nettoyage et de soin de la peau, cette composition etant stable et reactive |
US8357383B2 (en) | 2003-12-22 | 2013-01-22 | Conopco, Inc. | Personal care implement containing a stable reactive skin care and cleansing composition |
US8986721B2 (en) | 2003-12-22 | 2015-03-24 | Unilever Home & Personal Care Usa Division Of Conopco, Inc. | Personal care implement containing a stable reactive skin care and cleansing composition |
WO2006009997A2 (fr) * | 2004-06-21 | 2006-01-26 | The Procter & Gamble Company | Voile non tisse boucle |
JP2008503656A (ja) * | 2004-06-21 | 2008-02-07 | ザ プロクター アンド ギャンブル カンパニー | ループ不織布ウェブ |
WO2006009997A3 (fr) * | 2004-06-21 | 2006-03-23 | Procter & Gamble | Voile non tisse boucle |
WO2006038965A1 (fr) * | 2004-09-30 | 2006-04-13 | Kimberly-Clark Worldwide, Inc. | Compositions rafraichissantes pour la peau |
JP2006188514A (ja) * | 2004-12-28 | 2006-07-20 | Johnson & Johnson Consumer Co Inc | 皮膚手入れ用物品および皮膚手入れ方法 |
US8173559B2 (en) | 2006-11-30 | 2012-05-08 | The Procter & Gamble Company | Extensible nonwoven webs containing multicomponent nanocomposite fibers |
US8168550B2 (en) | 2006-11-30 | 2012-05-01 | The Procter & Gamble Company | Extensible nonwoven webs containing monocomponent nanocomposite fibers |
WO2010141642A1 (fr) * | 2009-06-03 | 2010-12-09 | The Procter & Gamble Company | Nappe fibreuse structurée perméable au fluide |
CN102458330A (zh) * | 2009-06-03 | 2012-05-16 | 宝洁公司 | 结构化纤维网 |
CN102458333A (zh) * | 2009-06-03 | 2012-05-16 | 宝洁公司 | 结构化纤维网 |
US9439816B2 (en) | 2009-06-03 | 2016-09-13 | The Procter & Gamble Company | Structured fibrous web |
WO2010141578A1 (fr) * | 2009-06-03 | 2010-12-09 | The Procter & Gamble Company | Réseau fibreux structuré |
US8759606B2 (en) | 2009-06-03 | 2014-06-24 | The Procter & Gamble Company | Structured fibrous web |
WO2010141309A1 (fr) * | 2009-06-03 | 2010-12-09 | The Procter & Gamble Company | Voile de fibres structuré |
RU2497492C2 (ru) * | 2009-06-03 | 2013-11-10 | Дзе Проктер Энд Гэмбл Компани | Проницаемое для жидкости структурированное волокнистое полотно |
US9045847B2 (en) | 2010-04-21 | 2015-06-02 | Johnson & Johnson Consumer Companies, Inc. | Foaming porous pad for use with a motorized device |
US9080267B2 (en) | 2010-04-21 | 2015-07-14 | Johnson & Johnson Consumer Companies, Inc. | Foaming porous pad for use with a motorized device |
EP2386672A3 (fr) * | 2010-04-21 | 2011-11-23 | Johnson & Johnson Consumer Companies, Inc. | Plaquette poreuse en mousse pour une utilisation avec un dispositif motorisé |
US8308702B2 (en) | 2010-04-21 | 2012-11-13 | Johnson & Johnson Consumer Companies, Inc. | Foaming porous pad for use with a motorized device |
WO2013035072A1 (fr) * | 2011-09-08 | 2013-03-14 | Vile Glenn | Nanofibres bioactives |
GB2495109B (en) * | 2011-09-29 | 2016-06-08 | Gama Healthcare Ltd | A wet wipe |
GB2495109A (en) * | 2011-09-29 | 2013-04-03 | Gama Healthcare Ltd | A wet wipe impregnated with an aqueous alkyl glucoside and /or alkyl polyglucoside mixture |
US8853143B2 (en) | 2011-09-29 | 2014-10-07 | Gama Healthcare Limited | Wet wipe |
US11839531B2 (en) | 2014-09-10 | 2023-12-12 | The Procter And Gamble Company | Nonwoven webs with hydrophobic and hydrophilic layers |
US10045889B2 (en) | 2014-09-12 | 2018-08-14 | The Procter & Gamble Company | Nonwoven material having discrete three-dimensional deformations with wide base openings and specific fiber concentrations |
US10182949B2 (en) | 2014-09-12 | 2019-01-22 | The Procter & Gamble Company | Nonwoven material having discrete three-dimensional deformations with wide base openings that are base bonded to additional layer |
CN106687087A (zh) * | 2014-09-12 | 2017-05-17 | 宝洁公司 | 具有形成带有变化的宽度和宽基部开口的突起部的离散的三维变形部的非织造材料 |
CN106687091A (zh) * | 2014-09-12 | 2017-05-17 | 宝洁公司 | 具有带有宽基部开口的离散的三维变形部的非织造材料 |
WO2016040104A1 (fr) * | 2014-09-12 | 2016-03-17 | The Procter & Gamble Company | Matériau non tissé comportant des déformations tridimensionnelles discrètes formant des protubérances ayant une largeur variable et des ouvertures de base larges |
US10045888B2 (en) | 2014-09-12 | 2018-08-14 | The Procter & Gamble Company | Nonwoven material having discrete three-dimensional deformations with wide base openings |
US10064766B2 (en) | 2014-09-12 | 2018-09-04 | The Procter & Gamble Company | Nonwoven material having discrete three-dimensional deformations that are configured to collapse in a controlled manner |
US10076898B2 (en) | 2014-09-12 | 2018-09-18 | The Procter & Gamble Company | Apparatus having forming members with surface texture for making nonwoven material having discrete three-dimensional deformations with wide base openings |
US10105268B2 (en) | 2014-09-12 | 2018-10-23 | The Procter & Gamble Company | Nonwoven material having discrete three-dimensional deformations with differential opacity regions |
WO2016040115A1 (fr) * | 2014-09-12 | 2016-03-17 | The Procter & Gamble Company | Matériau de non-tissé comportant des déformations tridimensionnelles distinctes avec de larges ouvertures de base et des concentrations de fibre spécifiques |
US10500826B2 (en) | 2014-09-12 | 2019-12-10 | The Procter & Gamble Company | Method of making nonwoven material having discrete three-dimensional deformations with wide base openings |
WO2016040101A1 (fr) * | 2014-09-12 | 2016-03-17 | The Procter & Gamble Company | Matériau non tissé présentant des déformations tridimensionnelles distinctes à larges ouvertures au niveau de la base |
CN106687091B (zh) * | 2014-09-12 | 2020-08-04 | 宝洁公司 | 具有带有宽基部开口的离散的三维变形部的非织造材料 |
EP3288512B1 (fr) | 2015-04-27 | 2022-01-19 | Medtrade Products Limited | Pansement |
US10610423B2 (en) | 2016-03-08 | 2020-04-07 | The Procter & Gamble Company | Absorbent article comprising a topsheet/acquisition web laminate |
US11696856B2 (en) | 2017-03-09 | 2023-07-11 | The Procter & Gamble Comoany | Three-dimensional materials having apertures and voids |
WO2022073601A1 (fr) * | 2020-10-07 | 2022-04-14 | Essity Hygiene And Health Aktiebolag | Tampon nettoyant pour la peau traité avec une lotion nettoyante auto-émulsifiante appropriée pour le démaquillage |
WO2022073602A1 (fr) * | 2020-10-07 | 2022-04-14 | Essity Hygiene And Health Aktiebolag | Tampon de nettoyage de la peau traité avec une lotion de nettoyage appropriée pour le démaquillage |
WO2024026088A1 (fr) * | 2022-07-29 | 2024-02-01 | Kimberly-Clark Worldwide, Inc. | Procédé de formation de matériaux non tissés multicouches avec des projections topographiques par retrait différentiel |
Also Published As
Publication number | Publication date |
---|---|
EP1572147A1 (fr) | 2005-09-14 |
JP4058073B2 (ja) | 2008-03-05 |
MXPA05006592A (es) | 2005-08-16 |
JP2006520324A (ja) | 2006-09-07 |
AU2003301011A1 (en) | 2004-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8877316B2 (en) | Cloth-like personal care articles | |
JP4058073B2 (ja) | 布状のパーソナルケア用品 | |
CN100396271C (zh) | 布状个人护理制品 | |
DE60026533T2 (de) | Körperpflegeartikel mit vliesstoff | |
US7115551B2 (en) | Cleansing articles for skin or hair | |
DE60015926T3 (de) | Wasser-abfluss begrenzende reinigungsartikel | |
CN101495019B (zh) | 个人清洁制品及清洁皮肤或毛发的方法 | |
US6638527B2 (en) | Substantially dry cleansing product of improved latherability and wet flexibility | |
DE60110135T2 (de) | Vorrichtungen mit texturierter Folie | |
BRPI0502821B1 (pt) | produto absorvente para o cuidado pessoal e/ou de limpeza para aplicações cosméticas e/ou dermatológicas, conjunto de produto absorvente e seu uso | |
CZ2002330A3 (cs) | Výrobky osobní péče | |
MXPA02001299A (es) | Articulos para cuidado personal. | |
JP2005530740A (ja) | 識別可能な活性ゾーンを有している身体手入れ用製品 | |
US20030228352A1 (en) | Cleansing articles for skin or hair | |
MXPA02007297A (es) | Articulos de limpieza que comprenden areas de beneficio aisladas. | |
KR20020063893A (ko) | 한정된 침출 값을 나타내는 친수성 컨디셔닝제를 함유하는퍼스널 케어 물품 | |
US20050202068A1 (en) | Disposable nonwoven mitt | |
US20150272836A1 (en) | Total body baby wipe | |
KR20020063895A (ko) | 양이온성 고분자 코아세르베이트 조성물을 함유하는퍼스널 케어 물품 | |
JP2002306367A (ja) | 身体清浄用シート | |
MXPA06010333A (en) | A disposable nonwoven mitt | |
KR20050019122A (ko) | 피부 또는 모발용 세정 물품 | |
MXPA00002591A (en) | Cleansing and conditioning article for skin or hair |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003814118 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2005/006592 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005509994 Country of ref document: JP Ref document number: 20038A69663 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1-2005-501084 Country of ref document: PH |
|
WWP | Wipo information: published in national office |
Ref document number: 2003814118 Country of ref document: EP |